completeness_percent,publisher,quality_score,pid,error_percent,id,weighted_error_percent,weighted_quality_rating,schema_version,title,quality_rating,weighted_quality_score,weighted_completeness_percent
4.76,,29.12,11dee486-22d2-4cf4-a955-512249e61645,46.51,0056a5c8-4f98-4e9e-b74a-bd498be71c0d,46.03,Not Rated,1.1.7,KPIC,Not Rated,29.36,4.76
19.05,,33.95,602cbc9b-0113-4712-8c4a-0efe8d86b77c,51.16,00a784aa-ea3a-4a57-9612-81b0745e0763,50.79,Not Rated,1.1.7,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - Wales,Not Rated,41.27,33.33
19.05,,33.95,24de9d1a-1f48-4c10-b8fc-a3bd7449e191,51.16,00e1b694-3072-4d25-ab2d-a1de59629ae3,50.79,Not Rated,1.1.7,Mental Health Inpatient and Day Case - Scottish Morbidity Record (SMR04),Not Rated,41.27,33.33
50.0,ALLIANCE > HQIP,61.05,b0979e07-3331-408f-853b-5eeba80ce8f9,27.91,00ffee70-43d6-4a81-8568-32b0b6d9e39c,26.98,Not Rated,1.1.7,National Paediatric Diabetes Audit - Parent and Patient Recorded Experience measures,Not Rated,59.52,46.03
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,19fa25a7-c15d-441c-b635-ad49043e7a96,18.6,0121c132-5be6-414e-853b-885ff301854f,17.46,Bronze,1.1.7,PTCL Biobank,Bronze,71.43,60.32
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,399a6d67-7577-4476-a3b6-4bbceb5a8ff7,16.28,01470238-7a17-47a5-a131-17178ba26a0a,15.87,Bronze,1.1.7,Human Developmental Biology Resource (HDBR),Silver,72.22,60.32
19.05,,31.62,ea1aca1f-6ddb-44a0-b530-0645a26b2bee,55.81,01a5c44c-c2fd-4c1e-856e-9875ee1beafa,60.32,Not Rated,1.1.7,BathTAP Switching Cohort 2,Not Rated,36.5,33.33
19.05,,30.45,,58.14,01eb52c3-3f21-4e31-8b27-5e70327543b2,65.08,Not Rated,1.1.7,UK Biobank,Not Rated,34.12,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,21044030-1cd5-46b1-b072-c9959fd330b4,16.28,0315886c-f34a-4f1d-8f76-2dfa80a6e949,15.87,Bronze,1.1.7,Cam-UroOnc Biorepository,Silver,72.22,60.32
28.57,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,48.0,4dfec37d-dd24-465f-85ea-30209aff3a26,32.56,039c0b29-63f6-4ce9-8d89-87012a52e44f,33.33,Not Rated,1.1.7,The Leicester City and County Chronic Kidney Disease Cohort,Not Rated,45.24,23.81
61.9,HUB > BREATHE,70.48,2f1244b8-7cbf-4fa3-8534-433efd769d48,20.93,03abf37c-41b2-4ff3-9c09-2cfea438526a,20.63,Bronze,1.1.7,"4 Country ChrOnic: estimating respiratory disease burden in adults, South India",Bronze,66.67,53.97
19.05,,32.78,becd2624-9a01-4f01-bcf8-56e94545a49a,53.49,03b7acd5-ecfe-4cd6-a6dc-bf9e3f98c772,55.56,Not Rated,1.1.7,National Asthma and COPD Audit (NACAP): Adult Asthma secondary care clinical,Not Rated,38.88,33.33
19.05,,32.78,1fb479b1-98d4-4d7b-91a2-8368ce3dc77c,53.49,03cdf92e-b6ea-4e1d-a861-e9da4372ed36,55.56,Not Rated,1.1.7,NIHR BioResource: Consent records,Not Rated,38.88,33.33
59.52,OTHER > UNIVERSITY COLLEGE LONDON,64.64,529f126b-660c-4c31-aeb2-765dac1d9df0,30.23,03fb3b18-4419-44f7-a035-9ddfecfcadfc,36.51,Not Rated,1.1.7,COVIDsortium,Not Rated,65.87,68.25
16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,e653b264-3e44-4ed1-a376-86df45db7f72,37.21,0477b06f-cbed-4949-982e-ce248a47ed1a,36.51,Not Rated,1.1.7,SOLUS,Not Rated,38.89,14.29
92.86,HUB > DISCOVER NOW,87.13,ed08c844-343e-44fa-a02d-3ad5ecf25184,18.6,04f22c93-53df-440a-a71a-50d6827450bc,22.22,Gold,1.1.7,North West London COVID-19 Patient Level Situation Report (NWL COVID19 SITREP),Gold,87.31,96.83
19.05,,32.78,f2af20f9-af84-40ce-8a07-7d095948653e,53.49,04f28919-aa6c-4beb-b186-0ad0043c1c6c,55.56,Not Rated,1.1.7,NIHR IBD BioResource: Sample holding,Not Rated,38.88,33.33
26.19,ALLIANCE > HQIP,44.49,1982d9ef-890a-41ff-a86a-de61d65aaa09,37.21,04fb4aac-415b-4493-986b-65bbef5214d3,36.51,Not Rated,1.1.7,National Asthma and COPD Audit Programme (NACAP):COPD and adult asthma secondary care organisational dataset,Not Rated,42.86,22.22
95.24,ALLIANCE > SAIL,90.64,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef,13.95,05716e41-9842-4c07-8ddd-af9f9231e056,15.87,Gold,1.1.7,Bowel Screening Wales,Gold,92.06,100.0
95.24,ALLIANCE > SAIL,89.48,dc22db56-8791-4e96-9ce6-6b6a58b1241f,16.28,05a0baf4-72ea-4e02-b4fb-64c37bb1eb0e,20.63,Gold,1.1.7,COVID-19 Shielded People list,Gold,89.69,100.0
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,edd55990-a616-4a9c-a4a2-38af136a349b,16.28,0664f988-276e-4268-af43-1986a3101f38,15.87,Bronze,1.1.7,INCA Trial,Silver,72.22,60.32
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,01492322-9b33-41cc-9f51-484024e45878,16.28,069c213c-eb04-463e-a300-7614c03cf623,15.87,Bronze,1.1.7,HCV Research UK,Silver,72.22,60.32
92.86,HUB > PIONEER,87.13,0eb789bb-0047-46ac-83ff-631f31e98da0,18.6,06dee089-8c10-4a8b-aa94-7cb699dc3c80,19.05,Gold,1.1.7,"OMOP dataset: Hospital COVID patients: severity, acuity, therapies, outcomes",Gold,89.68,98.41
16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,5f45bcd1-970b-44ba-8ae2-0fb49b85ffa9,37.21,0711cc7e-80d5-4781-a1ab-2637ea176ceb,36.51,Not Rated,1.1.7,Millennium Clinical Events,Not Rated,38.89,14.29
80.95,HUB > BREATHE,84.66,bb8de9d2-cc38-4c40-b104-ffd167f64f76,11.63,0715a950-3999-46d8-a646-6496866638a1,12.7,Silver,1.1.7,Prospective Observation of Fibrosis in the Lung Clinical Endpoints,Silver,79.37,71.43
19.05,,33.95,602cbc9b-0113-4712-8c4a-0efe8d86b77c,51.16,077a21b9-5c5a-4c68-a9f0-b4fa3384aead,50.79,Not Rated,1.1.7,COVID-19 Sequence Data,Not Rated,41.27,33.33
19.05,,32.78,da91f0eb-1761-485b-8b7f-9121b6a1d004,53.49,0786f8b9-77b1-4bc4-8464-28c664298adb,55.56,Not Rated,1.1.7,Cancer Network Information System (CNIS / CANISC),Not Rated,38.88,33.33
76.19,HUB > PIONEER,75.31,323dc330-aad9-472a-b579-ab66f5f75906,25.58,07e3ac82-a38d-45f3-9933-07439f6a761d,25.4,Silver,1.1.7,The impact of COVID on hospitalised patients with COPD; a dataset in OMOP,Bronze,79.36,84.13
19.05,,33.95,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b,51.16,084ab1d8-78f6-4c04-b829-6891c6463ca9,50.79,Not Rated,1.1.7,Breast Test Wales (SBTW),Not Rated,41.27,33.33
80.95,ALLIANCE > SAIL,80.01,e4004e0e-6adb-4b11-82c2-af0caf61d751,20.93,08846261-45f0-4bcf-9801-fe785dcef1c9,22.22,Silver,1.1.7,Careers Wales dataset,Silver,83.34,88.89
4.76,,29.12,a2eddb27-c8bd-42ae-94f8-2a3026220da3,46.51,089a0dd5-b2bd-4152-8033-d53552fe2c80,46.03,Not Rated,1.1.7,Klang Asthma Cohort,Not Rated,29.36,4.76
19.05,,32.78,0e903b9e-a329-478a-937c-480eecee4996,53.49,08bffe91-46aa-4718-ab3a-9e9b60353ea2,55.56,Not Rated,1.1.7,National Joint Registry - Primary Shoulder Replacement dataset,Not Rated,38.88,33.33
19.05,,32.78,419e5a82-2d82-48a7-a8f3-a83e64a54e92,53.49,08d1a4f5-92b0-4142-a38d-8bac734086e8,55.56,Not Rated,1.1.7,Tayside Pathology,Not Rated,38.88,33.33
19.05,,32.78,750063ea-6bfd-4492-9748-2a18080cf6ea,53.49,0910383a-44d6-4652-98da-550df7204416,55.56,Not Rated,1.1.7,NHS Tayside and Fife Accident & Emergency Dataset (ISD/National),Not Rated,38.88,33.33
73.81,HUB > PIONEER,74.12,86632207-1e57-4272-b178-ea069a13cae1,25.58,0942304f-8b91-4258-af9c-3a1801c7e79f,25.4,Silver,1.1.7,The acute presentation of pregnant women to non-maternity Emergency departments,Bronze,78.57,82.54
4.76,,29.12,834618f3-0c6d-4ed2-abae-39208c6b3080,46.51,0969dc51-1ab9-469a-8b35-3ec63f30fa89,46.03,Not Rated,1.1.7,National Cardiac Audit Programme - National Heart Failure Audit,Not Rated,29.36,4.76
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,1fdf266c-d5d8-418d-a423-81265da540a2,16.28,097cc6bd-ce98-47ec-a73d-5d2c250f2697,15.87,Bronze,1.1.7,ICON9 Trial,Silver,72.22,60.32
19.05,,32.78,4b8286e2-c4e4-4db4-8fd9-5f1c8b4e56de,53.49,09d1cc0f-4b4d-4525-853a-012ece4a1ab2,55.56,Not Rated,1.1.7,National Joint Registry - Revision Hip Replacement dataset,Not Rated,38.88,33.33
4.76,,29.12,6b2aca2c-b03a-44ba-80a1-883b744421b6,46.51,09f04291-670d-4db0-a3e4-7e0d84555231,46.03,Not Rated,1.1.7,Development of ELISA and Rapid Testing Kits for COVID-19,Not Rated,29.36,4.76
4.76,,29.12,df288318-6663-417d-9870-666e75920bed,46.51,0a137eec-4288-400b-8c47-0275319c9f09,46.03,Not Rated,1.1.7,Lothian Birth Cohort 1921 (LBC1921),Not Rated,29.36,4.76
95.24,ALLIANCE > SAIL,89.48,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,16.28,0abfceb7-5a56-4559-b0d4-88326e0331a3,20.63,Gold,1.1.7,Pathology Data from WRRS,Gold,89.69,100.0
19.05,,32.78,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,53.49,0ac16d3d-5ca8-4e25-ad46-ce8e03a04e17,55.56,Not Rated,1.1.7,Pathology Data from WRRS (PATH) - Legacy,Not Rated,38.88,33.33
78.57,NCS > OFFICE FOR NATIONAL STATISTICS,76.5,2f66bcf9-e626-4e8d-bc6e-2d3958e709d8,25.58,0ac9438e-da8d-4488-bdc6-8285d1401b1d,28.57,Silver,1.1.7,Census 2011 E&W - Household structure for COVID-19 models,Silver,78.57,85.71
19.05,,31.62,d5c0cc93-3347-46f0-b8dd-f44e82718e38,55.81,0af73a56-5683-4072-99c0-01c84355d0d0,60.32,Not Rated,1.1.7,Mental Health Dataset (MHDS) for CPRD GOLD,Not Rated,36.5,33.33
4.76,,29.12,9d242d12-2d2e-4941-93e4-9ec40d239dd1,46.51,0b06a5c0-f015-4ce6-bf53-cab304334ae0,46.03,Not Rated,1.1.7,Determinants of Adolescent Social Wellbeing & Health (DASH),Not Rated,29.36,4.76
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,ebe6c9dd-fb95-4301-a929-c21b8077753a,18.6,0b7ea326-fc05-4aca-a962-3f93128b91d1,19.05,Bronze,1.1.7,HPB Biobank,Bronze,70.64,60.32
19.05,,33.95,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,51.16,0b835c3e-9968-4f12-8aad-c4f10a7d460f,50.79,Not Rated,1.1.7,Welsh Demographic Service Dataset (WDSD),Not Rated,41.27,33.33
19.05,,33.95,4c33a5d2-164c-41d7-9797-dc2b008cc852,51.16,0bffc029-b739-4974-8855-8912a152834a,50.79,Not Rated,1.1.7,Patient Episode Dataset for Wales (PEDW),Not Rated,41.27,33.33
66.67,HUB > BREATHE,74.03,de496590-26b3-4e74-bc5e-1ff5c83f5b43,18.6,0c219a61-a1d6-4c5b-bec2-3537454e4137,19.05,Bronze,1.1.7,Teleconsultation in remote rural India: management of COPD and Asthma,Bronze,69.05,57.14
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,35985f8e-f01a-41cc-a9e2-30299d3d6eed,18.6,0c50801d-1079-4879-b608-5e8f112b313f,19.05,Bronze,1.1.7,Tissue Access for Patient Benefit (TAPb),Bronze,70.64,60.32
71.43,HUB > BREATHE,77.58,25bc9862-5b6c-4dda-80b2-46642d9e518a,16.28,0c78d1cf-4ba6-44f4-adcf-16c15142d8fb,19.05,Bronze,1.1.7,Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II),Silver,69.84,58.73
19.05,,32.78,291c0dd4-0988-42d2-8e0b-878a892add57,53.49,0c8fcf41-177b-4ca8-a01f-d86ca8bd5a03,55.56,Not Rated,1.1.7,Substance Misuse Dataset (SMDS),Not Rated,38.88,33.33
47.62,ALLIANCE > NHS DIGITAL,57.53,f3bb6a68-2c32-40a7-9a79-61a718068893,32.56,0c98200b-48b5-418a-b8d0-a7708abc1f39,30.16,Not Rated,1.1.7,Mental Health Services Data Set - Community,Not Rated,57.94,46.03
19.05,,31.62,51b41359-1558-48df-9950-88f75ca6ac4c,55.81,0cd32bab-357b-4ea2-bba0-eca90b7b36e9,60.32,Not Rated,1.1.7,"Problem, Diagnosis and Procedures",Not Rated,36.5,33.33
4.76,,29.12,ae1898da-7fe5-4fe0-b10d-9f06cdec1735,46.51,0d65fabc-6cb0-4a77-a01d-cb341b0b053c,46.03,Not Rated,1.1.7,NIHR IBD BioResource: NHS Trust data,Not Rated,29.36,4.76
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,12288034-00a4-47a8-a779-1cf7a55270e4,16.28,0d6ab9af-c43b-490d-b39c-2d72de46a661,15.87,Bronze,1.1.7,The Cleft Collective,Silver,73.81,63.49
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,6f1b9a4e-2367-47f1-a985-3ed9bf3a7211,16.28,0d70b5c8-da5d-49c5-8ff5-0bdc7b5f6306,15.87,Bronze,1.1.7,MRC Brain Banks Network,Silver,72.22,60.32
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,8648d251-6186-4383-82fc-c036a87c3842,16.28,0d79e0d8-9b3d-4450-9c34-0539673dc9a5,15.87,Bronze,1.1.7,Leeds NIHR Biomarker Research Tissue Bank,Silver,72.22,60.32
19.05,,32.78,32edd77d-533c-423f-b045-937507f8505d,53.49,0ddb1d67-e0b9-4b08-898c-9957a09d7e69,55.56,Not Rated,1.1.7,Renal Register – PHS National Dataset,Not Rated,38.88,33.33
73.81,HUB > DATA-CAN,70.62,616c4488-65a5-4608-a187-0c6bc78b359a,32.56,0ddcb454-2372-4180-9ba0-a7e1896d4fe2,33.33,Bronze,1.1.7,Real Time Data Network (RTDN),Bronze,73.02,79.37
71.43,ALLIANCE > NHS DIGITAL,71.76,2ed7bbbc-80db-46c2-a45b-632dda40794b,27.91,0e07413c-892c-4f06-bd22-2a917eb5c905,30.16,Bronze,1.1.7,Cancer Registration Data,Bronze,74.61,79.37
64.29,ALLIANCE > NHS DIGITAL,60.05,29c61f09-c4a1-425f-9bbc-888c23d99516,44.19,0e6e6ed5-ab81-4d7f-b06a-768bf33357ca,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v4 (Sensitive) Episodes,Not Rated,64.28,77.78
19.05,,33.95,ae3fd121-141d-466b-b002-06c3959116d0,51.16,0e9e034a-913a-4764-8615-961c3647b268,50.79,Not Rated,1.1.7,"Cancer and cerebrovascular events: frequency, cancer types and outcomes",Not Rated,41.27,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,c0dcceca-c8cf-4269-a0e0-0c18b6ba2de1,16.28,0ecedaa2-e8f5-4eb2-ad3f-fc2ce433fc36,15.87,Bronze,1.1.7,Cardamon Clinical Trial Samples,Silver,72.22,60.32
19.05,,33.95,656b2c22-9e57-4f15-9b3c-1969da6495ca,51.16,0efcd6ce-4e7a-4f8e-8903-1a987ec76b1c,50.79,Not Rated,1.1.7,Better Rx BRIT2 Patient GP Dataset,Not Rated,41.27,33.33
4.76,,29.12,2b640175-725a-465f-9aec-6794e6d27791,46.51,0f1a2789-e8b3-4e36-9622-65d76cebff26,46.03,Not Rated,1.1.7,National Cardiac Audit Programme -  Congenital Heart Disease Audit (NCHDA),Not Rated,29.36,4.76
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,b5533cb5-0c59-495b-9b11-3c401daeb958,16.28,0faa4c3e-edf5-4ae8-9b26-c59c98e26b57,15.87,Bronze,1.1.7,UKALL14 Trial,Silver,72.22,60.32
64.29,ALLIANCE > NHS DIGITAL,60.05,9c8bd383-b117-4167-a25c-9e15fa5ec1c6,44.19,0fc61ace-397d-4489-9e62-77f88082e775,49.21,Not Rated,1.1.7,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Events,Not Rated,64.28,77.78
4.76,,29.12,949d9d7a-a3f1-480a-8563-3fb024300561,46.51,1045ca85-0c8f-453b-9da3-778144cf3744,46.03,Not Rated,1.1.7,"National Audit of Dementia - spotlight audit on  psychotropic medication, 2019",Not Rated,29.36,4.76
19.05,,32.78,c0fc84af-aeab-4c7e-aa0b-8264baff55d9,53.49,1046cc4d-bd35-43de-a156-80bddb3eb415,55.56,Not Rated,1.1.7,COVID-19 Test Trace and Protect (CTTP),Not Rated,38.88,33.33
19.05,,33.95,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf,51.16,108d652d-3afb-4001-8ae6-b5a42e8b2daa,50.79,Not Rated,1.1.7,NHS 111 Dataset (NHSO),Not Rated,41.27,33.33
19.05,,32.78,61a607a9-b404-41e0-a52e-0c6d0ce8c2be,53.49,1096dcb8-2a9d-49bb-a455-35e657c1e1a2,55.56,Not Rated,1.1.7,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (GOLD),Not Rated,38.88,33.33
19.05,,33.95,a95beeb8-9316-442c-8699-22fc4b2170e5,51.16,10bd5205-5d7d-4d77-baef-4a6237ce7c75,50.79,Not Rated,1.1.7,Antimicrobial prescribing surveillance data during the COVID-19 pandemic,Not Rated,41.27,33.33
4.76,,29.12,27e1ffc7-5804-40e2-83e2-93f570906127,46.51,112db000-f69f-47a4-8dd7-db7b6d839e68,46.03,Not Rated,1.1.7,Bangladesh Asthma Hajj Study,Not Rated,29.36,4.76
19.05,,32.78,3d2d9c5e-6111-4583-a6db-07affd628f1e,53.49,115109e7-9a35-420f-831e-0707bc96375c,55.56,Not Rated,1.1.7,UK SARS-CoV-2 viral sequencing data (COG-UK) - Lineage/Variant Data - NI,Not Rated,38.88,33.33
28.57,ALLIANCE > HQIP,48.0,01ad25ed-8cde-43d7-bc77-d8cc3d165df4,32.56,1199f5b5-99f0-4aae-9769-ab754f05dcdb,33.33,Not Rated,1.1.7,National Maternity and Perinatal Audit Organisational Survey 2019,Not Rated,45.24,23.81
19.05,,33.95,9890eee9-44d4-49f7-8674-16c05a5f82e0,51.16,125202ff-1d00-4f8e-96e1-1d5a310ab326,50.79,Not Rated,1.1.7,2019 UK Parkinson's Audit - Occupational therapy,Not Rated,41.27,33.33
19.05,,32.78,62903826-acfc-4d60-9010-cd70b4f556c1,53.49,126b50ad-d0c8-4c75-a477-69420d4601b4,55.56,Not Rated,1.1.7,Lighthouse,Not Rated,38.88,33.33
4.76,,29.12,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2,46.51,12d62b02-2167-407d-acdb-6ddb9d251d36,46.03,Not Rated,1.1.7,NIHR IBD BioResource: SNP imputation data,Not Rated,29.36,4.76
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,38fe1a10-ebf9-4dc1-8c35-2e7b33b1f6b5,18.6,12dba445-dfa9-46af-abc0-5bd3701061a7,17.46,Bronze,1.1.7,UK primary Sjogren's syndrome Registry,Bronze,71.43,60.32
19.05,,32.78,4352ef1c-67d7-4f2e-b256-1efaac61dacd,53.49,131ccbe5-28dc-4abf-8a44-05f470d1be1d,55.56,Not Rated,1.1.7,"Cataract surgery and visual outcomes at QE Hospital, Birmingham, UK",Not Rated,38.88,33.33
19.05,,32.78,af10ec29-1866-4726-b33f-3948afe182f2,53.49,135f2650-ea0c-4cad-80ac-c86449a176a8,55.56,Not Rated,1.1.7,Tayside Radiology,Not Rated,38.88,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,47fc8f03-eba1-4efa-ae3e-148a76b56517,18.6,1406c52a-e5d6-4c57-883d-62e405eb604a,17.46,Bronze,1.1.7,Manchester Eye Tissue Repository,Bronze,71.43,60.32
61.9,HUB > BREATHE,70.48,bcbc41cb-99f7-482e-ba3d-561164abbd4e,20.93,1450ff1a-4526-4a6e-b9e9-25969878449d,22.22,Not Rated,1.1.7,COPDMAP Consortium,Bronze,64.28,50.79
54.76,HUB > BREATHE,69.24,e3ca35c1-b2e2-4479-adf1-6a78b1c8c088,16.28,145916c8-d3ca-4465-a719-93dd0770a6e4,17.46,Not Rated,1.1.7,Optimum Patient Care Research Database,Bronze,64.28,46.03
19.05,,32.78,3efd9b30-1f84-48c0-a3e0-402ecb5c7724,53.49,147576e2-b445-4d36-aecc-d604302bd34e,55.56,Not Rated,1.1.7,National Asthma and COPD Audit  (NACAP): secondary care  – CYP asthma (org),Not Rated,38.88,33.33
95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,34f0c2bd-d42e-4441-a89b-e0e384f12afa,20.93,148ebbaa-28f4-42e0-a27f-8587e516c3bf,30.16,Silver,1.1.7,Cystic Fibrosis Patient Sweat Tests,Gold,84.92,100.0
19.05,,33.95,3326d554-ca11-4dc6-aff0-c5b314442d27,51.16,14a90909-997f-4676-ae52-e19c01670e23,50.79,Not Rated,1.1.7,Practice postcode linked deprivation measures for CPRD GOLD,Not Rated,41.27,33.33
95.24,ALLIANCE > SAIL,89.48,1eb67fd5-33f6-49dd-a43d-854fff9f25f5,16.28,15805559-2115-4822-b91f-635de36fb289,20.63,Gold,1.1.7,Active Adult Survey,Gold,89.69,100.0
80.95,HUB > PIONEER,77.69,5bf9bf39-3cd7-4a54-994b-9914405f945e,25.58,1584af1e-9683-4727-8c9b-9bea8beaa68d,28.57,Silver,1.1.7,UHB 2020 Winter Society of Acute Medicine Benchmarking Audit,Silver,80.16,88.89
4.76,,29.12,ea2d54a2-a6d4-4e82-b2e4-95184f00bbdc,46.51,15aebc30-1e52-4a36-8b17-f9801f35f649,46.03,Not Rated,1.1.7,Health and Employment After Fifty (HEAF),Not Rated,29.36,4.76
95.24,GENOMICS ENGLAND,88.32,4cc5ed33-3190-4f80-953b-cabd5a2b1c7c,18.6,15efea36-d022-495c-a5b6-90f51631a643,19.05,Gold,1.1.7,GENOMICS ENGLAND 100K QUICK VIEW,Gold,90.47,100.0
83.33,ALLIANCE > ISARIC 4C,81.2,84336be3-23bd-466e-b29b-df48db897665,20.93,1638cce2-12f5-410b-9624-86d2f407c502,26.98,Silver,1.1.7,COVID-19 Clinical Information Network (CO-CIN),Silver,80.95,88.89
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,d17efe5d-325f-4fcf-b25e-87d1f6269bea,16.28,16445ebd-bd45-4ded-a7ae-05f33f676598,15.87,Bronze,1.1.7,MFT Biobank,Silver,73.81,63.49
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,c51ab59a-33ce-4145-a642-7f3f96bca545,16.28,167cc04b-23b8-4a9e-9ff9-6c8e07d6a561,15.87,Bronze,1.1.7,Cambridge Blood and Stem Cell Biobank,Silver,72.22,60.32
19.05,,33.95,27690c58-a5da-4359-909a-8e19ff6ca463,51.16,16d40748-66f1-4fc3-bdb3-7c8103cadeb7,50.79,Not Rated,1.1.7,2019 UK Parkinson's Audit - Physiotherapy,Not Rated,41.27,33.33
19.05,,31.62,9ea2f685-d6c2-49fe-a0e2-735910584d67,55.81,16f11980-e2e7-4f79-8e33-39ba4dc3547f,60.32,Not Rated,1.1.7,Suspected Cancer Pathway Daily (SPCD),Not Rated,36.5,33.33
16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,88eb839c-bc51-45f0-b15e-ea89bba9ffca,37.21,172242ce-a1c5-4915-9c71-686f6e7d5789,36.51,Not Rated,1.1.7,ARIA Medonc,Not Rated,38.89,14.29
19.05,,32.78,b88c2b24-b75d-4d28-9391-2dbac1605a17,53.49,177c34b4-b74a-406a-a73a-4250d1fb9c1b,55.56,Not Rated,1.1.7,Demography,Not Rated,38.88,33.33
80.95,HUB > PIONEER,77.69,5acfadf9-21a7-4517-a1b2-620d20469611,25.58,1785cc1a-ace0-4980-8352-5977b2b72969,28.57,Silver,1.1.7,UHB 2019 Summer Society of Acute Medicine Benchmarking Audit,Silver,80.16,88.89
19.05,,33.95,a7d8c6a8-0825-4e73-8f29-3d76194d7114,51.16,17c58f15-93ab-4239-b05a-6b9ea82f6f37,50.79,Not Rated,1.1.7,Rural-Urban classification for CPRD GOLD,Not Rated,41.27,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,e10a660d-b84c-475f-abd4-024dd1af7a5d,18.6,17cd75a2-e2b5-440c-89b1-22c9f3b03a03,17.46,Bronze,1.1.7,IoN Trial,Bronze,71.43,60.32
19.05,,32.78,a29feafa-7bdd-44e9-b977-c9d26425e67f,53.49,185c4410-cea3-4bac-a192-1e1dd8842872,55.56,Not Rated,1.1.7,CPRD GOLD,Not Rated,38.88,33.33
19.05,,32.78,9a36f3f8-3b7e-4e61-8993-b9cc2734fcb8,53.49,18e2ce4c-b0a0-4f2b-a12c-0d18bb1a165a,55.56,Not Rated,1.1.7,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - England,Not Rated,38.88,33.33
95.24,ALLIANCE > GENOMICS ENGLAND,89.48,98999c67-0133-4f11-be95-b84ee5727c84,16.28,1900af1a-bd21-4157-ac48-203eec682073,20.63,Gold,1.1.7,GENOMICS ENGLAND 100K BIOINFORMATICS DATA,Gold,89.69,100.0
19.05,,32.78,bcf6e5ce-986d-4b84-9c9c-69de966e8bbd,53.49,19525c5f-92ee-41b6-bb79-673624b27bdd,55.56,Not Rated,1.1.7,Improving Access to Psychological Therapies Data Set,Not Rated,38.88,33.33
19.05,,32.78,70e37f44-5c3e-4c83-a42a-89b3476d1d45,53.49,199b8c9f-baf2-4eb8-a8fe-783f58eceb2e,55.56,Not Rated,1.1.7,COVID-19 Consolidated Deaths (CDDS),Not Rated,38.88,33.33
4.76,,29.12,2fea047c-ae65-43d5-a1e3-43447981c165,46.51,1a2ecd43-745f-4a67-acd6-27023f1f9c5b,46.03,Not Rated,1.1.7,3CN (Cirrhosis Cohort),Not Rated,29.36,4.76
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,c9f82f86-79e1-4067-932f-5e6dc939006d,16.28,1a412ff0-6275-4cab-a485-bb76befc7afe,15.87,Bronze,1.1.7,UK real-world lymphoid tissue bank,Silver,73.81,63.49
95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,9cf5dbd3-a109-4e8d-b1bb-7e4126bd887f,20.93,1a4b65e9-5241-4081-9cbb-43a8c8c6ea3b,30.16,Silver,1.1.7,Cystic Fibrosis Patient CFQ-R,Gold,84.92,100.0
19.05,,33.95,36886b21-12ff-45e7-82bc-fb5308c12450,51.16,1bafa55c-5616-47db-8ac8-798038146254,50.79,Not Rated,1.1.7,"Diabetic Eye Screening: the Birmingham, Solihull and Black Country Data Set",Not Rated,41.27,33.33
28.57,ALLIANCE > HQIP,46.84,4559a14f-563d-4fd2-93ae-27c6c0fd891e,34.88,1bbcb128-dd3e-4f56-81d5-17df2dab3c52,34.92,Not Rated,1.1.7,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - contextual data,Not Rated,44.45,23.81
19.05,,32.78,5362cfea-d554-43ba-916a-4460da39cc0c,53.49,1c524f7c-ee22-4bdc-877b-8dddc03e3aa2,55.56,Not Rated,1.1.7,Deaths General Registrar Office – National Records Scotland,Not Rated,38.88,33.33
4.76,,29.12,185e9c5c-e686-4174-bcba-5e2f584b5cbb,46.51,1ca52b96-27d9-491a-b5f0-5787852d39d2,46.03,Not Rated,1.1.7,Sero-surveillance to monitor the trend of SARS-CoV-2 infection in rural India,Not Rated,29.36,4.76
54.76,HUB > BREATHE,65.75,3b378225-48e1-45fa-b62d-fc4ed4b39bec,23.26,1cb397d5-a86d-4354-b1f7-565b7ef5054b,23.81,Not Rated,1.1.7,Asthma self-management behaviour in Bangladesh and Pakistan,Not Rated,61.11,46.03
19.05,,31.62,8c60a308-1e47-4a0c-8b69-9259f05338cb,55.81,1cc3dc2c-adf3-4c66-ab7b-cfc00388a6a8,60.32,Not Rated,1.1.7,Labour Force Survey (Person),Not Rated,36.5,33.33
19.05,,32.78,826be5be-9977-49f9-b6d1-83ed9de08ebe,53.49,1d2acc70-0e2d-4601-bbbb-569a49bfaa5b,55.56,Not Rated,1.1.7,Tayside Microbiology: Tests,Not Rated,38.88,33.33
95.24,ALLIANCE > SAIL,89.48,1789286a-deaf-49df-88cd-660e92934af6,16.28,1d46f920-e253-4e7d-a72a-843d068d3c69,20.63,Gold,1.1.7,Critical Care Dataset,Gold,89.69,100.0
47.62,ALLIANCE > NHS DIGITAL,57.53,f48ad0a1-f90c-4a81-8c04-b23f2d8baf7a,32.56,1d5e3b05-8ce3-4f80-ae3a-f6031ad8cf69,30.16,Not Rated,1.1.7,Mental Health Services Data Set - Service Users,Not Rated,57.94,46.03
19.05,,31.62,0e6aaabb-0efc-4a69-a9a7-aa98888c04bd,55.81,1dc6e88f-d2de-41ab-8e40-a708dc453cdf,60.32,Not Rated,1.1.7,ICNARC - Intensive Care National Audit and Research Centre for QResearch,Not Rated,36.5,33.33
19.05,ALLIANCE > BARTS HEALTH,39.76,3ec5f1c4-95c0-4b1d-899b-399cec32ad49,39.53,1e465797-5e54-4667-9120-d373e75be64f,38.1,Not Rated,1.1.7,Somerset Cancer Registry,Not Rated,38.88,15.87
19.05,,32.78,b7152f21-0f2c-4ed9-a013-51e725242f94,53.49,1e875c15-4a99-4c3e-9621-e4ebf594469f,55.56,Not Rated,1.1.7,UK Renal Registry - CKD and AKI on Dialysis Dataset,Not Rated,38.88,33.33
19.05,,32.78,7749d90e-dd7a-4697-8a9c-666491c64a0c,53.49,1f6118ce-4051-4ba6-b13e-63dca0032d8d,55.56,Not Rated,1.1.7,Emergency Care Data Set (ECDS),Not Rated,38.88,33.33
19.05,,32.78,dc22db56-8791-4e96-9ce6-6b6a58b1241f,53.49,1fd6e7d5-266a-4c79-b492-7045910cd291,55.56,Not Rated,1.1.7,COVID-19 Shielded People List (CVSP),Not Rated,38.88,33.33
28.57,ALLIANCE > HQIP,48.0,059a6495-a7d5-435b-8e2b-806c6ccccf2e,32.56,203cc8b4-7711-4d1f-9213-af982d6cff28,33.33,Not Rated,1.1.7,Sentinel Stroke National Audit Programme Clinical Dataset,Not Rated,45.24,23.81
92.86,HUB > INSIGHT,85.97,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc,20.93,208f79dc-2294-4370-8f16-0d0f7bec9d10,23.81,Gold,1.1.7,Moorfields Eye Image Dataset Release 001,Silver,86.51,96.83
19.05,,32.78,8ba190b7-4c29-4558-a256-50e1f2242874,53.49,20e2a770-d086-4b17-858f-805bd53d18c7,55.56,Not Rated,1.1.7,CovPall - Survey of Palliative Care Services,Not Rated,38.88,33.33
80.95,ALLIANCE > SLaM,74.19,a25a9892-9141-4e78-8415-945ba73da11e,32.56,21cd4b8e-f4f5-44a6-83eb-b7799e98ba55,31.75,Bronze,1.1.7,South London and Maudsley NHS Foundation Trust (SLaM) Clinical Record Interactive Search (CRIS) platform,Bronze,69.84,71.43
4.76,,29.12,261bcf76-8621-4f0d-b2e6-310993d73daa,46.51,21d1277b-baf8-4fb8-826e-3f4910d18098,46.03,Not Rated,1.1.7,NIHR BioResource: Returned datasets,Not Rated,29.36,4.76
78.57,ALLIANCE > SAIL,76.5,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf,25.58,22173802-db99-475e-b95e-d69798734077,30.16,Silver,1.1.7,NHS 111 Dataset,Silver,77.78,85.71
19.05,,33.95,f48b7c05-6a44-480c-84c6-4f7a684f29f8,51.16,226b52f4-1be8-46c2-86a4-261eb48ec542,50.79,Not Rated,1.1.7,SAIL Dementia e-Cohort (SDEC),Not Rated,41.27,33.33
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,351cc017-caff-4303-8a48-1aa1b90fce2b,16.28,22739526-317f-4b0e-a23b-ece0c859958f,15.87,Bronze,1.1.7,QTL Programme at MRC HGU,Silver,73.81,63.49
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,c232fa07-5d28-4bdc-b540-1ad8d933c5f9,16.28,227fe0ea-d76e-4c14-a33e-ca255380937d,15.87,Bronze,1.1.7,Children's Cancer and Leukaemia Group (CCLG) Tissue Bank,Silver,72.22,60.32
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,029b7f0f-911e-46ce-837f-031959f067da,16.28,22974866-44c7-4176-9c51-6b57a1dda39d,15.87,Bronze,1.1.7,University of Liverpool - GCP Laboratory Facility,Silver,72.22,60.32
21.43,ALLIANCE > BARTS HEALTH,40.95,3598723f-62fb-4377-9a8b-b264ced1aabd,39.53,22aecb42-9ea3-4d60-b392-d3cdd0a806f8,38.1,Not Rated,1.1.7,CDE Encounters,Not Rated,40.48,19.05
95.24,GENOMICS ENGLAND,85.99,3f2b37f1-e8f7-42e5-83c4-fc9e1c58725d,23.26,239e8253-a997-4676-8940-16b74a004365,28.57,Silver,1.1.7,GENOMICS ENGLAND 100K RARE DISEASE & COMMON,Silver,85.72,100.0
19.05,,32.78,750063ea-6bfd-4492-9748-2a18080cf6ea,53.49,23d790f2-de80-4c7a-b57a-03c8467c54e9,55.56,Not Rated,1.1.7,NHS Tayside and Fife Accident & Emergency Dataset (PHS/National),Not Rated,38.88,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,d387ed7c-14fa-49e2-8ced-df0f9372eb88,18.6,24f2374a-e804-434e-a805-e29b332b0693,17.46,Bronze,1.1.7,SWIFT-RTB,Bronze,71.43,60.32
83.33,ALLIANCE > SAIL,80.03,add6226b-0f21-439a-84a6-51dc26cdc425,23.26,2550f814-0849-4d19-b83e-edef46b157fb,26.98,Silver,1.1.7,Intensive Care National Audit and Research Centre - Covid19,Silver,81.75,90.48
19.05,,32.78,0a467180-a898-44d8-a586-ca4762de362e,53.49,260f4fb2-b40a-4e20-888d-1e3c9c2ddd8e,55.56,Not Rated,1.1.7,DOLORISK,Not Rated,38.88,33.33
64.29,ALLIANCE > NHS DIGITAL,60.05,2964d1b0-2630-468a-82c1-00f5ac901b3d,44.19,263ad0a8-ae90-4c1d-85d6-c3d2470eb2b7,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v4 (Non-Sensitive) Episodes,Not Rated,64.28,77.78
64.29,ALLIANCE > NHS DIGITAL,60.05,dc37fcd6-1e68-46e5-b73d-4896e069746a,44.19,263f28a4-9835-4856-b1c3-0a0d4085f207,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v2.6 (Sensitive),Not Rated,64.28,77.78
73.81,ALLIANCE > TISSUE DIRECTORY,78.77,62fdfd1c-f195-49cc-b3a1-7d9fd2cc8e1b,16.28,263f4ce3-7ccf-45c3-9d41-c1f5ed14cc81,15.87,Bronze,1.1.7,Arden Tissue Bank,Silver,74.6,65.08
19.05,,33.95,50ef6443-ed4b-40f9-97fb-1cfd53be6579,51.16,268d54cf-189e-46ea-8f0e-71ad8907bea3,50.79,Not Rated,1.1.7,Welsh Dispensing Dataset (WDDS),Not Rated,41.27,33.33
19.05,,33.95,d2d57b7f-95d8-425f-b2fd-cc9aff05e659,51.16,26ac9d75-df76-49e5-ba41-d4c0e83a8765,50.79,Not Rated,1.1.7,Child Health Systems Programme - 27-30Months Review,Not Rated,41.27,33.33
76.19,ALLIANCE > TISSUE DIRECTORY,78.8,4883530f-1c8d-49aa-886e-ea3b958772ea,18.6,270b55a8-a9ee-44ee-8db6-eb214e721eea,17.46,Bronze,1.1.7,Scottish Human Papillomavirus Archive,Silver,74.6,66.67
78.57,HUB > PIONEER,76.5,38ff49e2-dffa-4103-87a8-386f9f424d22,25.58,273e091c-d0b3-4529-9cd2-4bc1a1b6195a,25.4,Silver,1.1.7,"Deeply phenotyped sepsis patients within hospital: onset, treatments & outcomes",Silver,80.16,85.71
35.71,HUB > BREATHE,53.9,cffcf30d-cedb-421b-a5dc-6726633cb99a,27.91,274238a8-ec06-4ee4-83ae-a419a925d43b,28.57,Not Rated,1.1.7,Unified Cohorts Research Network,Not Rated,50.8,30.16
19.05,,31.62,3c749cfc-4008-4916-b64f-969d6a754c0f,55.81,27a97f1b-e7ac-4723-87db-0a4d9e3ed4b6,60.32,Not Rated,1.1.7,NIHR IBD BioResource: SNP chip data,Not Rated,36.5,33.33
19.05,,32.78,5e1ee577-f1d1-48ae-861e-6a5f2f510773,53.49,2879b7f9-9bf1-4c6d-88cb-fade32b0ec3f,55.56,Not Rated,1.1.7,SIMD,Not Rated,38.88,33.33
19.05,,33.95,4abba8ec-9a67-4334-91fc-e624173f3055,51.16,2887c7b4-66d4-404c-a352-83fcff441568,50.79,Not Rated,1.1.7,Cholecystectomy and post-operative complications from over 9000 surgical cases,Not Rated,41.27,33.33
19.05,ALLIANCE > BARTS HEALTH,38.59,31920b14-d114-410f-8255-522e6451c44e,41.86,29de7178-dcf3-4859-bd96-ca6d944db5f8,39.68,Not Rated,1.1.7,DENDRITE Dataset,Not Rated,38.09,15.87
4.76,,29.12,2f4c56b3-ca6a-4b30-a7f0-d83e68192c5b,46.51,2a17a802-a2da-4bfc-8571-b2015350eed4,46.03,Not Rated,1.1.7,Treatment of Bangladeshi children with severe pneumonia,Not Rated,29.36,4.76
19.05,,32.78,51a8dfba-5c94-48bd-9c68-3707f0ebc2a2,53.49,2a4ef602-0485-47d2-a6f7-9e2ccf849a5d,55.56,Not Rated,1.1.7,National Audit of Care at the End of Life - Quality Survey,Not Rated,38.88,33.33
64.29,ALLIANCE > NHS DIGITAL,60.05,7c2b435c-5442-4a05-9b8d-08024ec57c30,44.19,2a725f9d-c4a9-4c89-aa37-b3c25cc83389,49.21,Not Rated,1.1.7,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Records,Not Rated,64.28,77.78
19.05,,32.78,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6,53.49,2a826781-0f58-44d6-89f3-7d899eb3cd45,55.56,Not Rated,1.1.7,National Asthma and COPD Audit (NACAP): COPD secondary care clinical dataset,Not Rated,38.88,33.33
92.86,ALLIANCE > SAIL,87.13,a380bd6b-009f-4b78-b638-ba9ee62be2eb,18.6,2b09ea87-5b22-4049-b7dd-de0889699115,22.22,Gold,1.1.7,Millennium Cohort Study,Gold,88.09,98.41
78.57,HUB > DATA-CAN,75.33,00b897c7-d50d-486a-af1b-bd94821b58f7,27.91,2b40a784-79ea-4403-a4bd-0950a7a36a6c,26.98,Silver,1.1.7,Leeds-IQVIA Collaboration,Bronze,79.36,85.71
19.05,,33.95,d47c809f-3da8-4f8a-b1ee-258d21aad530,51.16,2b77663f-c71d-4138-8fad-f45a1f8b1222,50.79,Not Rated,1.1.7,Maternity Inpatient and Day Case - Scottish Morbidity Record (SMR02),Not Rated,41.27,33.33
71.43,ALLIANCE > TISSUE DIRECTORY,75.25,3e5fb54a-84ec-4888-9a72-4093c6e90dbc,20.93,2bd45ffb-b22f-4f02-968b-f5ab8f9d6342,20.63,Bronze,1.1.7,UCL Infection DNA Bank,Bronze,71.43,63.49
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,13c71637-144e-4742-8aea-aefb778a360e,16.28,2c3e75c3-141a-4d29-b7f0-0dbe14fb18fd,15.87,Bronze,1.1.7,MDSBio,Silver,72.22,60.32
19.05,,32.78,a380bd6b-009f-4b78-b638-ba9ee62be2eb,53.49,2ca2a23d-64c3-4691-9289-197436dddfa3,55.56,Not Rated,1.1.7,Millennium Cohort Study Dataset (MCSD),Not Rated,38.88,33.33
19.05,,32.78,68b04d3b-17b4-4a04-a8a3-e2a93ed231df,53.49,2cb07157-1c99-48dc-9926-0ad968a09166,55.56,Not Rated,1.1.7,Higher Education Statistics Agency (HESA) Student Data,Not Rated,38.88,33.33
95.24,GENOMICS ENGLAND,87.16,14c31b39-f189-4417-bd38-635268495593,20.93,2d4b933d-1c8b-4fde-860e-c324454d28f9,23.81,Gold,1.1.7,GENOMICS ENGLAND 100K NHSD LINKED DATA,Gold,88.09,100.0
19.05,,31.62,080a90e4-4bc6-4153-a4c6-c120eef5ba94,55.81,2d4d0d89-edfb-448a-b95b-a3c0401ebe75,60.32,Not Rated,1.1.7,COVID-19 Vaccination Adverse Reaction,Not Rated,36.5,33.33
57.14,HUB > GUT REACTION,68.1,ae1898da-7fe5-4fe0-b10d-9f06cdec1735,20.93,2d6e8e68-2fc9-4b9c-a517-c5c5677af225,22.22,Not Rated,1.1.7,IBD NIHR BioResource: NHS Trust data,Bronze,62.7,47.62
19.05,,33.95,368ad790-3ad8-4f93-9a7c-0bfb64dc6015,51.16,2d7a047c-a90f-48e4-82ee-9a8a082a696e,50.79,Not Rated,1.1.7,Welsh Cancer Intelligence and Surveillance Unit (WCISU),Not Rated,41.27,33.33
19.05,,32.78,acfbef89-344c-49a5-8079-7344f4316e0f,53.49,2d9240b4-6f54-4d00-9c2e-d19220c33211,55.56,Not Rated,1.1.7,NHS Tayside - A&E drugs given during an A&E visit,Not Rated,38.88,33.33
19.05,,32.78,ad8f07ef-a984-449b-8a60-d1dd564cc36d,53.49,2dd188f3-0b5c-4cf7-a077-97b78746d254,55.56,Not Rated,1.1.7,Death Registration data for CPRD Aurum,Not Rated,38.88,33.33
19.05,,33.95,8ee61578-e298-423a-be22-cb0438023e5c,51.16,2e821540-cce6-4b75-94a1-7e210045fe86,50.79,Not Rated,1.1.7,Cafcass England (CAFE),Not Rated,41.27,33.33
19.05,,32.78,3d2d9c5e-6111-4583-a6db-07affd628f1e,53.49,2e98ae87-b10d-4aa0-acec-773a2b028af1,55.56,Not Rated,1.1.7,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - NI,Not Rated,38.88,33.33
95.24,ALLIANCE > SAIL,89.48,4c33a5d2-164c-41d7-9797-dc2b008cc852,16.28,2ef8bfd7-3edb-49e0-a1eb-edc181c03e1d,17.46,Gold,1.1.7,Patient Episode Dataset for Wales,Gold,91.27,100.0
4.76,,29.12,6464fb4f-2838-495b-9963-4001204ed166,46.51,2f9c0340-2116-41f5-bdbd-921561476061,46.03,Not Rated,1.1.7,Community perception on public health measures for COVID-19 prevention/control,Not Rated,29.36,4.76
19.05,,32.78,5362cfea-d554-43ba-916a-4460da39cc0c,53.49,2fcd3d4f-773b-4adc-a8cf-c80841c92d51,55.56,Not Rated,1.1.7,Deaths – National Records Scotland,Not Rated,38.88,33.33
19.05,,32.78,209d7fae-0521-4d07-8a4d-e0843a46a107,53.49,3008933e-6fc1-415c-b2c6-ebb12e8f3b99,55.56,Not Rated,1.1.7,CDE Patient Demographics,Not Rated,38.88,33.33
19.05,,32.78,f06ec631-77d0-4b12-a21f-f11e7af49ba5,53.49,30524e8c-c92c-4f01-84bd-c5593ada3e43,55.56,Not Rated,1.1.7,Covid-19 UK Non-hospital Antigen Testing Results,Not Rated,38.88,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,e46dccbf-484d-45d2-a42a-4d308b87c113,16.28,30a0ee0e-d9f9-4341-b00c-2fab8f122b5f,15.87,Bronze,1.1.7,Watch and Wait Trial,Silver,72.22,60.32
19.05,,33.95,602cbc9b-0113-4712-8c4a-0efe8d86b77c,51.16,30e1343e-0628-47aa-b4f6-756cdb6e54c6,50.79,Not Rated,1.1.7,COVID-19 Sequence Data (CVSD),Not Rated,41.27,33.33
19.05,,33.95,98cda353-0011-45b2-80ca-4ed24cd084bf,51.16,31503f67-c546-4223-aec6-9255263e8b66,50.79,Not Rated,1.1.7,General Acute Inpatient and Day Case - Scottish Morbidity Record (SMR01),Not Rated,41.27,33.33
4.76,,29.12,07a0d0ee-93a0-49ab-801d-a9322875f2cd,46.51,31b487d4-7beb-4eed-82bb-9ebbb8b9c066,46.03,Not Rated,1.1.7,Crohn's Disease Metabolic Syndrome & Related Disease Outcomes,Not Rated,29.36,4.76
19.05,,33.95,a6575d98-0b2b-4c06-b9c6-88c1729257b9,51.16,31b7387f-5760-4c82-b320-051b3f18180d,50.79,Not Rated,1.1.7,"A synthetic dataset of 15,000 ""patients"" with Community Acquired Pneumonia (CAP)",Not Rated,41.27,33.33
4.76,,29.12,9254f941-db57-4a97-922e-880b84855a21,46.51,320d4c1e-df08-4eaa-ab9f-bd342d1799a0,46.03,Not Rated,1.1.7,Webex Cohort,Not Rated,29.36,4.76
19.05,,33.95,6dcd9c0e-d5f8-46f9-9d4a-335943e46c21,51.16,32639ab2-f23c-4d2b-96f8-c2139d50563b,50.79,Not Rated,1.1.7,A dataset of hospitalised patients with Sarcoma,Not Rated,41.27,33.33
19.05,,33.95,a4ecb8df-c72f-4018-8f23-e180c28dfdb6,51.16,32b56dc6-5731-4976-823b-86ea1625b9ed,50.79,Not Rated,1.1.7,Cancer Patient Experience Survey (CPES) for CPRD GOLD,Not Rated,41.27,33.33
19.05,,32.78,e06b951b-e9d8-4a2c-a51f-1d819f669205,53.49,32f2d582-3b99-44a8-ac30-0a0819fc2523,55.56,Not Rated,1.1.7,Falls and Fragility Fracture Audit  National Hip Fracture clinical dataset,Not Rated,38.88,33.33
95.24,HUB > BREATHE,88.32,8604bcdc-235a-4c70-b29b-1617396815e6,18.6,333d92ca-3a32-41bd-8b16-96aee2dc85b1,22.22,Gold,1.1.7,Wales Asthma Observatory,Gold,88.89,100.0
4.76,,29.12,4e232aa8-ad56-4d82-adcc-cd06715a5c45,46.51,3373aa9c-219e-4036-91a5-78bb98e8a7f5,46.03,Not Rated,1.1.7,National Bowel Cancer Audit -  Organisational Survey dataset,Not Rated,29.36,4.76
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,ff875c08-58e6-4e33-8ffe-6f51c8364333,18.6,33e4b8c6-23cc-4c5f-a7a5-8380035b6601,17.46,Bronze,1.1.7,TRICON8B,Bronze,71.43,60.32
19.05,,32.78,67020745-9def-4c6e-b5ac-bb273bd0a20e,53.49,34396fa9-0691-42a6-9477-e49e3ae854e6,55.56,Not Rated,1.1.7,National Neonatal Research Database,Not Rated,38.88,33.33
19.05,,32.78,780c0a71-0264-4843-939d-1336eee60d40,53.49,3485968c-0ac8-4c90-bfb0-a9faca4a24f9,55.56,Not Rated,1.1.7,CPRD Cardiovascular Disease Synthetic Dataset,Not Rated,38.88,33.33
19.05,,32.78,2ba72371-1527-4d8d-94e2-f795e45b9f77,53.49,349f5326-67b5-4ff8-a9b8-8e6c4e42a9f2,55.56,Not Rated,1.1.7,Emergency Department (eEMS),Not Rated,38.88,33.33
19.05,,33.95,9dc76035-dd6c-4246-8686-403087ed8890,51.16,34c47ecf-09ff-4f12-afaa-50c785d482c5,50.79,Not Rated,1.1.7,Rural Payments Wales (RPWD),Not Rated,41.27,33.33
19.05,,32.78,4dd97609-2753-46ed-8066-3482d6dbdb34,53.49,3587e2f5-1cf5-4dd3-82ed-c36be7eab130,55.56,Not Rated,1.1.7,Welsh Ambulance Services NHS Trust (WASD),Not Rated,38.88,33.33
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,1c455ad3-af51-4b93-aff4-c5d3dacfa9f4,16.28,359006d7-1c6c-43c2-8905-09b016398ae1,15.87,Bronze,1.1.7,BRAIN UK,Silver,73.81,63.49
4.76,,29.12,0a305b29-cf23-4261-9299-5251e41ee9f0,46.51,3591992f-cfae-4e26-96e7-da80997e81e7,46.03,Not Rated,1.1.7,National Audit of Dementia Round 4 - organisational checklist,Not Rated,29.36,4.76
19.05,,33.95,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5,51.16,35919e8c-5cea-4d79-bf3f-e28efec1b686,50.79,Not Rated,1.1.7,NIHR BioResource: Full Blood Counts,Not Rated,41.27,33.33
19.05,,32.78,855a84b2-9d58-4b2b-a450-b6c6d534e403,53.49,35cc06b0-3de1-45b0-8d40-9a8da9b77866,55.56,Not Rated,1.1.7,NHS Tayside and Fife Virology,Not Rated,38.88,33.33
4.76,,29.12,8187f77f-65e3-435e-ad7e-d7f22e2fcf80,46.51,35fde6f6-ff7d-44f0-92fc-1d28b488cbc1,46.03,Not Rated,1.1.7,The Malaysian Asthma Hajj Study,Not Rated,29.36,4.76
64.29,ALLIANCE > NHS DIGITAL,60.05,c123f74c-0731-428e-b31b-eee2723df54d,44.19,36047c5f-7d57-4d25-a114-2bcc6c11708f,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v3_3.5 (Sensitive),Not Rated,64.28,77.78
54.76,HUB > BREATHE,66.91,af8cdc87-789e-4bea-9d8b-927aa689d211,20.93,36e6b617-ecd5-4ae2-87d6-4a00bb2c653a,20.63,Not Rated,1.1.7,Exploring the provision of supportive care for patients with COPD in Malaysia,Bronze,63.5,47.62
19.05,,33.95,48c44534-0184-471e-93b8-1385f92c6631,51.16,375dae92-2015-478b-b1bc-5de90b6d53a9,50.79,Not Rated,1.1.7,Glaucoma dataset at University Hospitals Birmingham,Not Rated,41.27,33.33
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,8d77f0ad-f376-4d61-a97d-5e996c2bbe72,16.28,37687806-bab2-4de8-87a7-844a0061e7f8,15.87,Bronze,1.1.7,Bristol Dental School Saliva Bank,Silver,73.81,63.49
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,89e2d798-c488-4eaf-a50f-a93616093304,16.28,381413fe-8808-47f8-b8df-e65baa543ae4,15.87,Bronze,1.1.7,UK MND Collections,Silver,73.81,63.49
92.86,HUB > DISCOVER NOW,85.97,2c5f3ef6-53f8-42e6-a077-8718261df026,20.93,38194ca7-57f5-40ff-b463-900e306cd40f,26.98,Silver,1.1.7,North West London Pathology (NWL PATH),Silver,84.92,96.83
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,f20bf814-ee80-4e67-ab00-afff884ddbb4,18.6,38254214-35f1-4564-b7bb-aab331732dab,19.05,Bronze,1.1.7,NIHR Nottingham Digestive Diseases Collection,Bronze,70.64,60.32
19.05,,31.62,b67f0edd-fed2-4d68-a25f-d225759aa3b0,55.81,382d8665-a580-4ac1-a279-4fa53cb5bcc1,60.32,Not Rated,1.1.7,Admitted Patient Care Dataset,Not Rated,36.5,33.33
95.24,ALLIANCE > SAIL,90.64,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,13.95,38468759-3351-4722-9eeb-4c6dc9fa44ce,15.87,Gold,1.1.7,Congenital Anomaly Register and Information Service,Gold,92.06,100.0
19.05,,33.95,131784c0-769d-4f7b-b7d0-b5f4b89886d4,51.16,38b0da08-c889-4538-95f2-f2f2c1a86919,50.79,Not Rated,1.1.7,National Exercise Referral Scheme (NERS),Not Rated,41.27,33.33
78.57,HUB > PIONEER,76.5,a9018475-452b-4864-bbc3-80eda2067820,25.58,391ab58c-3412-4fa0-96f6-fdd5ae380b86,25.4,Silver,1.1.7,Clinical response thresholds (acuity) in acutely unwell patients: onset-outcome,Silver,80.16,85.71
64.29,ALLIANCE > NHS DIGITAL,62.38,2f73575d-23c8-4bb8-87db-115cde076127,39.53,3935e2fd-0c30-4f56-8388-45a02e0499b4,42.86,Bronze,1.1.7,Bridge file: Hospital Episode Statistics to Diagnostic Imaging Dataset,Not Rated,67.46,77.78
4.76,,29.12,224b1065-340b-4c01-842f-d422911d9334,46.51,39445f3f-c05c-4967-81a9-77a34529ad8e,46.03,Not Rated,1.1.7,Optimising the treatment of Bangladeshi adults with severe pneumonia or ARDS,Not Rated,29.36,4.76
4.76,,29.12,41f5c96c-a27a-4015-be50-af967b6c4bac,46.51,396e55fb-9a71-4b8c-9e33-2e7179a87d1f,46.03,Not Rated,1.1.7,Neuropathic Pain Profiling in Retroviral Infection Study (NIPPR),Not Rated,29.36,4.76
4.76,,29.12,37c82bb7-eaae-4f16-97b6-045373b7ba18,46.51,3a0a0acd-c549-41f4-8188-14235decf473,46.03,Not Rated,1.1.7,"BRIAN App - Patient data; treatments, PROMs, multi-modal data and demographics",Not Rated,29.36,4.76
19.05,,33.95,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,51.16,3a0d2dea-32c4-40bc-8ad8-be8cd20440b8,50.79,Not Rated,1.1.7,Congenital Anomaly Register and Information Service (CARS),Not Rated,41.27,33.33
19.05,,31.62,811a54fb-8b79-442f-8e28-a725a0561a15,55.81,3a880d1a-bd02-4d23-bca0-4b6ac45b09f1,60.32,Not Rated,1.1.7,SICSAG Daily (Scottish Intensive Care Audit Group),Not Rated,36.5,33.33
95.24,ALLIANCE > SAIL,89.48,12a77014-4a77-4eb1-8b26-f49689352d1b,16.28,3ab70331-aa54-4f0d-aa95-ea2b95bed9d5,20.63,Gold,1.1.7,Annual District Birth Extract,Gold,89.69,100.0
95.24,ALLIANCE > SAIL,89.48,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c,16.28,3abe6b38-e479-4eb3-87d6-ef4803ff88f9,20.63,Gold,1.1.7,Emergency Department Data Set,Gold,89.69,100.0
19.05,,32.78,b0979e07-3331-408f-853b-5eeba80ce8f9,53.49,3adb43c7-cc13-423a-9625-8fd571bbcb26,55.56,Not Rated,1.1.7,National Paediatric Diabetes Audit - Parent and Patient Experience measures,Not Rated,38.88,33.33
88.1,HUB > GUT REACTION,84.75,44ca2cf8-679e-447c-a9eb-55b32159679a,18.6,3b0a3b33-dbd5-4cb0-b863-0e1fd80c9a1e,22.22,Silver,1.1.7,IBD NIHR BioResource: Consent records,Silver,84.92,92.06
28.57,ALLIANCE > HQIP,46.84,24b88d1a-4363-4619-870e-9ba9fc5d09e1,34.88,3b6d2dbe-0241-4c38-9038-2d6ce1e280de,34.92,Not Rated,1.1.7,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - case note audit,Not Rated,44.45,23.81
19.05,ALLIANCE > BARTS HEALTH,39.76,4c4bc482-16f5-462f-8daf-51ec6492074d,39.53,3b752633-8274-4418-b15b-4502bab03935,38.1,Not Rated,1.1.7,CDE Surginet Documentation,Not Rated,38.88,15.87
19.05,,32.78,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1,53.49,3b8357ac-bf06-44c4-9a43-8e772bec709c,55.56,Not Rated,1.1.7,IBD NIHR BioResource: Demographic,Not Rated,38.88,33.33
19.05,,33.95,b8f2c611-21d0-424e-a1ed-6976b1c207ec,51.16,3b84d205-2175-4c9a-bbe3-d0e24434e625,50.79,Not Rated,1.1.7,"Investigations, interventions, and outcomes for acute coronary syndrome",Not Rated,41.27,33.33
64.29,HUB > GUT REACTION,72.84,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2,18.6,3bb25cba-b4dc-47f1-ab5e-b63f89500612,19.05,Bronze,1.1.7,IBD NIHR BioResource: SNP imputation data,Bronze,69.05,57.14
19.05,,32.78,1eb67fd5-33f6-49dd-a43d-854fff9f25f5,53.49,3c14d319-4ff5-42ff-b440-400f099f9b13,55.56,Not Rated,1.1.7,Active Adult Survey Dataset (AASD),Not Rated,38.88,33.33
71.43,ALLIANCE > TISSUE DIRECTORY,76.42,bbcdc352-e0f7-4672-93a7-134bcf5001b1,18.6,3c23941a-42a7-4940-b32f-aea743c0dc2a,17.46,Bronze,1.1.7,Tissue Solutions Ltd,Silver,72.22,61.9
19.05,,32.78,bff94600-a254-4111-82f7-6167084d81ca,53.49,3c870bf2-acfb-44d1-8437-06ebb3c0993c,55.56,Not Rated,1.1.7,Postponed Admitted Procedures (CAPD),Not Rated,38.88,33.33
19.05,,31.62,9ad92ce4-7410-4edc-a5ac-2c0c64915f4c,55.81,3c899660-32e3-4acc-9583-9d8251bd6f80,60.32,Not Rated,1.1.7,Vaccine Adverse Reactions data for QResearch,Not Rated,36.5,33.33
92.86,HUB > DISCOVER NOW,87.13,9f1df859-f1d0-4f1e-959e-affd05138a25,18.6,3d51dc99-c44f-44ff-bdab-da205c5e394e,22.22,Gold,1.1.7,North West London Outpatient Care Data (NWL OP),Gold,87.31,96.83
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,fdf9ac68-fc89-4adf-9a73-3a94a9974aef,16.28,3db58c78-fc8b-49b2-a847-b43fd0184500,15.87,Bronze,1.1.7,Ethical Tissue - University of Bradford,Silver,72.22,60.32
19.05,,31.62,86f46be3-bc29-4820-8363-de6530a94c6f,55.81,3e4d27e2-baa8-4bb5-a711-d0b36f1f278c,60.32,Not Rated,1.1.7,Diagnostic Imaging Dataset,Not Rated,36.5,33.33
19.05,,31.62,0e47bbf0-0d60-4c7c-85a5-543957635471,55.81,3e923281-bfde-48a8-86fd-73e429cce811,60.32,Not Rated,1.1.7,CPRD GOLD ICNARC,Not Rated,36.5,33.33
4.76,,29.12,36f54a48-6f0a-4827-a86b-fd677a22a88f,46.51,3ed8d3fe-92a3-43bc-9fba-274fb34847af,46.03,Not Rated,1.1.7,Higher Education Statistics Agency (HESA),Not Rated,29.36,4.76
4.76,,29.12,fc66381e-cc46-4bca-85fc-fc2ee09cc5dd,46.51,3ee4c2af-ff04-4dcf-830e-420e0a21a6d2,46.03,Not Rated,1.1.7,mHealth for pneumonia prevention,Not Rated,29.36,4.76
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,4684d391-a6a7-44f7-bf4b-62b6b693f9fa,16.28,3f00330d-1f45-4cab-86c2-e91b7c1a59e9,15.87,Bronze,1.1.7,Multiple Sclerosis and Parkinson's Tissue Bank,Silver,72.22,60.32
19.05,,31.62,1c27bfbf-c659-42ff-8afe-d58250b49c07,55.81,3f6962d8-1f4c-49b0-80a8-e491d5205827,60.32,Not Rated,1.1.7,Outpatient Appointment Dataset,Not Rated,36.5,33.33
78.57,ALLIANCE > BARTS HEALTH,75.33,d6e8163f-2ab8-4880-bbb6-a174b4a95632,27.91,3fbef1ac-fa6d-4c72-836d-3a8d8a0f7b08,26.98,Silver,1.1.7,Barts Health NHS Trust COVID-19 EHR Extracted Dataset,Bronze,79.36,85.71
78.57,HUB > PIONEER,75.33,cfa1ef13-8ae0-4827-8a0f-9d2df5244725,27.91,3fc555e1-3e36-46dc-bef1-2d94d560bcb2,30.16,Silver,1.1.7,The impact of ethnicity and multi-morbidity on C19 hospitalised outcomes,Bronze,77.78,85.71
19.05,,32.78,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9,53.49,3fcdcced-e16a-4f04-a521-ffe1047f37cb,55.56,Not Rated,1.1.7,National Paediatric Diabetes Audit - survey of workforce in PDUs,Not Rated,38.88,33.33
95.24,ALLIANCE > SAIL,90.64,29a714e1-5289-4362-be24-2848c954344e,13.95,3fceb952-0b21-40f4-bd69-fa5cd7ad7df9,15.87,Gold,1.1.7,Cafcass Wales,Gold,92.06,100.0
4.76,,29.12,56130df6-1880-4600-a7a4-afa9a4bcc895,46.51,3fd2760d-ab12-48ee-8b32-b229aead60a4,46.03,Not Rated,1.1.7,Estimating Chronic Respiratory Disease burden in adults in Asian LMICs,Not Rated,29.36,4.76
16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,e830b2a5-14d6-4643-a206-619bf5372dc8,37.21,40573895-497b-4d47-90e1-6aafe70b93f6,36.51,Not Rated,1.1.7,Endobase,Not Rated,38.89,14.29
71.43,ALLIANCE > SAIL,72.93,0e38bbf4-c788-4a1a-9af8-a24821250154,25.58,41a667eb-1c84-4665-b0d4-d26405d277c5,26.98,Bronze,1.1.7,Domiciliary Social Care Worker [DSCW],Bronze,75.4,77.78
64.29,HUB > BREATHE,74.0,4346676d-6108-47de-b579-6cef74c6acef,16.28,41ac5dfd-7b23-4f1b-a91e-03e8186e4ab8,17.46,Bronze,1.1.7,Care-seeking practices for childhood pneumonia in non/tribal areas of Pune India,Bronze,69.05,55.56
80.95,ALLIANCE > CPRD,76.52,bfb90d2b-746d-44a6-a896-4979d73d9276,27.91,41ce265a-c252-45c4-9b80-d764b0737f38,30.16,Silver,1.1.7,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Aurum,Silver,79.37,88.89
19.05,,32.78,fdfa5116-4f44-457d-99ef-e8c1852aa858,53.49,41f6dfe9-d5e2-4641-9953-1589c7d35e07,55.56,Not Rated,1.1.7,Death Registration Data - Finalised Extracts,Not Rated,38.88,33.33
19.05,,32.78,33b36393-3760-40d8-bb98-61806fea5398,53.49,425e39b4-cc2b-4a15-851a-a0093ef1e1f8,55.56,Not Rated,1.1.7,National Asthma and COPD Audit (NACAP): secondary care  – CYP asthma (clinical),Not Rated,38.88,33.33
61.9,ALLIANCE > NHS DIGITAL,61.19,e9b43936-e700-40c9-8b32-57ed44583f3d,39.53,4262e057-6978-4e4c-a05d-c4f328422090,39.68,Bronze,1.1.7,Mental Health and Learning Disabilities Data Set,Not Rated,67.46,74.6
95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,9c1727f6-2032-413f-bf60-470769b2616e,20.93,42ac7c27-a37b-4081-8a33-51ac077e6a4e,30.16,Silver,1.1.7,Cystic Fibrosis Patient Microbiology Cultures,Gold,84.92,100.0
19.05,,32.78,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,53.49,42e4299f-1e06-4e24-ab40-b71949f5cba3,55.56,Not Rated,1.1.7,Pathology - PATH,Not Rated,38.88,33.33
19.05,,32.78,2193ad56-6671-4ecc-9ecf-6da84e23e9fd,53.49,4330b6ee-f333-4cd8-90b9-0f43f7cb0b67,55.56,Not Rated,1.1.7,Covid-19 Infection Survey linked with VOA and EPC data,Not Rated,38.88,33.33
92.86,ALLIANCE > SAIL,89.45,d415a5c5-8432-4a81-937f-12135ade6de7,13.95,45499ef9-daca-4a88-8493-c3c1a92960d0,15.87,Gold,1.1.7,Welsh Ambulance Services NHS Trust,Gold,91.27,98.41
69.05,HUB > BREATHE,76.38,c15bc3ad-c053-496b-863f-1d54075d5bd4,16.28,458d7f2d-9ba8-4593-862c-14160692d494,17.46,Bronze,1.1.7,Asthma and COPD: practices and perceptions of GPs in rural India,Silver,70.63,58.73
19.05,,32.78,a325f33e-bac8-49af-896f-1e025941dae8,53.49,459387f3-c484-441d-9abb-b6ee22df86d2,55.56,Not Rated,1.1.7,Public Health Research Database (PHRD),Not Rated,38.88,33.33
64.29,ALLIANCE > NHS DIGITAL,60.05,9c31a2bd-ff3a-4379-a4b8-0b90527a4c38,44.19,46493a09-b3bb-4c0e-b944-82665ee21508,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v4 (Sensitive) Events,Not Rated,64.28,77.78
28.57,ALLIANCE > HQIP,46.84,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9,34.88,46762bdc-42f9-4c92-92fe-9c757083ad33,34.92,Not Rated,1.1.7,National Paediatric Diabetes Audit - Spotlight survey of workforce in Paediatric Diabetes Units,Not Rated,44.45,23.81
95.24,ALLIANCE > SAIL,90.64,a0c27454-8cbe-418f-bdae-a85d5e92e9d4,13.95,46e30817-b19e-40f2-9b06-9611b2985148,15.87,Gold,1.1.7,Maternity Indicators Dataset,Gold,92.06,100.0
4.76,,29.12,d57d7956-d13e-49c4-bb31-889b8e560596,46.51,46f6e0d3-412e-4799-8683-1ca649b99eec,46.03,Not Rated,1.1.7,Developing and Evaluating Interventions to Improve Asthma Care,Not Rated,29.36,4.76
28.57,ALLIANCE > HQIP,48.0,fe6a4c83-f46f-4f61-8460-e120fdf8d864,32.56,4710222c-9830-4ae4-8be6-b25c723812e1,33.33,Not Rated,1.1.7,Sentinel Stroke National Audit Programme Acute Organisational survey dataset,Not Rated,45.24,23.81
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,6ac9b356-00f1-49da-825a-6eb04d18e49d,16.28,47d22aea-cbe9-47d4-8f65-45861d9c5f6f,15.87,Bronze,1.1.7,Tayside Biorepository,Silver,72.22,60.32
19.05,,32.78,44ca2cf8-679e-447c-a9eb-55b32159679a,53.49,47e26b2b-8be1-4595-a327-a9f00e0d4712,55.56,Not Rated,1.1.7,NIHR IBD BioResource: Consent records,Not Rated,38.88,33.33
71.43,ALLIANCE > TISSUE DIRECTORY,75.25,425f4534-51c4-4f75-8ca0-d7c731dbd903,20.93,47f57de8-aa71-4df1-af4a-a81e37d4ae8c,19.05,Bronze,1.1.7,"St Thomas' Hospitals Plasma, serum & DNA Bio bank from patients with antiphospholipid antibodies",Bronze,72.22,63.49
92.86,HUB > DISCOVER NOW,87.13,0fb33df6-ab36-4170-9fad-1eaf35a3a812,18.6,48182af6-2ccd-44b2-92d5-69cc140e7d67,22.22,Gold,1.1.7,North West London Primary Care Prescriptions Data (NWL PCP),Gold,87.31,96.83
19.05,,33.95,ef850406-2993-43ec-80b9-ef504734f2ac,51.16,483be944-b3ea-4037-b22b-4e9ffca3e613,50.79,Not Rated,1.1.7,A granular assessment of the day-to-day variation in emergency presentations,Not Rated,41.27,33.33
19.05,,32.78,3c661240-e4d2-456c-a809-133c23f9c469,53.49,483f49ea-07b3-4efb-8bad-0d9af5ed5f0f,55.56,Not Rated,1.1.7,National Vascular Registry - Organisational Audit dataset,Not Rated,38.88,33.33
28.57,ALLIANCE > HQIP,46.84,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7,34.88,489cb34a-f20d-4fe0-849a-db85f00141f5,34.92,Not Rated,1.1.7,Falls and Fragility Fracture Audit Programme National Audit of Inpatient Falls clinical dataset,Not Rated,44.45,23.81
19.05,,32.78,56993820-96e4-4a1f-9de1-bad53108c201,53.49,48deb24e-7a15-48d7-ba2c-c477ae61b55d,55.56,Not Rated,1.1.7,NIHR BioResource: Sample holding,Not Rated,38.88,33.33
28.57,ALLIANCE > HQIP,46.84,949d9d7a-a3f1-480a-8563-3fb024300561,34.88,491cc634-05e8-48fe-9018-ffb9e7eed84e,34.92,Not Rated,1.1.7,"National Audit of Dementia - spotlight audit on the prescription of psychotropic medication, 2019",Not Rated,44.45,23.81
19.05,,32.78,3f3df3be-05a8-42b2-89d9-f731deb7ea66,53.49,4a4f5d83-e8fb-4249-9275-2a42d9f76c53,55.56,Not Rated,1.1.7,Cancer registration data for CPRD Aurum,Not Rated,38.88,33.33
19.05,,32.78,af10ec29-1866-4726-b33f-3948afe182f2,53.49,4abe1436-3a14-4779-aa03-28929e817411,55.56,Not Rated,1.1.7,Tayside & Fife Radiology,Not Rated,38.88,33.33
28.57,ALLIANCE > HQIP,46.84,2c737d63-69f4-4a02-8df9-54c1e65e845f,34.88,4b2fbd88-71c7-4572-99ea-5987a72a0c1a,34.92,Not Rated,1.1.7,Epilepsy 12 - National organisational audit (service descriptor questionnaire) and Trust profile,Not Rated,44.45,23.81
4.76,,29.12,cda770e3-0d4d-466f-8102-c56beff04848,46.51,4b3d70f4-ce62-478b-9ada-0419850d17af,46.03,Not Rated,1.1.7,South East London Community Health Study (SELCoH),Not Rated,29.36,4.76
19.05,,33.95,6c4ed998-0f05-415c-a3e4-42430bb62d24,51.16,4b59ff6f-2830-4f2b-b35a-623ef4520eb8,50.79,Not Rated,1.1.7,Systemic Anti-Cancer Therapy Dataset (SACT),Not Rated,41.27,33.33
92.86,ALLIANCE > SAIL,89.45,c74a9b9e-1fea-4aac-99fd-54e30668e085,13.95,4b6d3344-e73a-4f46-8e9d-fabb85827772,15.87,Gold,1.1.7,Daily Situation Report Data,Gold,91.27,98.41
19.05,,32.78,a9ac99fe-32be-40ef-9509-03e6b2713ddf,53.49,4b79bce2-6d1c-448b-969e-56b424f3d57a,55.56,Not Rated,1.1.7,National Early Inflammatory Arthritis Audit - organisational survey dataset,Not Rated,38.88,33.33
19.05,,32.78,8d3f3e58-be79-4450-b2e3-f5ab8a25fb0e,53.49,4bf36706-8176-4525-a3f4-3b96f68e48de,55.56,Not Rated,1.1.7,HES Outpatient data for CPRD Aurum,Not Rated,38.88,33.33
4.76,,29.12,1a02bc11-a378-4f9e-82f9-c52674b388bd,46.51,4c171540-5caa-42f7-868d-1d4d7b969f11,46.03,Not Rated,1.1.7,Assessment of ASHA’s workload and its determinants,Not Rated,29.36,4.76
64.29,HUB > BREATHE,72.84,2581994d-5be2-4465-bb62-60c4c97e8e2b,18.6,4cb9082f-619d-4be2-8d09-641f2c573d38,19.05,Bronze,1.1.7,"Prevention, detection, treatment: adult lung disease/cancer in rural Tamil Nadu",Bronze,68.25,55.56
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,264a1987-a8cb-4a83-81e0-70b4c3893b7d,16.28,4cde083a-bf5a-4f57-97c6-38632e10050d,15.87,Bronze,1.1.7,Obesity Research Biobank Syndicate (ORBiS),Silver,72.22,60.32
28.57,ALLIANCE > HQIP,48.0,306274ee-a098-43cc-b113-2df8116a8703,32.56,4d0c3779-9251-4a4a-9eff-41a47869157f,33.33,Not Rated,1.1.7,National Oesophago-Gastric Cancer Audit - clinical dataset,Not Rated,45.24,23.81
28.57,ALLIANCE > HQIP,48.0,4ca76471-6970-4ad4-87c7-fae77a98cbf5,32.56,4d1271dd-b256-454b-9b13-be38bef73f15,33.33,Not Rated,1.1.7,Paediatric Intensive Care Audit Network - core dataset (admission),Not Rated,45.24,23.81
19.05,,31.62,c388676c-a5e5-419c-967c-239c1f0c3c5c,55.81,4d560a49-6ab2-460c-980f-94d76d1527f2,60.32,Not Rated,1.1.7,NIHR BioResource: SNP chip data,Not Rated,36.5,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,c6e0e70e-7f23-4a44-a2cf-1d7d87be7808,16.28,4dd3f23c-44be-4126-aac5-ba655d07855c,15.87,Bronze,1.1.7,POUT-T,Silver,72.22,60.32
19.05,,32.78,1d35e229-13eb-4be1-9dae-4752b6c27c4a,53.49,4eb62568-e89c-4d85-af0e-095e1e5b8a36,55.56,Not Rated,1.1.7,Death Registration data for CPRD GOLD,Not Rated,38.88,33.33
19.05,,33.95,6c8894f0-3675-4e65-baa8-88ce539b3fd1,51.16,4f32f054-0183-4515-8c18-00cd7a5a63af,50.79,Not Rated,1.1.7,"Longitudinal hospital prescribing data for >48,000 deeply phenotyped patients",Not Rated,41.27,33.33
19.05,,33.95,777d6ac1-6879-4750-9a85-9e42d28bb8d4,51.16,4f385ff8-109c-4e7e-ad09-ee0021864989,50.79,Not Rated,1.1.7,QResearch®,Not Rated,41.27,33.33
4.76,,29.12,7e5f0247-f033-4f98-aed3-3d7422b9dc6d,46.51,4f38a842-d30b-41db-9a6e-cd271f8a3392,46.03,Not Rated,1.1.7,Trusted Research Environments for CVD-COVID-UK / COVID-IMPACT,Not Rated,29.36,4.76
4.76,,29.12,3b5907da-256d-49a3-b24b-00893afe8bdd,46.51,4f3fff58-7c32-4879-8ac2-f3c7641fbb85,46.03,Not Rated,1.1.7,National Audit of Dementia Round 4 - carer experience survey,Not Rated,29.36,4.76
28.57,ALLIANCE > HQIP,46.84,11deee42-5876-4ebe-acca-e996702e1343,34.88,501b0226-1cbf-4717-8dee-adf189dd0088,34.92,Not Rated,1.1.7,"Maternal, Newborn and Infant Clinical Outcome Review Programme - perinatal surveillance dataset",Not Rated,44.45,23.81
28.57,ALLIANCE > HQIP,46.84,3558f8a1-6d52-4b59-b513-51c068095bc2,34.88,50609a73-30a0-46ca-847d-4a9c1bfec5fc,34.92,Not Rated,1.1.7,National Cardiac Audit Programme - Myocardial Ischaemia National Audit Project (MINAP),Not Rated,44.45,23.81
4.76,,29.12,ef6e68d6-dcba-410c-943c-26ca21376a3a,46.51,51221591-a4d4-4b9f-a220-b72d860d99fd,46.03,Not Rated,1.1.7,National Audit of Dementia Round 4 - staff questionnaire,Not Rated,29.36,4.76
19.05,,33.95,cfdafacb-48f0-4ad8-9f20-193a5eec2da4,51.16,51ad73b3-dd3e-44ad-b941-0d5d12bcb0cd,50.79,Not Rated,1.1.7,Looked After Children Wales (LACW),Not Rated,41.27,33.33
19.05,,31.62,98bfe17f-be12-47b1-943a-2d3a621b7618,55.81,51f9de9e-5fcd-4629-bdfc-7719359a7ec6,60.32,Not Rated,1.1.7,The Airwave Health Monitoring Study,Not Rated,36.5,33.33
19.05,ALLIANCE > BARTS HEALTH,39.76,621dd611-adcf-4434-b538-eecdbe5f72cf,39.53,5271131b-ba5b-452d-b230-077094a031c2,38.1,Not Rated,1.1.7,ARIA Dataset,Not Rated,38.88,15.87
4.76,,29.12,beeee4fb-55ab-41b0-9287-33f008e9d6bf,46.51,52db3903-e6c1-4f03-b6ee-909967fe3d16,46.03,Not Rated,1.1.7,Respiratory rate counters in paediatric pneumonia diagnosis,Not Rated,29.36,4.76
4.76,,29.12,17f80626-5adf-4777-9ccf-7f0cd107daa6,46.51,53099fb6-18ff-4edc-b76d-225dade94db3,46.03,Not Rated,1.1.7,Scarred Liver,Not Rated,29.36,4.76
92.86,HUB > DISCOVER NOW,85.97,de9cf0f5-b26a-4363-9df8-3628a4aa6b6e,20.93,535a0983-6618-4211-a939-ae2edfe26f9a,26.98,Silver,1.1.7,North West London Adult Social Care Data (NWL ASC),Silver,84.92,96.83
19.05,,30.45,e600dae2-a83c-4b7a-8d23-af4ac31ca374,58.14,53846ac7-61b7-4403-8556-c319d04b546d,65.08,Not Rated,1.1.7,National Records of Scotland (NRS) - Deaths Data,Not Rated,34.12,33.33
73.81,HUB > PIONEER,74.12,cacba424-6c2c-4b57-8f5b-64e92a78370a,25.58,53b7c446-667b-409e-920e-67cb516de3ae,25.4,Silver,1.1.7,Ventilatory strategies and outcomes for patients with COVID: a dataset in OMOP,Bronze,78.57,82.54
19.05,,32.78,1c49a822-6432-468b-8ba5-6aab534654b9,53.49,53dbbca0-b57d-4f93-8f05-37f626f9a7bc,55.56,Not Rated,1.1.7,Scottish Medical Imaging (SMI) Research Dataset,Not Rated,38.88,33.33
19.05,,33.95,b32325d7-7f00-4d20-9935-dd02e1bc6932,51.16,542bf16f-baea-4fca-be51-fcef9732494a,50.79,Not Rated,1.1.7,Cervical Screening Wales (SCSW),Not Rated,41.27,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,f13258c3-f85a-4772-b42e-da8a84c5064a,16.28,54a7dd45-d6c7-4b4d-801d-2becd2b694f1,15.87,Bronze,1.1.7,Epilepsy Society Brain and Tissue Bank,Silver,72.22,60.32
19.05,,32.78,8321071e-88ef-4d7e-8cf8-ab826c00096c,53.49,555f609d-c48d-431a-98b4-fb4198b5ad79,55.56,Not Rated,1.1.7,HES Outpatients data for QResearch,Not Rated,38.88,33.33
19.05,,30.45,3a65467a-61a1-4801-ba73-1e062de75c85,58.14,5575bf81-2d52-40e3-b95a-7ba43d718965,65.08,Not Rated,1.1.7,RTDS - Radiotherapy treatment data set for QResearch,Not Rated,34.12,33.33
4.76,,29.12,ffdf167b-f3a3-4d78-a228-2865aea90509,46.51,55b311a8-7162-410c-8cf7-eef1ac9ff544,46.03,Not Rated,1.1.7,IBD Registry COVID-19,Not Rated,29.36,4.76
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,c0318a31-a32c-4d3a-9591-dfe9352bf2b9,16.28,567b23fe-abf2-4e2e-88f7-505dfeaa3cde,15.87,Bronze,1.1.7,LBIH Biobank,Silver,72.22,60.32
4.76,,29.12,2f36b7b3-e50f-459f-a691-f62dde65e2bd,46.51,567b5d24-07df-4430-8466-4444ecbe86c8,46.03,Not Rated,1.1.7,Assessing the feasibility and effectiveness of introducing pulse oximetry,Not Rated,29.36,4.76
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,5f4c825d-d6c3-453e-9667-8cdf2329b6e1,18.6,56f3e791-a204-4f67-a4d0-52803148d71a,17.46,Bronze,1.1.7,TNT: Triple Negative breast cancer Trial,Bronze,71.43,60.32
4.76,,29.12,cd20517c-2f75-40e9-9ee8-563d32624b55,46.51,5727d014-0c5c-4dcb-89c9-ff33e1b680bb,46.03,Not Rated,1.1.7,Wellcome Sanger Institute: Whole Exome Sequencing,Not Rated,29.36,4.76
19.05,,32.78,18bfe765-5733-41f3-8114-0a1ec2524b5b,53.49,57458394-945e-4e6a-abc7-91df0f44cb60,55.56,Not Rated,1.1.7,NIHR IBD BioResource: Health and Lifestyle Questionnaire,Not Rated,38.88,33.33
78.57,NCS > OFFICE FOR NATIONAL STATISTICS,76.5,e253257c-48c2-491b-b3b9-205161a16a7e,25.58,575514e3-6e8f-4218-bd75-ff32742abc52,31.75,Silver,1.1.7,Coronavirus and the social impacts on Great Britain,Silver,76.19,84.13
95.24,ALLIANCE > SAIL,89.48,f5f6d882-163d-4ef1-a53e-000fba409480,16.28,57726e95-afe2-4d62-ab1e-81d90eb0ec1d,17.46,Gold,1.1.7,COVID-19 Test results,Gold,91.27,100.0
19.05,,31.62,d1490c18-b6a0-46a2-915f-d7145f02e36f,55.81,57a2febd-6ff7-402b-9503-b362d476257f,60.32,Not Rated,1.1.7,CPRD Aurum ICNARC,Not Rated,36.5,33.33
19.05,,33.95,9c535c8d-ebac-4212-b602-fc2489df2c92,51.16,580b029e-4cce-44db-9c76-f8530cf599db,50.79,Not Rated,1.1.7,National Radiotherapy Dataset (RTDS) for CPRD Aurum,Not Rated,41.27,33.33
19.05,,33.95,c74a9b9e-1fea-4aac-99fd-54e30668e085,51.16,58c38549-7b97-427e-94b2-591d700e233b,50.79,Not Rated,1.1.7,Daily Situation Report Data (DSRD),Not Rated,41.27,33.33
4.76,,29.12,e0d00cb7-62e1-4a38-8df6-cf537b59228d,46.51,590e7bb7-a6e3-4f87-af2f-e46943f98ce9,46.03,Not Rated,1.1.7,Exploration of Pneumonia Related Policy Formation and Implementation in Pakistan,Not Rated,29.36,4.76
4.76,,29.12,cf9bc775-1db7-44e4-9a16-317d5bb063a2,46.51,598ab9d9-04a3-4628-be64-d8f026d266ac,46.03,Not Rated,1.1.7,Computational Framework to Interpret Chest X-rays and Diagnose Pneumonia,Not Rated,29.36,4.76
4.76,,29.12,ac7016ce-f7a9-4c71-bebb-6af6efa27844,46.51,59f5b724-234f-401d-a8f5-df35ea9ecdc9,46.03,Not Rated,1.1.7,National Cardiac Audit Programme - Percutaneous Coronary Interventions (PCI),Not Rated,29.36,4.76
19.05,,32.78,2439a88e-d961-4152-a7b5-042097946209,53.49,5a108169-4afd-4e02-908b-c65bddc3bd2e,55.56,Not Rated,1.1.7,HES Patient Reported Outcomes Measures (PROMs) data for CPRD GOLD,Not Rated,38.88,33.33
4.76,,29.12,5f37e3c2-b5ac-43eb-8eba-ac94dbbff103,46.51,5a6009f8-c74a-4e72-b2a1-83be100f7841,46.03,Not Rated,1.1.7,National Cardiac Audit Programme - National Adult Cardiac Surgery Audit (NACSA),Not Rated,29.36,4.76
19.05,,32.78,b8d009d0-0163-4aaf-8bd6-ad363c859862,53.49,5ad2e0c9-f0ba-4947-90f7-b19431080f83,55.56,Not Rated,1.1.7,National Joint Registry - Primary Ankle Replacement dataset,Not Rated,38.88,33.33
19.05,,33.95,597524d4-038e-4fc2-aff9-1c9b87d3e16c,51.16,5b456d15-cb68-4944-839c-c25a2986e572,50.79,Not Rated,1.1.7,Longitudinal C-reactive protein concentrations in COVID-19: an OMOP dataset,Not Rated,41.27,33.33
92.86,HUB > DISCOVER NOW,85.97,721db252-8069-433d-bb6d-4b44b243d364,20.93,5b9b7964-615b-438a-b151-d2f884a24aee,26.98,Silver,1.1.7,North West London Accident and Emergency Data (NWL A&E),Silver,84.92,96.83
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,e57dd7a2-3c5c-4285-8001-8e2589c395e9,16.28,5bb40472-fc5d-4b16-a0a6-d1d42fd1d3e8,15.87,Bronze,1.1.7,VinCaP,Silver,72.22,60.32
19.05,,32.78,e2f5d637-94b3-447b-b7eb-ea957ce449b6,53.49,5c2cd37f-a930-4e92-85a4-76394838ce90,55.56,Not Rated,1.1.7,Cancer registration data for CPRD GOLD,Not Rated,38.88,33.33
52.38,HUB > BREATHE,61.08,9711e6cc-426c-4cef-afb3-64382f8d7ed4,30.23,5c7ae78d-53e6-427d-a3a9-52538f8342dc,31.75,Not Rated,1.1.7,International Severe Asthma Registry,Not Rated,55.55,42.86
19.05,,31.62,48627b2d-f247-4921-9ee1-6c37adfff10d,55.81,5ca0f47a-307f-448e-911c-24e01c79120f,60.32,Not Rated,1.1.7,Mental Health Dataset (MHDS) for CPRD Aurum,Not Rated,36.5,33.33
19.05,,32.78,17056e83-ee5a-4fe7-86e1-f09563256be1,53.49,5cd5a6a1-f7a2-4d83-a3e3-423495c3a281,55.56,Not Rated,1.1.7,Education Daily Attendance Dataset (EDAD),Not Rated,38.88,33.33
19.05,,32.78,e508951d-e118-4217-84a4-722e50fdd400,53.49,5ce6905a-8b54-4d6c-9da6-e2d57ce45419,55.56,Not Rated,1.1.7,National Waiting List Diagnostics,Not Rated,38.88,33.33
19.05,,32.78,32edd77d-533c-423f-b045-937507f8505d,53.49,5cf49b5c-bb8d-4ab2-90ce-74d801f7c090,55.56,Not Rated,1.1.7,Renal Register – ISD National dataset,Not Rated,38.88,33.33
19.05,,33.95,2ec8d8e3-35bc-4304-83e8-3afed4438cd5,51.16,5d577e70-2b9b-4286-81f3-824978dc3069,50.79,Not Rated,1.1.7,Moorfields Ophthalmic Prescription 004,Not Rated,41.27,33.33
19.05,,31.62,4b8675d3-dd87-4cca-804c-aaf0e4ff8140,55.81,5de9d313-fb9f-4dbf-a959-1329062eb1ef,60.32,Not Rated,1.1.7,NIHR BioResource: Case report form,Not Rated,36.5,33.33
16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,59d72237-6969-4f59-9e87-48138978abe8,37.21,5e022f8f-4d07-44bb-a87c-43e31200fe1e,36.51,Not Rated,1.1.7,ARIA Radonc,Not Rated,38.89,14.29
19.05,,32.78,03280e87-6975-4a2a-967d-b332cb788e44,53.49,5e044863-b792-4256-aa45-3235a6546e39,55.56,Not Rated,1.1.7,National Joint Registry - Primary Hip Replacement dataset,Not Rated,38.88,33.33
92.86,HUB > DISCOVER NOW,87.13,2d3ec99a-a087-4355-8539-5a22cef58910,18.6,5e19a471-64e3-4aa4-ac56-6901d5e39e28,25.4,Silver,1.1.7,North West London Mental Health Data (NWL MH),Gold,85.72,96.83
95.24,ALLIANCE > SAIL,89.48,fa257aa8-51fc-4eb7-a448-e473fa54686d,16.28,5e2a7277-dc64-499a-b16d-51850d9ad00b,20.63,Gold,1.1.7,Emergency Department Dataset Daily,Gold,89.69,100.0
19.05,,32.78,10ffac16-d0c2-4d53-ab6a-69a38e283223,53.49,5e442584-9acd-4e8d-9448-5f8f2b937d56,55.56,Not Rated,1.1.7,NHS Tayside and Fife Biochemistry (Lab Data Restructured),Not Rated,38.88,33.33
19.05,,33.95,bf392537-82b4-4d71-ace0-e7bea3b167fb,51.16,5e9d4a4b-544c-4739-b079-62f353086fde,50.79,Not Rated,1.1.7,Moorfields AMD Dataset Release 002,Not Rated,41.27,33.33
19.05,,32.78,0a852454-ee67-443b-a091-d13499a71b41,53.49,5ef3573a-274a-41e1-8f64-9330109d59d1,55.56,Not Rated,1.1.7,National Cancer Registration and Analysis Service,Not Rated,38.88,33.33
19.05,,32.78,69996d55-ead8-4c8a-a2b6-eb5cdc0e7d75,53.49,5fbc74c1-e305-4697-bb02-1de6585d6113,55.56,Not Rated,1.1.7,HES Admitted Patient Care data for QResearch,Not Rated,38.88,33.33
19.05,,31.62,628e9ad9-28c5-4d58-9ec5-04a63be9b4cf,55.81,5fdfa652-eda8-4709-89e0-02d8412851d4,60.32,Not Rated,1.1.7,Covid-19 Infection Survey,Not Rated,36.5,33.33
95.24,HUB > DISCOVER NOW,87.16,1032850f-7631-4d9e-a760-b0532bffd21a,20.93,601f1504-2706-405b-94cb-8cd14231f434,26.98,Gold,1.1.7,North West London population data (NWL POP),Gold,86.51,100.0
19.05,,33.95,108ba1b0-994d-449c-b192-2331698e477d,51.16,602dc3ef-8c76-4ad4-941b-0a39e50481e7,50.79,Not Rated,1.1.7,"Investigating the impact of frailty, age and illness severity during COVID-19",Not Rated,41.27,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,71eb0192-1124-4b27-86e4-1139e0047a02,16.28,60b148f7-b48c-49c4-9286-b83691cfc7b2,15.87,Bronze,1.1.7,STAMPEDE,Silver,72.22,60.32
19.05,,32.78,3858647c-5161-45dc-ba49-66a4fc4499c2,53.49,61b34cfb-041b-46a3-801d-1932b92795b9,55.56,Not Rated,1.1.7,Weekly SUS Inpatient Dataset,Not Rated,38.88,33.33
19.05,,32.78,fa9c25eb-1ce0-4f44-b6a6-46ec8caeef40,53.49,61df41f6-6d91-4144-b29d-489dd73c48a1,55.56,Not Rated,1.1.7,COVID-19 Wastewater data,Not Rated,38.88,33.33
19.05,,32.78,ed2de8fe-a204-4a4e-bcfa-9e3ad85e2fee,53.49,62663e36-f8cb-4ca0-9fdf-bca1023726d3,55.56,Not Rated,1.1.7,HES Admitted Patient Care data for CPRD Aurum,Not Rated,38.88,33.33
95.24,GENOMICS ENGLAND,87.16,ea748742-568a-46e2-b603-2fada49024e1,20.93,62c01293-83a5-4d4d-9d36-9d7aa2bf120f,23.81,Gold,1.1.7,GENOMICS ENGLAND 100K PHE LINKED DATA,Gold,88.09,100.0
35.71,HUB > BREATHE,53.9,2454a964-be58-4d1f-8f9a-ffae9db9129c,27.91,62fef8d2-c397-43c3-b14a-69cf89423887,28.57,Not Rated,1.1.7,Vitamin D supplementation meta-analyses,Not Rated,50.8,30.16
19.05,,32.78,add6226b-0f21-439a-84a6-51dc26cdc425,53.49,63f5c784-e0ee-46db-bbe5-279164033ed4,55.56,Not Rated,1.1.7,Intensive Care National Audit and Research Centre - Covid19 (ICNC),Not Rated,38.88,33.33
19.05,,32.78,826be5be-9977-49f9-b6d1-83ed9de08ebe,53.49,6421830a-148d-4f86-8cd3-cefb5177610c,55.56,Not Rated,1.1.7,Tayside Microbiology Lab,Not Rated,38.88,33.33
19.05,,31.62,fcf5a844-f48d-428e-aa06-abe64e66185e,55.81,645168a0-21b1-4e13-85d8-266ad9040af8,60.32,Not Rated,1.1.7,Suspected Cancer Pathway Monthly (SPCM),Not Rated,36.5,33.33
19.05,,32.78,fa8bf269-4769-491b-b398-fa63137d14ab,53.49,6456c509-aa71-45de-b4f4-251448e45cbc,55.56,Not Rated,1.1.7,Intensive Care National Audit and Research Centre (ICCD),Not Rated,38.88,33.33
4.76,,29.12,7e5f0247-f033-4f98-aed3-3d7422b9dc6d,46.51,646d65df-fc4c-4680-b949-79ec8f40b406,46.03,Not Rated,1.1.7,"Trusted Research Environments for CVD-COVID-UK in England, Scotland, and Wales",Not Rated,29.36,4.76
19.05,,30.45,050163dc-1728-4ac5-a7d9-4dd3ca0ca12a,58.14,649261ce-833f-459e-908c-2ef93c5fed41,65.08,Not Rated,1.1.7,Civil Registration - Deaths,Not Rated,34.12,33.33
19.05,,33.95,368ad790-3ad8-4f93-9a7c-0bfb64dc6015,51.16,658c4030-3a6d-4e67-abea-25601a478861,50.79,Not Rated,1.1.7,Welsh Cancer Intelligence and Surveillance Unit (WCSU),Not Rated,41.27,33.33
92.86,ALLIANCE > SAIL,88.29,97896866-ab5e-408a-ac5a-072802db9faf,16.28,65c8a30c-de2c-47bf-87e4-18c86e75e54a,20.63,Gold,1.1.7,Diagnostic and Therapy Services Waiting Times,Gold,88.89,98.41
19.05,,33.95,e4004e0e-6adb-4b11-82c2-af0caf61d751,51.16,65ce36d2-f5fa-4a10-b210-b917fbb7c8a5,50.79,Not Rated,1.1.7,Careers Wales Dataset (CARW),Not Rated,41.27,33.33
19.05,,32.78,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7,53.49,65eaa19c-e4b6-4611-922a-4be585a6d348,55.56,Not Rated,1.1.7,Falls and Fragility Fracture Audit  Programme - Inpatient Falls clinical dataset,Not Rated,38.88,33.33
19.05,,32.78,0c43c0b6-de3a-478b-8190-4da37fbe5ff5,53.49,6615ba0a-9bcf-4a3b-8204-283c5e741b2b,55.56,Not Rated,1.1.7,Fife Microbiology Lab,Not Rated,38.88,33.33
64.29,HUB > BREATHE,72.84,7d23e729-72b0-4dd1-820d-07697b49acd0,18.6,661b27db-38d4-4a9c-ac40-e3146ef12350,19.05,Bronze,1.1.7,Theory of Planned Behaviour Intervention: respiratory disease in South India,Bronze,68.25,55.56
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,5ef75d71-73ce-4451-9d7a-a39dd82b712f,16.28,6620b221-6909-4106-a49e-f1b5820be2f3,15.87,Bronze,1.1.7,interNational Anaplastic Thyroid Cancer Tissue Bank (iNATT),Silver,72.22,60.32
92.86,ALLIANCE > ROYAL COLLEGE OF GENERAL PRACTITIONERS,83.64,d5049af5-e351-4b22-8f75-6f3dfc96419b,25.58,664513d6-d766-461d-a69e-206a928cd14f,30.16,Silver,1.1.7,The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care sentinel network and database,Silver,83.34,96.83
28.57,ALLIANCE > HQIP,46.84,becd2624-9a01-4f01-bcf8-56e94545a49a,34.88,668eefeb-fb5c-46d8-a052-12fa8da4931b,34.92,Not Rated,1.1.7,National Asthma and COPD Audit Programme (NACAP): Adult Asthma secondary care clinical dataset,Not Rated,44.45,23.81
19.05,,32.78,05e6752e-3a0b-4809-aa14-207b4761ef60,53.49,670dbf72-0140-4228-b2de-4ad1ba1c920d,55.56,Not Rated,1.1.7,Scotland Accident and Emergency,Not Rated,38.88,33.33
19.05,,32.78,10ffac16-d0c2-4d53-ab6a-69a38e283223,53.49,672a54ba-0b41-4573-adf8-e97158fad9bc,55.56,Not Rated,1.1.7,NHS Tayside and Fife Biochemistry,Not Rated,38.88,33.33
19.05,,32.78,c294bb01-062b-494e-942b-1efe8cbac3dc,53.49,674c290e-36c6-4d9b-a908-a23e89a6745c,55.56,Not Rated,1.1.7,NHS Tayside and Fife Haematology,Not Rated,38.88,33.33
4.76,,29.12,3cc81e6c-0c17-4ccd-8202-a9aceb82c989,46.51,6762c371-8f4a-4511-910a-faf85760eab2,46.03,Not Rated,1.1.7,National Cardiac Audit Programme - Cardiac Rhythm Management (CRM),Not Rated,29.36,4.76
19.05,,32.78,3f073707-50b4-48cf-93b6-76843519a5c0,53.49,67ab8a56-99d7-4951-aacb-5dca0b8ffa35,55.56,Not Rated,1.1.7,National Waiting List Clock Stops,Not Rated,38.88,33.33
80.95,HUB > BREATHE,84.66,6277abc6-c039-4886-8489-d4a2cdb8190c,11.63,67cd0c2b-3944-4bc4-a03a-4081ee67847f,12.7,Silver,1.1.7,Genetics of Asthma Severity & Phenotypes,Silver,79.37,71.43
19.05,,32.78,c38541a7-cf43-4bfd-928d-75613abc8e3f,53.49,682b4d85-732a-4440-922d-07191a604143,55.56,Not Rated,1.1.7,UK Renal Registry - AKI Lab Alerts Dataset,Not Rated,38.88,33.33
19.05,,32.78,1fcaf429-8762-454c-b999-c5fdd757b880,53.49,68906d25-384c-4152-86b5-50c5170ad94c,55.56,Not Rated,1.1.7,Epilepsy 12 - clinical audit,Not Rated,38.88,33.33
19.05,,32.78,49e63323-e564-48ac-9f11-cf77bf0fe20b,53.49,69220bf9-f223-4e88-91c8-8ae8eab9f438,55.56,Not Rated,1.1.7,Tayside & Fife Diabetes – Summary and a range of diabetes related datasets.,Not Rated,38.88,33.33
19.05,,31.62,8e739a01-bcfa-4b75-b7f8-e694ee185f8d,55.81,693fd389-a3a9-4cc9-9a13-6218d84292fd,60.32,Not Rated,1.1.7,Business Insights and Conditions Survey (BICS),Not Rated,36.5,33.33
19.05,,32.78,617f9f54-3fb6-40c3-b391-fe51d1fc7c49,53.49,697690e1-e766-43be-bf89-244aab0641a8,55.56,Not Rated,1.1.7,HES Diagnostic Imaging Dataset for CPRD Aurum,Not Rated,38.88,33.33
19.05,,32.78,faf2fc49-d09f-4ea2-a2cb-b1d30fffa406,53.49,69833273-2b81-4657-8d80-5bafb2c0834d,55.56,Not Rated,1.1.7,"Deaths – CHI, Community Health Index",Not Rated,38.88,33.33
28.57,ALLIANCE > HQIP,46.84,8a3ec96a-0600-4c6d-8761-9d277f07b9da,34.88,6a11bc97-b57a-458f-8a3e-98c71221cb5c,34.92,Not Rated,1.1.7,National Asthma and COPD Audit Programme (NACAP): primary care workstream resources,Not Rated,44.45,23.81
92.86,HUB > DISCOVER NOW,88.29,1fe1e7bb-ef6e-4d89-9824-bb560afc81f0,16.28,6a390359-1e26-470f-a4e5-bfb31a5ed643,20.63,Gold,1.1.7,North West London Patient Index (NWL PI),Gold,88.1,96.83
73.81,ALLIANCE > NHS DIGITAL,70.62,fa2ec63d-f76d-4555-8fc1-f4bd66e3c60d,32.56,6a63513f-92cb-43ce-b0dd-fdb1113150c9,36.51,Bronze,1.1.7,Mental Health Services Data Set,Bronze,72.22,80.95
19.05,,33.95,7c087b3c-cc04-4d3d-894b-7ea5419fa714,51.16,6a9a3c4c-95d4-45da-9520-c3b9aceb6d13,50.79,Not Rated,1.1.7,UHB Linked Diabetic Eye Disease from National Screening to Hospital Eye Care,Not Rated,41.27,33.33
66.67,HUB > PIONEER,70.55,7b1c1f1a-4fb2-452d-9a3c-7748992b1fa4,25.58,6ae22437-38d7-4c47-b529-e100e15c81ab,26.98,Bronze,1.1.7,Synthetic Dataset: Patients at risk of sudden death: hypertrophic cardiomyopathy,Bronze,73.81,74.6
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,71e898d1-db8c-4887-a605-dd6336b92a34,16.28,6aebcd6d-10c6-44cd-80d6-b5a90791db4f,15.87,Bronze,1.1.7,York Tissue Bank,Silver,73.81,63.49
19.05,,33.95,bf392537-82b4-4d71-ace0-e7bea3b167fb,51.16,6af010f2-5973-486f-a44b-ef296455bee6,50.79,Not Rated,1.1.7,Moorfields AMD Dataset 002,Not Rated,41.27,33.33
19.05,,32.78,b5439bc5-8141-4a13-a024-a6db2003b40e,53.49,6bbafb1d-09d3-443f-83db-cfd3a58a5e20,55.56,Not Rated,1.1.7,National Cancer TRE,Not Rated,38.88,33.33
76.19,ALLIANCE > TISSUE DIRECTORY,77.63,bdda7221-7c02-4ced-b7a8-3806a073d981,20.93,6bc36f07-d55a-4a97-afab-29d93dc65bde,19.05,Bronze,1.1.7,Sheffield Brain Tissue Bank (SBTB),Silver,73.81,66.67
69.05,HUB > BREATHE,76.38,01c3d08c-6948-4059-a027-3437e4f5d53b,16.28,6bca5d27-5b98-45e7-b834-6980ba5db5c9,15.87,Bronze,1.1.7,Leicester Respiratory Research Database,Silver,73.02,61.9
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,2dc1218d-df5f-4025-826c-cf5ca7d67882,16.28,6bde3902-5d69-4c24-9d10-f84a63efdb22,15.87,Bronze,1.1.7,Leeds Breast Research Tissue Bank,Silver,72.22,60.32
19.05,,32.78,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc,53.49,6c12c555-c011-4f43-b98f-df0bfaad6b05,55.56,Not Rated,1.1.7,Moorfields Eye Image BioResource 001,Not Rated,38.88,33.33
4.76,,29.12,4a5c610f-019d-450a-90c5-0fe315027f56,46.51,6cae7a61-568d-40b1-984a-1dd9365f9c71,46.03,Not Rated,1.1.7,Effects of second-hand smoke on pregnant women: a phenomenological study,Not Rated,29.36,4.76
28.57,ALLIANCE > HQIP,48.0,03e77b9d-57b8-44d5-8d64-9b1325958b22,32.56,6cd16bca-395b-4dbc-a817-15fd55a1a8e8,33.33,Not Rated,1.1.7,National Vascular Registry Audit Carotid Lower Limb Amputation clinical dataset,Not Rated,45.24,23.81
71.43,ALLIANCE > TISSUE DIRECTORY,75.25,7f9672fa-dad5-479d-a929-52719e8cc2fa,20.93,6ceec25d-2c8e-4dd7-8f99-2e56ec63c298,20.63,Bronze,1.1.7,DARWIN1 Trial,Bronze,71.43,63.49
4.76,,29.12,680a7d41-0fd1-4b32-a2cd-190e338f8ac7,46.51,6dd170f2-c9fe-4496-9499-26783d84e3c2,46.03,Not Rated,1.1.7,Exploring Personal Preparedness and Self-Protective Measures during COVID-19,Not Rated,29.36,4.76
61.9,HUB > BREATHE,70.48,dae5b81c-db28-414b-9328-5596632a8732,20.93,6dd62b6b-d832-4c65-a101-20fe9edd75fc,20.63,Bronze,1.1.7,"Introducing pulse oximetry in IMNCI, primary health facilities in Pune India",Bronze,66.67,53.97
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,37886fb5-d0ae-400f-89eb-78664897bcf2,16.28,6dd6c679-7c5f-4d8e-b1e4-8f1447425e96,15.87,Bronze,1.1.7,Wales Cancer Bank,Silver,72.22,60.32
19.05,,32.78,733b1060-f958-4c3e-ab6a-2b87901d9a9a,53.49,6e1400af-cdad-4843-b8f2-ccc7d444e833,55.56,Not Rated,1.1.7,HES Accident and Emergency data for CPRD GOLD,Not Rated,38.88,33.33
19.05,,31.62,fede31c6-a9c5-4cfb-9866-9b58b2199cff,55.81,6e47173e-651a-404e-a0b2-1fa1cbd887b1,60.32,Not Rated,1.1.7,Covid-19 Second Generation Surveillance System,Not Rated,36.5,33.33
28.57,ALLIANCE > HQIP,46.84,4b33fc6d-3cac-4404-adac-d693328456fa,34.88,6e70b32a-dfbc-46d3-9784-479f3f09527e,34.92,Not Rated,1.1.7,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - organisational audit,Not Rated,44.45,23.81
19.05,,32.78,584bf8c8-d58f-44c6-9b65-e1611144fd54,53.49,6e92101b-a660-4854-9a19-040324b6c9b3,55.56,Not Rated,1.1.7,Annual District Death Daily (ADDD),Not Rated,38.88,33.33
4.76,,29.12,19b4cd38-3828-4bb1-a980-4f7420658965,46.51,6eef1d16-2283-4932-aa6c-c71ae7fa9e3e,46.03,Not Rated,1.1.7,TwinsUK,Not Rated,29.36,4.76
83.33,ALLIANCE > SAIL,80.03,fa8bf269-4769-491b-b398-fa63137d14ab,23.26,6f348bdc-21e4-459b-b658-dc839a1e2133,26.98,Silver,1.1.7,Intensive Care National Audit and Research Centre,Silver,81.75,90.48
19.05,,32.78,e87410ec-a819-43db-99d1-f887c977e525,53.49,6f9a4cb1-7c5a-4671-838a-9554a6491266,55.56,Not Rated,1.1.7,National Early Inflammatory Arthritis Audit - patient survey,Not Rated,38.88,33.33
19.05,,32.78,14a39e96-8ac3-4df3-b42b-07718121c585,53.49,6fbdc930-be40-4492-ba79-82d06d49b539,55.56,Not Rated,1.1.7,"NHS Tayside A&E, Diagnosis dataset during A&E visit",Not Rated,38.88,33.33
19.05,,32.78,a77e52cc-d404-45d6-835f-32e2dc46778a,53.49,6fd8abda-7e49-436c-9131-a1f607569c14,55.56,Not Rated,1.1.7,Covid-19 UK Non-hospital Antibody Testing Results,Not Rated,38.88,33.33
19.05,,32.78,14a39e96-8ac3-4df3-b42b-07718121c585,53.49,6ffc7fd8-732f-4360-b38b-fa94dd75a13d,55.56,Not Rated,1.1.7,"NHS Tayside A&E, Diagnosis During A&E visit",Not Rated,38.88,33.33
19.05,,32.78,5692eade-5738-48ed-8527-39be9caaa7b5,53.49,7017aede-b38a-4b70-b7b2-aade001d0cc0,55.56,Not Rated,1.1.7,School Workforce Annual Census (SWAC),Not Rated,38.88,33.33
19.05,,31.62,dca0c95b-ae7d-4163-8c3b-a881f779df02,55.81,70491568-676d-43e4-b3c3-b1db4f1ff530,60.32,Not Rated,1.1.7,National Records of Scotland (NRS) - Stillbirth Data,Not Rated,36.5,33.33
19.05,,33.95,8ca05f55-af73-42bd-b682-851c2c54a6cc,51.16,705f86b8-4c2f-4ed5-b792-3a0d49d14c75,50.79,Not Rated,1.1.7,GoDARTS,Not Rated,41.27,33.33
19.05,,32.78,2b847fd2-0f65-43b7-84e1-10cec99d699e,53.49,708839a0-d003-4917-bbd9-92741f54ab75,55.56,Not Rated,1.1.7,National Waiting List Clock Starts,Not Rated,38.88,33.33
19.05,,31.62,a20643c7-ef15-4f7d-9e48-5a9f23a645c1,55.81,70ad0b2c-a8dd-4f91-a5b8-adca272bf215,60.32,Not Rated,1.1.7,BathTAP Switching Cohort 3,Not Rated,36.5,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,7dcd5c0a-1922-4fe2-9b7e-090e4c39861b,18.6,70b4d407-288a-4945-a4d5-506d60715110,17.46,Bronze,1.1.7,CASPS: A Phase II trial of Cediranib in ASPS patients,Bronze,71.43,60.32
4.76,,29.12,009bcb87-05f3-46e6-8866-7e4df698cb19,46.51,70c318c4-b388-4102-924e-5419d44c1679,46.03,Not Rated,1.1.7,CuT-AsthMa: Culturally tailored school-based intervention for asthma in Malaysia,Not Rated,29.36,4.76
19.05,,33.95,120106fb-49b4-4bc0-b30c-50a59c5c6253,51.16,719dd9c9-9aa5-426d-981a-57f0ad3f1480,50.79,Not Rated,1.1.7,Moorfields DMO Dataset 003,Not Rated,41.27,33.33
73.81,ALLIANCE > AVON LONGITUDINAL STUDY OF PARENTS AND CHILDREN,78.77,255d70c6-9a50-4b62-adc0-44216606a216,16.28,71b8569c-b582-499c-85aa-909b825f6ea6,15.87,Bronze,1.1.7,Avon Longitudinal Study of Parents and Children,Silver,74.6,65.08
19.05,,33.95,99dc4159-00d0-4874-b158-fe30244b53a1,51.16,71f9cf07-0560-42b4-a0fe-5de725dacd31,50.79,Not Rated,1.1.7,"Hospitalised and ventilator acquired pneumonia severity, treatments, outcomes",Not Rated,41.27,33.33
4.76,,29.12,39d7ad29-be30-4e12-a7c8-d8757141de85,46.51,7257d45c-6697-4c49-bbce-de0d456c0678,46.03,Not Rated,1.1.7,NIHR BioResource: SNP imputation data,Not Rated,29.36,4.76
19.05,,32.78,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f,53.49,72eb9599-aa37-4c17-bc56-a7833e8038db,55.56,Not Rated,1.1.7,National Paediatric Diabetes Audit - survey of diabetes-related technologies,Not Rated,38.88,33.33
16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,5505e91d-9e0a-4969-87d5-00f256d91306,37.21,72fe91de-b0c0-423a-ad68-bd7067b20ad8,36.51,Not Rated,1.1.7,Infoflex Cancer Registry,Not Rated,38.89,14.29
78.57,HUB > PIONEER,77.66,16a09f1b-3654-4ec3-9913-fb70cb1e2364,23.26,730b3e54-1f59-4c07-b5d6-e6b63e4dda35,23.81,Silver,1.1.7,"Deeply-phenotyped hospital COVID patients: severity, acuity, therapies, outcomes",Silver,80.95,85.71
78.57,HUB > BREATHE,84.63,b8bcda0b-3c90-4382-aeb7-b01fc27e58fa,9.3,73462506-32c5-43a0-963e-06d67e967b97,11.11,Silver,1.1.7,UK BiLEVE Consortium Dataset,Silver,79.37,69.84
19.05,,31.62,c71fbdc3-0311-4b3f-a9ff-7d2f2c0ba993,55.81,73941d19-6fcd-40e9-a7bd-ef0d91f93de9,60.32,Not Rated,1.1.7,Critical Care Minimum Dataset,Not Rated,36.5,33.33
95.24,NIHR Health Informatics Collaborative Viral Hepatitis Theme,80.18,66be725a-b950-4bf8-9a35-7e33ce765a25,34.88,73f54071-62bf-48f5-8be1-569208b18ab8,39.68,Silver,1.1.7,HIC Hepatitis v2,Silver,80.16,100.0
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,576fbcf8-ff25-4230-ae69-e72ca02b95f1,16.28,74241b17-23b7-4233-b7b9-1a484aa053b0,15.87,Bronze,1.1.7,Myeloma XII clinical trial samples,Silver,72.22,60.32
19.05,,32.78,02ddc5c9-03d4-40e4-9934-e60817ec8f3e,53.49,747d57aa-a02b-411c-9403-2e3ec9d3e5b5,55.56,Not Rated,1.1.7,NIHR IBD BioResource: Contact detail,Not Rated,38.88,33.33
4.76,,29.12,dec09f2e-a93f-41e2-8217-72431ea4a19e,46.51,74b54e34-0e01-4447-be1d-e9da3e03cd2e,46.03,Not Rated,1.1.7,NIHR BioResource: Metabolite data,Not Rated,29.36,4.76
4.76,,29.12,587a94e6-48a4-4e5e-8230-4018897bc7c7,46.51,74be1c67-ab42-4716-a63b-be3f5de0d489,46.03,Not Rated,1.1.7,National Audit of Dementia Round 4 - casenote audit,Not Rated,29.36,4.76
19.05,,32.78,e355c9b9-44f0-4ba3-a872-645aa88f4f2b,53.49,75dabfb3-69b7-4192-b257-d0d814e5872d,55.56,Not Rated,1.1.7,National Paediatric Diabetes Audit - core clinical dataset,Not Rated,38.88,33.33
19.05,,33.95,131784c0-769d-4f7b-b7d0-b5f4b89886d4,51.16,76535d6e-ce0c-407c-ba22-1b2420a1e654,50.79,Not Rated,1.1.7,National Exercise Referral Scheme,Not Rated,41.27,33.33
19.05,,31.62,d4362d41-0838-4f41-bba3-c3268312c444,55.81,76ac3c66-8c3f-41c1-8de2-2b56dd5512dc,60.32,Not Rated,1.1.7,Hospital Episode Statistics Outpatients,Not Rated,36.5,33.33
19.05,,33.95,120106fb-49b4-4bc0-b30c-50a59c5c6253,51.16,77422eb1-7bdb-4205-b3d0-57d1add35317,50.79,Not Rated,1.1.7,Moorfields DMO Dataset Release 001,Not Rated,41.27,33.33
95.24,NHSX,90.64,31f0148b-f965-4136-ab39-6c5bbbf8c2d9,13.95,77824298-ef3b-40f7-a0a4-b6dedb2e7a02,15.87,Gold,1.1.7,The National COVID-19 Chest Imaging Database,Gold,92.06,100.0
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,7e60a651-b3d6-40ef-93dc-1f87dabee7be,16.28,7793f54e-73be-4c97-a941-ba105b1b0480,15.87,Bronze,1.1.7,Leeds Multidisciplinary Research Tissue Bank,Silver,73.81,63.49
4.76,,29.12,d858cd90-9a2f-4330-9bbe-46e047a5d0a2,46.51,77adbbe0-6cc7-426d-b485-4ac1f05a746b,46.03,Not Rated,1.1.7,UK Longitudinal Linkage Collaboration (UK LLC),Not Rated,29.36,4.76
19.05,,32.78,cba62a8d-5917-4912-ad4d-340472f7b904,53.49,77b48222-3a00-4dcc-b0ef-3f99dfae697e,55.56,Not Rated,1.1.7,Lifelong Learning Wales Record (LLWR),Not Rated,38.88,33.33
19.05,,31.62,33092502-12ef-4bc0-8400-5f63915cbf33,55.81,77dc7118-443c-4c85-a18c-e7bbe01e9e7a,60.32,Not Rated,1.1.7,1958 National Child Development Study - Pain data,Not Rated,36.5,33.33
19.05,,33.95,a0c27454-8cbe-418f-bdae-a85d5e92e9d4,51.16,77f4f3ec-31aa-4eb9-8896-a063ce831c9b,50.79,Not Rated,1.1.7,Maternity Indicators Dataset (MIDS),Not Rated,41.27,33.33
19.05,,32.78,f8af632e-442d-4931-a370-b7fa2fa4b896,53.49,783184b6-e8f4-4768-a3eb-442a7f044aaa,55.56,Not Rated,1.1.7,Systemic Anti-Cancer Treatment (SACT) data for CPRD Aurum,Not Rated,38.88,33.33
35.71,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,44.6,10ffac16-d0c2-4d53-ab6a-69a38e283223,46.51,7858978f-30e8-42e7-abe4-d9af5447c278,50.79,Not Rated,1.1.7,NHS Tayside and Fife Haematology Biochemistry (Lab Data Restructured),Not Rated,47.62,46.03
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,ce533c67-5565-4010-bedf-dca3863a9084,16.28,7862c1c2-d4d6-4b3c-aea1-1f15a5b3b5ea,15.87,Bronze,1.1.7,UCL / UCLH Biobank for Studying Health and Disease,Silver,73.81,63.49
95.24,ALLIANCE > SAIL,90.64,594cfe55-96e3-45ff-874c-2c0006eeb881,13.95,78ce070c-84db-4676-81c5-0c672f4e12e3,15.87,Gold,1.1.7,COVID-19 Symptom Tracker Dataset,Gold,92.06,100.0
64.29,ALLIANCE > NHS DIGITAL,60.05,efecbe58-4822-4f17-bf5c-92113d143db9,44.19,78fe2e13-7f40-406f-a584-04909d0ce060,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v4.1 (Sensitive) Episodes,Not Rated,64.28,77.78
19.05,,32.78,a4c595a6-cb41-4743-bea3-feb4d4c72091,53.49,7964fc83-017a-4786-918e-bab61f7ddd99,55.56,Not Rated,1.1.7,CAPS,Not Rated,38.88,33.33
19.05,,32.78,c7219fcb-cf19-474c-bdbf-8d72b84c9f0e,53.49,7966a272-a2ba-4763-904b-f7d1e00bcfcd,55.56,Not Rated,1.1.7,SACT - systemic anticancer treatment  for QResearch,Not Rated,38.88,33.33
19.05,,32.78,7b1c1f1a-4fb2-452d-9a3c-7748992b1fa4,53.49,796d97b4-6f3d-4ee8-8966-9238efdcac2d,52.38,Not Rated,1.1.7,Synthetic Dataset - Patients at risk of sudden death: hypertrophic cardiomyopathy,Not Rated,40.47,33.33
71.43,ALLIANCE > TISSUE DIRECTORY,76.42,314953f6-58e7-49c0-adfd-c60e623eba74,18.6,79b02690-798b-462d-9ced-f53c9e39d624,17.46,Bronze,1.1.7,Central England Haemato-oncology and oncology Research Biobank (CEHRB),Silver,73.02,63.49
19.05,,33.95,e179bd5b-0153-46d4-9e1b-4febd3f1153f,51.16,79dfcffd-3f50-4fa2-bd3a-8ef1464e7589,50.79,Not Rated,1.1.7,SCI Diabetes,Not Rated,41.27,33.33
64.29,ALLIANCE > NHS DIGITAL,60.05,1a8fc23c-b67b-4171-b5e1-1b650fce1ef4,44.19,7aa02796-787a-42c2-b97e-d008fa77e4b8,49.21,Not Rated,1.1.7,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Records,Not Rated,64.28,77.78
19.05,,31.62,204fa806-071d-4410-9c2c-143017d32d24,55.81,7aa38c5c-771c-4157-a008-32051a5aed4b,60.32,Not Rated,1.1.7,Education Wales (EDUW),Not Rated,36.5,33.33
19.05,,32.78,fc2fcaec-bd5b-4d43-9e0c-2fed36eff0e4,53.49,7ada943a-083d-44c5-a147-32e581e3ed20,55.56,Not Rated,1.1.7,NIHR BioResource: Contact detail,Not Rated,38.88,33.33
4.76,,29.12,ecb90b4a-6f4f-4398-a4f6-d64891c4a137,46.51,7b922498-1757-418d-96ca-64980a50b647,46.03,Not Rated,1.1.7,NIHR BioResource: Whole Genome Sequencing,Not Rated,29.36,4.76
19.05,,33.95,696cfc9f-090d-4328-94ac-140760a77c73,51.16,7d313fa6-941f-48ca-93e1-05d912d183ac,50.79,Not Rated,1.1.7,GPES Data for Pandemic Planning and Research (COVID-19),Not Rated,41.27,33.33
19.05,,33.95,e4f6d9a8-88d0-4781-b192-cd165451b272,51.16,7d414fa8-565b-451b-bc9c-fe2965c2bc5b,50.79,Not Rated,1.1.7,Children In Need Census Wales (CINW),Not Rated,41.27,33.33
19.05,,32.78,b0797c05-352f-455f-8d27-150b6f6354cc,53.49,7d98182a-18f8-4f2e-a59c-5048580557b5,55.56,Not Rated,1.1.7,National Early Inflammatory Arthritis Audit - clinical dataset,Not Rated,38.88,33.33
19.05,,33.95,b0049073-3335-433d-bdb9-de22547698f8,51.16,7daacbe5-082d-4c12-b801-0fb08932dada,50.79,Not Rated,1.1.7,COVID-19 Vaccination,Not Rated,41.27,33.33
47.62,HUB > BREATHE,61.02,57efab41-65fc-4069-8b9d-e5ced13cb4d3,25.58,7df79ee6-e67d-4ad9-89f3-23bee6cb0ec5,25.4,Not Rated,1.1.7,Effect of personal air pollution exposure on asthma control in children,Not Rated,57.94,41.27
45.24,HUB > BREATHE,58.67,36a5da45-772c-4c67-8ec3-84c9e67332d3,27.91,7e780260-e8d3-4541-b51e-213233dfc349,26.98,Not Rated,1.1.7,At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK,Not Rated,56.35,39.68
4.76,,29.12,0ad7a3dd-e720-49ef-9d27-c394a32b0326,46.51,7ec7c8c4-770b-41f0-87d0-38ea232ae5bd,46.03,Not Rated,1.1.7,Next Steps,Not Rated,29.36,4.76
19.05,,33.95,04cb9964-54fb-4529-b09b-735c3daa1c7b,51.16,7ed08209-f22e-4cdf-b8b5-e1d58b0bcaf9,50.79,Not Rated,1.1.7,Outpatient Appointments and Attendances - Scottish Morbidity Record (SMR00),Not Rated,41.27,33.33
19.05,,31.62,891150d2-85b5-4bed-88a8-7d65f75bb020,55.81,7ed274f8-c30f-4f97-af5f-808d212de7e8,60.32,Not Rated,1.1.7,COVID Therapeutics data for QResearch,Not Rated,36.5,33.33
88.1,HUB > INSIGHT,82.42,21fb56d1-726f-40e3-a998-e4b34ba3e46f,23.26,7f4fb30c-2a09-4d75-bed2-114751e06723,25.4,Silver,1.1.7,UHB Eye Image Dataset Release 001,Silver,84.92,95.24
19.05,,32.78,3598723f-62fb-4377-9a8b-b264ced1aabd,53.49,7f7860ee-6235-4e7d-95f3-df692f5d9630,55.56,Not Rated,1.1.7,CDE Encounter,Not Rated,38.88,33.33
19.05,,32.78,20fe153c-a5e5-4991-900e-8fa9988e771a,53.49,7fd81823-ee92-49d3-9147-d56515ca2831,55.56,Not Rated,1.1.7,National Community Child Health Database (NCCHD),Not Rated,38.88,33.33
95.24,GENOMICS ENGLAND,84.83,702f0198-bdfe-401e-97f2-35f5d26357ad,25.58,7fdb684d-bb7a-4d0b-8666-9f10510f071f,30.16,Silver,1.1.7,GENOMICS ENGLAND 100K CANCER & COMMON,Silver,84.92,100.0
76.19,ALLIANCE > SAIL,76.47,c0fc84af-aeab-4c7e-aa0b-8264baff55d9,23.26,80a7208f-c174-42bd-9127-e8f006de7c95,26.98,Silver,1.1.7,COVID-19 Test Trace and Protect [CTTP],Silver,77.78,82.54
4.76,,29.12,c2ced850-e75c-4428-8cc2-5338c34d138a,46.51,80c05b85-685e-49c7-8d78-dff6d131ed2f,46.03,Not Rated,1.1.7,Non-invasive assessment of portal hypertension using quantitative MRI (MRQuee),Not Rated,29.36,4.76
95.24,ALLIANCE > SAIL,90.64,b32325d7-7f00-4d20-9935-dd02e1bc6932,13.95,80e9c439-4909-4534-8bfe-6f01fdec7de7,15.87,Gold,1.1.7,Cervical Screening Wales,Gold,92.06,100.0
19.05,,33.95,d331159b-b286-4ab9-8b36-db39123ec229,51.16,80fc6c81-dd24-4f5f-870e-6c1cb7a1766d,50.79,Not Rated,1.1.7,Outpatient Database for Wales (OPDW),Not Rated,41.27,33.33
19.05,,33.95,d331159b-b286-4ab9-8b36-db39123ec229,51.16,8193e951-2ed8-4ccf-9fe5-5c2e6f933d60,50.79,Not Rated,1.1.7,Outpatient Dataset,Not Rated,41.27,33.33
19.05,,32.78,572cd3e2-9119-40ff-ab2e-49e8a0a02ab8,53.49,81c28c63-7cbb-49ce-86b4-c83e1c15fdba,55.56,Not Rated,1.1.7,Weekly SUS Outpatients Dataset,Not Rated,38.88,33.33
76.19,HUB > PIONEER,75.31,bf3fe16c-5377-4571-b5a5-7aa7e796594c,25.58,81c54c5a-ceb1-487c-820a-437b4dd002ca,25.4,Silver,1.1.7,Risk and outcomes of coagulopathies in acutely unwell adults,Bronze,79.36,84.13
4.76,,29.12,c3a75213-e310-4d32-81bb-fe9cff43ef2e,46.51,81d82bed-37f3-4975-ac21-5fcc1090853f,46.03,Not Rated,1.1.7,Inflammatory Bowel Disease datasets - Data profiling GWM,Not Rated,29.36,4.76
64.29,ALLIANCE > NHS DIGITAL,60.05,a27400b0-0efb-4af8-a7bc-e2c7e59796e3,44.19,8226b6fa-d815-4f15-9064-b56beb0fddb1,49.21,Not Rated,1.1.7,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Episodes,Not Rated,64.28,77.78
76.19,ALLIANCE > TISSUE DIRECTORY,77.63,fcb62cb3-c876-47a3-961e-fb27c6f718fa,20.93,826114ca-2563-4c0c-b023-3417ead32956,19.05,Bronze,1.1.7,Research Donors Ltd,Silver,73.81,66.67
19.05,,32.78,39055449-c074-4b58-adb2-b1c0d2441c4d,53.49,8286eef9-0533-488e-bf19-8fc0fa1dd00b,55.56,Not Rated,1.1.7,NHS Tayside and Fife Immunology (Extractable),Not Rated,38.88,33.33
4.76,,29.12,46f50b9b-b8e2-4ff1-a1b3-779174c3d032,46.51,828bc515-6b42-4492-a77e-cf20226ba041,46.03,Not Rated,1.1.7,Reasons for delay in seeking care for pneumonia in children under five,Not Rated,29.36,4.76
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,c6e1ea88-f5bf-4a57-953f-688f313fcb04,16.28,82f4cf19-9e6a-4c31-8cc3-085f3d44ba44,15.87,Bronze,1.1.7,Northern Ireland Biobank (NIB),Silver,73.81,63.49
4.76,,29.12,574cf7bc-dd70-4508-a66d-ac59d8d06639,46.51,830c22bb-4321-4fa3-ba04-be9b30518877,46.03,Not Rated,1.1.7,Hypertonic saline nasal irrigation and gargling for suspected COVID-19,Not Rated,29.36,4.76
19.05,,32.78,53585c9c-f588-41f8-b493-3d271a2794a8,53.49,83e2e155-1845-4bfd-a0c0-9e81b0a41397,55.56,Not Rated,1.1.7,Covid-19 Tests,Not Rated,38.88,33.33
61.9,HUB > BREATHE,67.0,b0a68ee7-742d-45dc-aae9-4be4e1655fc0,27.91,842e8c5c-a298-4942-9ac4-f95d1a5f87b3,26.98,Not Rated,1.1.7,Deriving and validating a clinical prediction rule for the diagnosis of asthma in primary care,Bronze,64.29,55.56
95.24,NIHR Health Informatics Collaborative Cardiovascular Theme,81.34,869a9b4e-3537-449f-9a59-a0eac523c4e4,32.56,844f3be0-f50d-4a88-9783-0928ad1c2aad,34.92,Silver,1.1.7,HIC Acute Coronary Syndromes,Silver,82.54,100.0
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,4a65f6d6-f2e4-4d98-a3a4-94a32206836d,16.28,8466ec6f-8a4c-4286-8138-04c35e12b1f8,15.87,Bronze,1.1.7,"Oncology Clinical Trials Office, University of Oxford",Silver,72.22,60.32
28.57,ALLIANCE > HQIP,46.84,c3e63860-bd61-4154-ab5f-ca927fb029c4,34.88,849d46e6-49a6-4456-a5ae-990c02012bf2,34.92,Not Rated,1.1.7,National Audit of Psychosis - Audit on Early Intervention in Psychosis services -  patient experience survey,Not Rated,44.45,23.81
45.24,OTHER > The University of Cambridge,60.99,8cbb73e2-a2c4-4caf-8dcd-6ac3795bb996,23.26,84b6d047-2a05-4fc0-8537-809dbb3d18ed,22.22,Not Rated,1.1.7,COMPARE,Not Rated,58.73,39.68
16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,67cea834-33f5-4ed7-9dc2-072ad077de07,37.21,84de0d13-f5bd-4c22-83d3-e1adb00d5a72,36.51,Not Rated,1.1.7,CRIS,Not Rated,38.89,14.29
92.86,HUB > DISCOVER NOW,87.13,c853b41b-fbd1-4896-b0fb-85303109fec4,18.6,850f99cb-f091-4f10-86ee-06a3eaa7df53,22.22,Gold,1.1.7,North West London Coordinate My Care (NWL CMC),Gold,87.31,96.83
19.05,,33.95,6225bc5d-ace2-498f-8a90-2d671771bc65,51.16,8559e83d-ba93-4c98-af86-286f87f54a14,50.79,Not Rated,1.1.7,Hospitalised Community Acquired Pneumonia granular pathway and outcome data,Not Rated,41.27,33.33
95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,4fcc8b11-2b9b-4f68-b51a-978749d89acc,20.93,8638e095-a609-463f-b36e-c4cac4519660,30.16,Silver,1.1.7,Cystic Fibrosis Patient Tendon Rupture,Gold,84.92,100.0
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,ccd6e59d-3582-4f47-a4cd-f5845192d75c,18.6,865f0e79-f862-493b-b863-b39b777d60ca,17.46,Bronze,1.1.7,Oxford Musculoskeletal Biobank,Bronze,71.43,60.32
78.57,HUB > BREATHE,83.47,cc6f926a-90cf-4083-84e7-131d1e63813b,11.63,8665b36e-f9a5-4062-ba56-d33fecfe3376,12.7,Silver,1.1.7,Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS),Silver,77.78,68.25
64.29,ALLIANCE > NHS DIGITAL,63.54,21aec912-444f-447d-b3c4-6791a6c82667,37.21,86d7088b-7a15-4e9a-b2b0-857a67e04650,41.27,Bronze,1.1.7,HES:Civil Registration (Deaths) bridge,Not Rated,67.46,76.19
19.05,,33.95,83059be4-071b-4a36-8ab1-9fde1e32e75e,51.16,86e4b1ad-e63c-4ab1-80f3-5c136ce7e94e,50.79,Not Rated,1.1.7,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (GOLD),Not Rated,41.27,33.33
47.62,HUB > BREATHE,62.18,eb76598f-e228-413c-82f3-231809062611,23.26,8821748d-9d8b-4787-91cc-0a58c5ab890d,23.81,Not Rated,1.1.7,EMEP4UK Pollution,Not Rated,58.73,41.27
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,786563e9-5377-4d18-8d32-65ff14d53987,16.28,88576066-fb5f-43e2-8af4-0904630b2f1b,15.87,Bronze,1.1.7,University of Southampton Faculty of Medicine Tissue Bank,Silver,72.22,60.32
19.05,,32.78,7958450d-bd25-42c4-b79e-0e3d0806ac21,53.49,88bf4a0e-28ea-4124-8121-f20aed9147de,55.56,Not Rated,1.1.7,HES Patient Reported Outcomes Measures (PROMs) data for CPRD Aurum,Not Rated,38.88,33.33
19.05,,32.78,1b677d33-8e87-4951-9658-e99ae73d963b,53.49,88dced95-f51d-4207-91ae-9e506195a419,55.56,Not Rated,1.1.7,CPRD GOLD CHESS,Not Rated,38.88,33.33
64.29,ALLIANCE > NHS DIGITAL,60.05,702201ff-e729-4e29-a428-32953c9a0332,44.19,895e5c2f-e484-4d08-91c6-35ac2f85c231,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v2.6 (Non-Sensitive),Not Rated,64.28,77.78
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,2f085ac6-d33d-4b9b-8a99-624cc51c3f17,16.28,89aac17d-f8a1-4ddc-9495-4adc278234a9,15.87,Bronze,1.1.7,Human Biomaterials Resource Centre,Silver,72.22,60.32
19.05,,32.78,a48c65e2-a4e0-4d05-9e9c-fc84e050dea0,53.49,89fe9e07-0d2f-4363-83fe-bad3c732eb20,55.56,Not Rated,1.1.7,CPRD COVID-19 Symptoms and Risk Factors Synthetic Dataset,Not Rated,38.88,33.33
19.05,,33.95,02397c83-62e6-4ec2-8366-89d211739564,51.16,8a0d67e2-6daa-4ebe-913b-eb5ede8801ba,50.79,Not Rated,1.1.7,"Studies Supported by NIHR CRN, ICD10 Coded, with Summary Site Recruitment Data",Not Rated,41.27,33.33
19.05,,32.78,d517e6fc-9a88-4647-b787-dcbed3635885,53.49,8a4d097a-3ef2-4452-b6e0-98e2baebb427,55.56,Not Rated,1.1.7,National Joint Registry - Primary Knee Replacement dataset,Not Rated,38.88,33.33
95.24,ALLIANCE > SAIL,89.48,70e37f44-5c3e-4c83-a42a-89b3476d1d45,16.28,8bbcf9f4-a3c4-4f26-aa0e-c5c46457afa3,20.63,Gold,1.1.7,COVID-19 Consolidated Deaths,Gold,89.69,100.0
19.05,,32.78,b4f076d2-c9a3-49ba-84f4-94148dc8511a,53.49,8bbfbc8c-dad2-4a0b-b255-4aae3687a371,55.56,Not Rated,1.1.7,National Joint Registry - Revision Ankle Replacement dataset,Not Rated,38.88,33.33
19.05,,33.95,4985feee-3c91-47be-a122-2e13073bdac9,51.16,8bffc58f-c78c-43c4-b74b-c94479a76f91,50.79,Not Rated,1.1.7,A dataset of monitored patient safety indicators in 3 acute hospital settings,Not Rated,41.27,33.33
19.05,ALLIANCE > BARTS HEALTH,39.76,10bf4c08-6702-44fe-8faa-1280dea6b0c9,39.53,8c7abca7-4292-4d1f-b311-c132a7adf109,38.1,Not Rated,1.1.7,Sectra PACS,Not Rated,38.88,15.87
28.57,ALLIANCE > HQIP,46.84,d94a604c-5733-4f07-93bb-e77b6ea2313f,34.88,8c8cf129-e87c-46b3-8812-19e07578ee89,34.92,Not Rated,1.1.7,Falls and Fragility Fracture Audit Programme Fracture Liaison Service Database clinical dataset,Not Rated,44.45,23.81
4.76,,29.12,fded6e24-8fef-47a4-a65e-9455bed043d3,46.51,8d00d72e-d10a-4cbc-8f81-95339b25c517,46.03,Not Rated,1.1.7,Cancer Patient Experience Survey (CPES) for CPRD Aurum,Not Rated,29.36,4.76
80.95,ALLIANCE > CPRD,77.69,83059be4-071b-4a36-8ab1-9fde1e32e75e,25.58,8d06cb09-640c-40db-8387-adf7fab54c3b,25.4,Silver,1.1.7,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Gold),Silver,81.75,88.89
80.95,ALLIANCE > CPRD,77.69,3bc43876-507b-4dff-bd2b-7df147322e15,25.58,8d24889c-ac3c-4b9d-a8bd-cf9effd64370,25.4,Silver,1.1.7,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Aurum),Silver,81.75,88.89
19.05,,32.78,faf2fc49-d09f-4ea2-a2cb-b1d30fffa406,53.49,8d33b7a7-151a-4e2e-b87f-b14371e0cb37,55.56,Not Rated,1.1.7,Deaths – Date of Death,Not Rated,38.88,33.33
64.29,ALLIANCE > NHS DIGITAL,62.38,31bb8022-f8b1-405a-a22f-140f7c4b4fa6,39.53,8d3f80d4-aeae-46f0-809b-cd6c51e24f75,42.86,Bronze,1.1.7,Bridge file: Hospital Episode Statistics to Mental Health Minimum Data Set,Not Rated,67.46,77.78
4.76,,29.12,216924f0-585e-4842-a165-78cf9e0af0aa,46.51,8da6766c-df44-4414-a858-4415e473ea76,46.03,Not Rated,1.1.7,Developing and evaluating interventions to improve asthma care: HEAL ASTHMA,Not Rated,29.36,4.76
4.76,,29.12,8a3ec96a-0600-4c6d-8761-9d277f07b9da,46.51,8daf5886-4813-465d-9145-3585a8c584bb,46.03,Not Rated,1.1.7,National Asthma and COPD Audit Programme (NACAP): Wales primary care dataset,Not Rated,29.36,4.76
4.76,,29.12,c0e3e61c-000c-43bb-9dd1-55698198a8b6,46.51,8e2a9ef9-bc60-4743-be2d-af453b091b38,46.03,Not Rated,1.1.7,Evaluating the Genetic Factors Associated with Non-Alcoholic Steatohepatitis.,Not Rated,29.36,4.76
61.9,ALLIANCE > IMPERIAL COLLEGE LONDON,64.67,25003f25-384c-4264-9c8f-dd8734ee5595,32.56,8e5e3ebe-c0ae-458f-bc75-a5a3368d4c2d,38.1,Not Rated,1.1.7,REal-time Assessment of Community Transmission (REACT-2),Not Rated,65.87,69.84
19.05,,32.78,fb3fac03-a428-4b3f-8058-5622e1fd57d8,53.49,8e75e0f9-40ed-4505-a8e8-20f21c69ddea,55.56,Not Rated,1.1.7,Children Receiving Care and Support Census (CRCS),Not Rated,38.88,33.33
47.62,ALLIANCE > NHS DIGITAL,57.53,275ac6a4-798b-4f49-a25e-008245050bbc,32.56,8eace3c2-1dc8-4708-9350-ad129b7d2bc9,30.16,Not Rated,1.1.7,Mental Health Services Data Set - Inpatients,Not Rated,57.94,46.03
19.05,,33.95,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,51.16,8f2cb486-6a3b-418e-8fb4-b85bc454eaf3,50.79,Not Rated,1.1.7,Welsh Longitudinal General Practice Dataset (WLGP) - Welsh Primary Care,Not Rated,41.27,33.33
19.05,,33.95,a265af2e-40fc-4759-af61-eab293cdad5a,51.16,8f54b1ad-b8cd-44a3-94d7-c98133ca913d,50.79,Not Rated,1.1.7,Unscheduled Care Data Mart,Not Rated,41.27,33.33
76.19,HUB > PIONEER,75.31,780bf7d0-9ee1-4641-a74f-dc148e361970,25.58,8fac682b-96be-4e21-a2a9-5fe66c3b35ff,25.4,Silver,1.1.7,The impact of hospitalised patients with COPD: from admission to outcome,Bronze,79.36,84.13
19.05,,33.95,3b1bb176-e22f-402a-b863-730d05b22021,51.16,8fc6bf25-df25-429f-be41-b7d5ffd4ff15,50.79,Not Rated,1.1.7,Eye images and retinopathy grades in diabetic eye screening,Not Rated,41.27,33.33
19.05,,33.95,b7d24b82-f8a4-4838-844c-ecd86ddf5db2,51.16,90671a93-53ba-44fe-90f5-b1e138a6819b,50.79,Not Rated,1.1.7,Rural-Urban classification for CPRD Aurum,Not Rated,41.27,33.33
19.05,,32.78,9a36f3f8-3b7e-4e61-8993-b9cc2734fcb8,53.49,90ace555-da01-4940-a3ef-78bb83976ff0,55.56,Not Rated,1.1.7,COVID-19 COG-UK Viral Genome (variant strain data),Not Rated,38.88,33.33
19.05,,30.45,1fc57971-5af5-499e-a500-4ffbb087f0c4,58.14,90db47a7-d082-4778-884c-78f9b6c7e57f,65.08,Not Rated,1.1.7,RAPID (Hospital Stay Level Data),Not Rated,34.12,33.33
19.05,,33.95,22e3943e-edb5-44a1-9e4e-22b0f7a31767,51.16,90f44ae7-8394-4fe5-8c1e-c9aa5bf0edf1,50.79,Not Rated,1.1.7,Prescribing Information System (PIS),Not Rated,41.27,33.33
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,93baeb13-cc4b-47fd-9dae-5ae5277cba54,16.28,914321d0-1d86-4974-a38d-97469f9ff2cd,15.87,Bronze,1.1.7,Bloodwise Childhood Leukaemia Cell Bank,Silver,73.81,63.49
19.05,,33.95,60c1557a-4541-429f-bbe5-f9edbdb34f8a,51.16,9147f060-0210-40a6-a557-ce744a63f912,50.79,Not Rated,1.1.7,"Demographic risk factors, biomarkers, physiology for Acute Compartment Syndrome",Not Rated,41.27,33.33
28.57,ALLIANCE > HQIP,46.84,3afbb83d-d47b-43b3-a202-0d3081e5d294,34.88,91b2fdab-1d0e-41a1-a9cc-1ebb536c7ee5,34.92,Not Rated,1.1.7,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - clinical audit,Not Rated,44.45,23.81
19.05,,32.78,855a84b2-9d58-4b2b-a450-b6c6d534e403,53.49,91f116fc-07f5-47cd-bdbd-f8b68629f98f,55.56,Not Rated,1.1.7,NHS Tayside Virology,Not Rated,38.88,33.33
59.52,HUB > BREATHE,68.13,50b47298-d935-4990-a002-e26b6bb26d30,23.26,91f1aef1-7dfe-4cb3-86ab-15e09f91e969,23.81,Not Rated,1.1.7,Seasonal Influenza Vaccine Effectiveness II,Bronze,64.28,52.38
4.76,,29.12,ee6013d6-5584-4275-b124-3113ee5ad37d,46.51,922f72c0-e3cb-4d89-a56f-50d938a87630,46.03,Not Rated,1.1.7,"Estimate the cost of care, quality of life and wider societal burden due to COPD",Not Rated,29.36,4.76
19.05,,32.78,12babf2b-42e8-4b1e-9143-3475a07bb343,53.49,925feb2c-195f-460c-bae7-f17ea652fd5d,55.56,Not Rated,1.1.7,National Joint Registry - Revision Elbow Replacement dataset,Not Rated,38.88,33.33
4.76,,29.12,a1bcea4c-89dd-4cdb-978c-43db676ed73c,46.51,927beb63-f650-4972-a3ad-af8e29dc26a5,46.03,Not Rated,1.1.7,Omega 3 Cohort,Not Rated,29.36,4.76
92.86,HUB > DATA-CAN,85.97,93582beb-e45a-47b6-aeab-d26f583e4c3b,20.93,931efe47-04eb-4ff3-aa62-97e2e4007aed,26.98,Silver,1.1.7,Yorkshire Specialist Register of Cancer in Children and Young People,Silver,84.92,96.83
95.24,ALLIANCE > SAIL,88.32,bcca421a-9077-4c47-9daa-b1bc030d3dee,18.6,9360bc6c-2a7d-4415-869d-3e853c558f4d,22.22,Gold,1.1.7,National Survey for Wales,Gold,88.89,100.0
19.05,,32.78,30ec0315-5242-40cb-93ad-2c6f244caad4,53.49,93a11fe9-c616-4964-9452-fdf736ec8f11,55.56,Not Rated,1.1.7,HES Maternity for QResearch,Not Rated,38.88,33.33
80.95,HUB > DATA-CAN,77.69,a47a8c77-3ced-43a0-acf0-3997c4eb5a29,25.58,93aeac00-2e6d-44d7-8643-092c587c241a,28.57,Silver,1.1.7,South West Primary Care Dataset,Silver,79.37,87.3
4.76,,29.12,64f78a5f-268f-4951-9c91-f7e7130baffa,46.51,94188672-a44d-4ae3-8bb3-f249891a5af7,46.03,Not Rated,1.1.7,Exploring psychological issues of primary care teams in Malaysia amidst COVID-19,Not Rated,29.36,4.76
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,15f07cef-f4cc-4a50-90bc-9fd40f8b6327,18.6,9445e723-655a-43d0-a4e5-50313d98eac0,17.46,Bronze,1.1.7,National Unified Renal Translational Research Enterprise (NURTuRE),Bronze,71.43,60.32
19.05,,31.62,471f101c-a45e-4620-8710-be3036a46fba,55.81,94c7dca9-a96f-4e77-b156-96676a701834,60.32,Not Rated,1.1.7,Covid Vaccination Dataset (CVVD),Not Rated,36.5,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,ecb82441-286f-408d-880c-9239a25fb5cd,16.28,94e28efd-a976-4748-81fd-956a598c26cb,15.87,Bronze,1.1.7,BioDock,Silver,72.22,60.32
80.95,ALLIANCE > PUBLIC HEALTH SCOTLAND,80.01,a265af2e-40fc-4759-af61-eab293cdad5a,20.93,94f983ec-af41-451a-af5d-657ac58207c6,20.63,Silver,1.1.7,Unscheduled Care Datamart,Silver,83.34,87.3
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,76d26f0f-0136-4ae5-8be9-37782a70bac5,16.28,94fab6d3-9753-4ffd-ade2-02d199d93f94,15.87,Bronze,1.1.7,RAPPER,Silver,73.81,63.49
19.05,,33.95,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,51.16,953f6cc1-bd69-4fbc-a91b-d33f6c7aa6ca,50.79,Not Rated,1.1.7,GP dataset - Welsh Primary Care,Not Rated,41.27,33.33
4.76,,29.12,a6ea6185-2e2e-4738-b7f1-dc052eae902e,46.51,95b26238-3379-4188-ad6c-a09657b77648,46.03,Not Rated,1.1.7,"4 Country ChrOnic Respiratory Disease study: PILOT PHASE, Islamabad",Not Rated,29.36,4.76
59.52,OTHER > UNIVERSITY COLLEGE LONDON,64.64,12f1ffbc-0ddd-4d6e-b126-2cccf6738658,30.23,96c73136-da1b-43de-9fd1-9d5e63631b14,33.33,Bronze,1.1.7,VIVALDI 2,Not Rated,68.25,69.84
83.33,ALLIANCE > SAIL,80.03,f48b7c05-6a44-480c-84c6-4f7a684f29f8,23.26,9709ee81-c5f1-4c01-a1ac-51ae2a0a60f3,23.81,Silver,1.1.7,SAIL Dementia e-Cohort,Silver,83.34,90.48
4.76,,29.12,025c9e8a-938b-4886-9e03-fcad90fe7157,46.51,97771ec7-2abb-4d6e-b630-77c61a5e314a,46.03,Not Rated,1.1.7,FFFAP -  National Hip Fracture Database Facilities Survey 2019,Not Rated,29.36,4.76
4.76,,29.12,0f754b8b-353e-4e8d-9ff0-03d5e0817e02,46.51,97a5f21e-c0a9-4a04-978b-9f054d7b6bcf,46.03,Not Rated,1.1.7,"Resilience, Ethnicity & Adolescent Mental Health (REACH)",Not Rated,29.36,4.76
64.29,ALLIANCE > NHS DIGITAL,60.05,eab996ed-b268-439a-bff4-19925698336a,44.19,97fa09e6-5ea5-41cd-baf8-20366db13a3f,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v4 (Sensitive) Records,Not Rated,64.28,77.78
19.05,,33.95,f6f2978d-4a49-4dd9-8615-78d28e6dc83c,51.16,9836e0e1-5ea2-4dc4-be5a-24e390b7fa33,50.79,Not Rated,1.1.7,Characterisation of hospitalised COPD exacerbations using real world data,Not Rated,41.27,33.33
73.81,ALLIANCE > TISSUE DIRECTORY,77.61,e5ec63dd-4da5-4119-99c8-5cc79045618c,18.6,99812cec-ea1c-4979-8e00-32df5bad000b,17.46,Bronze,1.1.7,RATHL Trial,Silver,73.02,63.49
19.05,,33.95,ee315149-c131-4b7c-b88a-9d4a3e1f7948,51.16,9991ac9c-0aab-4588-a862-eaab2e60a1f7,50.79,Not Rated,1.1.7,Clinical characteristics of hospitalised primary biliary cholangitis patients,Not Rated,41.27,33.33
19.05,,32.78,8e0221d4-dcfa-4580-834b-f44421fca3b5,53.49,99b505ee-44c6-497d-b30b-3ce80eba4047,55.56,Not Rated,1.1.7,Sars-CoV-2 Immunity & REinfection EvaluatioN (SIREN),Not Rated,38.88,33.33
4.76,,29.12,fe610510-fe78-461e-9c73-54dae67cade4,46.51,99bc7b04-5c5b-4e3d-baba-2f7ca4b9d802,46.03,Not Rated,1.1.7,The EPIC-Norfolk Study,Not Rated,29.36,4.76
19.05,,30.45,335905f0-4b94-451e-96f1-5b44f45ea923,58.14,9a18a460-e6d8-405e-84b1-d50c3fb74316,65.08,Not Rated,1.1.7,MR measures of liver fibrosis (MRker),Not Rated,34.12,33.33
80.95,ALLIANCE > CPRD,76.52,61a607a9-b404-41e0-a52e-0c6d0ce8c2be,27.91,9a5fdb85-7bd6-4073-9058-e45667d497a8,30.16,Silver,1.1.7,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Gold),Silver,79.37,88.89
4.76,,29.12,3907a55f-104b-4533-ba21-69bd5f08ce8f,46.51,9a836aa8-60c7-4911-943e-477b0ae8bbb8,46.03,Not Rated,1.1.7,Blended learning for primary care physicians on COPD in Bangladesh,Not Rated,29.36,4.76
19.05,,32.78,6c4ed998-0f05-415c-a3e4-42430bb62d24,53.49,9abb8804-de89-4aba-8877-0e9a405870fe,55.56,Not Rated,1.1.7,Systemic Anti-Cancer Therapy Dataset [SACT],Not Rated,38.88,33.33
19.05,,33.95,89c2c798-2e0f-4235-9cd9-e2347f2dfc50,51.16,9b356432-2650-4ded-aa75-657871b38fe3,50.79,Not Rated,1.1.7,Neovascular age related macular degeneration at University Hospitals Birmingham,Not Rated,41.27,33.33
28.57,ALLIANCE > HQIP,46.84,2b640175-725a-465f-9aec-6794e6d27791,34.88,9b7d2306-35e2-44a3-a97d-0b0e03a15336,34.92,Not Rated,1.1.7,National Cardiac Audit Programme - National Congenital Heart Disease Audit (NCHDA),Not Rated,44.45,23.81
47.62,ALLIANCE > NHS DIGITAL,57.53,add485fa-4c54-4a3e-8676-abe2ff4725a5,32.56,9b7f7994-0b9c-4809-b67d-45ae1f04ec5c,30.16,Not Rated,1.1.7,Mental Health Services Data Set - Currencies,Not Rated,57.94,46.03
78.57,HUB > DATA-CAN,75.33,bc839e9c-e303-4c3c-9c2c-9975602376e2,27.91,9bfba8a4-43c3-4356-93a5-3eb3b7bc247a,30.16,Silver,1.1.7,PHM and Cancer Outcomes in the WYH Cancer Alliance,Bronze,77.78,85.71
19.05,,33.95,0e38bbf4-c788-4a1a-9af8-a24821250154,51.16,9c2356fe-409f-4a34-9fbf-663d2add3902,50.79,Not Rated,1.1.7,Domiciliary Social Care Worker (DSCW),Not Rated,41.27,33.33
19.05,,33.95,ac755244-4143-4629-9170-a9e8fc98bb1e,51.16,9c31bd50-e999-4d4d-bb9d-545c00fcf23e,50.79,Not Rated,1.1.7,Optimum Patient Care Research Database (OPCRD),Not Rated,41.27,33.33
95.24,HUB > BREATHE,88.32,e22ddf52-7f9e-4072-ae61-cb722461b37d,18.6,9ca6e8d2-98d2-4757-84e1-287585400e55,22.22,Gold,1.1.7,"Extended Cohort for E-health, Environment and DNA (EXCEED)",Gold,88.89,100.0
19.05,,32.78,bcca421a-9077-4c47-9daa-b1bc030d3dee,53.49,9cb83fb7-e8d7-436b-b847-e4759b9589c5,55.56,Not Rated,1.1.7,National Survey for Wales Dataset (NSWD),Not Rated,38.88,33.33
19.05,,32.78,ea068fd4-1a96-4ed5-a010-8930afb968bb,53.49,9cc82b97-d508-4cb9-98ca-0105aa897bb6,55.56,Not Rated,1.1.7,UK Renal Registry - Kidney PREM dataset,Not Rated,38.88,33.33
90.48,HUB > GUT REACTION,84.78,f2af20f9-af84-40ce-8a07-7d095948653e,20.93,9d4f445e-f81e-45d7-bd83-7e9f68199b4f,23.81,Silver,1.1.7,IBD NIHR BioResource: Sample holding,Silver,85.72,95.24
19.05,,32.78,fbe1ae63-0c12-48e5-be16-87d6bc7bd179,53.49,9da5acec-1749-46a6-bf93-51457bbaa52c,55.56,Not Rated,1.1.7,National Vascular Registry -  Abdominal Aortic Aneurysm Repair clinical dataset,Not Rated,38.88,33.33
52.38,HUB > BREATHE,63.4,43fc768a-9d2c-4c6d-952f-d8570c487b4a,25.58,9de20d42-8e9b-45c8-8574-52a49fba826c,25.4,Not Rated,1.1.7,Respiratory social media database,Not Rated,59.52,44.44
95.24,ALLIANCE > SAIL,89.48,584bf8c8-d58f-44c6-9b65-e1611144fd54,16.28,9e67001e-7c77-4bc0-9af2-5138b5d638e4,20.63,Gold,1.1.7,Annual District Death Daily,Gold,89.69,100.0
19.05,,33.95,f102ca50-d1e4-44ec-924e-be89446652af,51.16,9ea7a624-ce4c-460e-b68f-0655dac36765,50.79,Not Rated,1.1.7,Radiotherapy Dataset (RTDS),Not Rated,41.27,33.33
19.05,,33.95,edfc20b7-5a5e-40c4-afd0-a7a5bba77003,51.16,9fe99176-1cbf-41f7-901d-245051dbe410,50.79,Not Rated,1.1.7,Granular ICU data focussing on the impact of lactate readings on outcomes,Not Rated,41.27,33.33
19.05,,32.78,14aaf184-5922-4459-affb-6c9e55c12176,53.49,9fff31ef-f927-4832-97cb-edcbb0a19839,55.56,Not Rated,1.1.7,Pregnancy Register for CPRD GOLD,Not Rated,38.88,33.33
19.05,,32.78,7465c65e-c321-42e9-a2f4-6bc664caf1fc,53.49,a0292641-9e1a-495d-a7f2-d9ce87ff0b88,55.56,Not Rated,1.1.7,Outpatient Referral (OPRD),Not Rated,38.88,33.33
19.05,,32.78,9623e62b-3c50-44aa-8923-0bbb94e7ad61,53.49,a03b66c6-f56d-40f8-bb9b-06751d97864c,55.56,Not Rated,1.1.7,National Joint Registry - Revision Shoulder Replacement dataset,Not Rated,38.88,33.33
19.05,,32.78,67020745-9def-4c6e-b5ac-bb273bd0a20e,53.49,a04b16f3-dd24-47de-8c20-699b88eb4da0,55.56,Not Rated,1.1.7,National Neonatal Research Database (NNRD),Not Rated,38.88,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,636e216a-072b-4c8b-b867-23b7666d2cb2,16.28,a06afa88-caba-4354-ac70-d05c67b34dfc,15.87,Bronze,1.1.7,UK CLL Trials Biobank,Silver,72.22,60.32
92.86,NIHR Health Informatics Collaborative Renal Transplantation Theme,77.83,359a322e-3781-4796-b6b2-81962fa19b7a,37.21,a0e0c0c2-072a-47ac-9252-e27b37ac024f,41.27,Silver,1.1.7,HIC Transplantation,Silver,78.57,98.41
64.29,ALLIANCE > NHS DIGITAL,60.05,7b31b427-b447-432e-9a6c-ad2099343491,44.19,a1a67182-e81b-4144-ac51-92a86f277eb2,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Events,Not Rated,64.28,77.78
28.57,ALLIANCE > HQIP,46.84,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f,34.88,a1d41f64-76e1-4576-a906-f64a7fe664c4,34.92,Not Rated,1.1.7,National Paediatric Diabetes Audit - Spotlight survey of diabetes-related technologies,Not Rated,44.45,23.81
95.24,ALLIANCE > SAIL,90.64,9c6e891f-6449-48d2-a1c3-8dd236e34bbd,13.95,a1e1ec62-d78c-40ac-9f90-66ef1dd865b2,15.87,Gold,1.1.7,Brecon dataset,Gold,92.06,100.0
19.05,,32.78,1982d9ef-890a-41ff-a86a-de61d65aaa09,53.49,a25181ec-a00c-4031-9f35-5cb072477e64,55.56,Not Rated,1.1.7,National Asthma & COPD Audit:COPD and adult asthma organisational dataset,Not Rated,38.88,33.33
19.05,,33.95,2843087f-23a4-4cfe-8e72-53f2b9562cc3,51.16,a2a324f8-ccd3-405b-a146-34bbb85cc34a,50.79,Not Rated,1.1.7,Enhanced Prescribing Database,Not Rated,41.27,33.33
95.24,HUB > DATA-CAN,87.16,ce4582a8-0985-46c6-b95f-29a5de862d4a,20.93,a337845e-1dde-445b-90cf-91d8b825e3a5,26.98,Gold,1.1.7,Comprehensive Patient Records for Cancer Outcomes,Gold,86.51,100.0
19.05,,31.62,fd8d0743-344a-4758-bb97-f8ad84a37357,55.81,a34797cd-4ee8-4f79-8c90-cda08b48bf3d,60.32,Not Rated,1.1.7,HDR UK Papers & Preprints,Not Rated,36.5,33.33
4.76,,29.12,dec5d8da-2d63-4ab8-927e-4a5a659dc541,46.51,a41cfa11-ee7f-4ebe-be2a-f1235e34951d,46.03,Not Rated,1.1.7,"Peer-led, Professionals Assisted Pulmonary Rehabilitation (PLPAPR): pilot study",Not Rated,29.36,4.76
95.24,ALLIANCE > SAIL,90.64,aae02f9e-1bad-415d-9730-c46a07a990aa,13.95,a45acd02-82d7-4bfe-9845-6b4df683bba8,15.87,Gold,1.1.7,Care Home Dataset,Gold,92.06,100.0
19.05,,32.78,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1,53.49,a4936ec2-002e-4927-9a46-29ae9b5d695f,55.56,Not Rated,1.1.7,NIHR IBD BioResource: Demographic,Not Rated,38.88,33.33
76.19,ALLIANCE > SAIL,76.47,464d8653-4e69-406b-93fd-d68c29d5dfdc,23.26,a4eb97a6-6a61-415b-9dfb-65503675ed00,25.4,Silver,1.1.7,Health & Attainment of Pupils in a Primary Education Network [HAPN],Silver,77.78,80.95
28.57,ALLIANCE > HQIP,48.0,79ae4881-6223-471a-a278-6b2d3b84f971,32.56,a513dd3b-7e58-4d7f-8164-0a4dbe0a96c0,33.33,Not Rated,1.1.7,Paediatric Intensive Care Audit Network - core dataset (referral),Not Rated,45.24,23.81
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,d0694e15-b6ba-4a95-962a-dbf627ca207c,16.28,a5163bce-7c03-4e61-8ebc-024939c047a8,15.87,Bronze,1.1.7,UK ME/CFS Biobank,Silver,73.81,63.49
19.05,,31.62,84336be3-23bd-466e-b29b-df48db897665,55.81,a5a4a55c-c311-445d-a21f-0e4acb42f227,60.32,Not Rated,1.1.7,ISARIC4C COVID-19 Clinical Information Network (CO-CIN),Not Rated,36.5,33.33
4.76,,29.12,95f385b1-4f5c-4a88-8e79-9613acc66938,46.51,a5b41636-a112-4631-aaee-215bc4cf200e,46.03,Not Rated,1.1.7,Air Quality Study: An ecological analysis of asthma health outcomes in Malaysia,Not Rated,29.36,4.76
28.57,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,46.84,d472a895-8587-4503-956e-3bd66d990979,34.88,a5c088cd-dae6-4c58-b381-a0d273585f4d,34.92,Not Rated,1.1.7,The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease,Not Rated,44.45,23.81
19.05,,33.95,4e5ba567-c452-4979-8e2e-865f7df20252,51.16,a5d1a44f-9e9d-4c6d-9ce0-53889d579781,50.79,Not Rated,1.1.7,Patient Medical Card Registration (NI),Not Rated,41.27,33.33
19.05,,32.78,e54d35a6-2e7c-422d-a4a5-a7da930b08f2,53.49,a6252de5-4fc3-4dc7-950b-2f2528f58533,55.56,Not Rated,1.1.7,Scottish Stillbirth and Infant Death Survey,Not Rated,38.88,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,5618f65d-23fc-4bd5-9a4c-73e4b330c3a6,18.6,a6472a29-17db-477c-bb6e-264686c8fc26,17.46,Bronze,1.1.7,plasmaMATCH,Bronze,71.43,60.32
19.05,,33.95,dec04153-f595-41ce-9d7e-5ef0c3fe8289,51.16,a69493b6-991d-40b5-ba81-2f70c424c557,50.79,Not Rated,1.1.7,Child Health Systems Programme - First Visit,Not Rated,41.27,33.33
4.76,,29.12,3b87eef0-bfb6-4bf4-84b9-29880197fec9,46.51,a7447f01-c3fd-43f1-8fc4-3e6f3b6e59ef,46.03,Not Rated,1.1.7,National Records of Scotland (NRS) - Births Data,Not Rated,29.36,4.76
16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,df70b490-3c00-458e-a6dd-ea3242a3ebac,37.21,a74f72ad-bf70-42e4-8933-069c7b53c7f9,36.51,Not Rated,1.1.7,LIMS,Not Rated,38.89,14.29
4.76,,29.12,929186f3-e230-4b52-a9f5-0c20af7f5ce2,46.51,a8364fd6-2247-4ef0-af8c-51c7b3ec24cd,46.03,Not Rated,1.1.7,The 1970 British Cohort Study (BCS70),Not Rated,29.36,4.76
4.76,,29.12,3731006a-ee7c-4d15-bc07-4eeb29a3d031,46.51,a889651d-a26e-4907-86a3-a06d100d13f5,46.03,Not Rated,1.1.7,NIHR BioResource: NHS Trust data,Not Rated,29.36,4.76
92.86,ALLIANCE > SAIL,88.29,ed131fee-0635-4613-a453-a383d5dd7cec,16.28,a8bb670a-b45b-48a6-8e4d-9e8f61de4f5b,17.46,Gold,1.1.7,Healthcare Workers Risk Assessment,Gold,90.47,98.41
28.57,ALLIANCE > HQIP,48.0,45310176-6331-4bdd-bc53-d9194e212a35,32.56,a8bfd0c4-1aec-47cc-9e45-00a713482fa2,33.33,Not Rated,1.1.7,Paediatric Intensive Care Audit Network - core dataset (transport),Not Rated,45.24,23.81
4.76,,29.12,c027d0ca-7c7d-4864-b4dd-8040f4020fbb,46.51,a8c8978f-b5dc-448c-9a03-4d961d79a863,46.03,Not Rated,1.1.7,Scottish Immunisation Recall System (SIRS),Not Rated,29.36,4.76
61.9,HUB > BREATHE,71.65,86838cad-d5d3-4b65-9c37-29b0c8c36309,18.6,a8f5117e-7523-452f-abf3-ced72f03cb2e,19.05,Bronze,1.1.7,Salford Lung Study,Bronze,68.25,55.56
73.81,HUB > PIONEER,74.12,ddf7f82f-b453-442d-b562-bb0157593831,25.58,a9b50e33-9974-4635-8e52-9c9b3cb87eb2,25.4,Silver,1.1.7,"Demography, interventions & outcomes of patients with Cerebrovascular Disease",Bronze,78.57,82.54
92.86,HUB > DISCOVER NOW,87.13,0f930154-0a0e-4bef-9464-59e657b904d6,18.6,a9f4a852-a1f2-4041-bb33-3a50e6c43f8d,22.22,Gold,1.1.7,North West London Primary Care Events Data (NWL PCE),Gold,87.31,96.83
64.29,ALLIANCE > NHS DIGITAL,60.05,348b12fb-7718-477e-a572-4fc3c716152d,44.19,aa019da2-0f2f-493c-95e8-7263ee735f46,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v3_3.5 (Non-Sensitive),Not Rated,64.28,77.78
80.95,ALLIANCE > SAIL,77.69,fc24482c-0f9b-445f-af7a-8598627c3b15,25.58,aa1fe6a9-79cc-4afc-bd38-ec0d5e4fc195,31.75,Silver,1.1.7,ONS 2011 Census Wales (CENW),Silver,78.57,88.89
19.05,,32.78,487222b7-5c13-4a92-8b41-044796048720,53.49,aa25e5e4-9d53-4f7b-a7fb-228835f6bfd8,55.56,Not Rated,1.1.7,Death Registration Data - Provisional Monthly Extracts,Not Rated,38.88,33.33
19.05,,32.78,1789286a-deaf-49df-88cd-660e92934af6,53.49,aabb918b-b15f-4c1e-a50a-8ceee6993d70,55.56,Not Rated,1.1.7,Critical Care Dataset (CCDS),Not Rated,38.88,33.33
4.76,,29.12,bfa012ad-e609-4d15-a824-6d143758ca4d,46.51,aad2340a-ab87-40ee-bfbe-c56adb01fd47,46.03,Not Rated,1.1.7,Assessing the eDPSEEA model in seasonal pollen induced asthma in Islamabad,Not Rated,29.36,4.76
19.05,,32.78,f75b02f0-a45f-433a-a669-420c8bd40720,53.49,ab0f56e2-681f-4e43-b798-94685ddc3c4a,55.56,Not Rated,1.1.7,Weekly SUS ECDS Dataset,Not Rated,38.88,33.33
4.76,,29.12,153c0ba6-f2ec-4fb4-b5a7-33e11cbdf7fc,46.51,ab2dafd8-b513-4b33-9365-5eb74f32f9d1,46.03,Not Rated,1.1.7,Developing Patient and Public Involvement in Research in Malaysia,Not Rated,29.36,4.76
4.76,,29.12,563c0bfc-437e-4c10-b144-b392d983017c,46.51,ab7f482c-42ea-4ddb-8c92-5ecc1be868ce,46.03,Not Rated,1.1.7,GOAL,Not Rated,29.36,4.76
19.05,,33.95,245bffa9-07c3-40b6-916b-161062cdf674,51.16,ac057e24-22d8-478e-8988-89fe4ee67b6c,50.79,Not Rated,1.1.7,Walker Study Data,Not Rated,41.27,33.33
19.05,,32.78,00201dde-1faf-41d3-b282-5c24c0ca3697,53.49,ac7927ca-ef8b-47d7-abce-33a03baaac5c,55.56,Not Rated,1.1.7,Tayside Bowel Screening Dataset,Not Rated,38.88,33.33
61.9,ALLIANCE > NHS DIGITAL,61.19,285ae0ae-196b-4a75-b1f1-78b07162acfa,39.53,acafb160-b18a-436e-90f1-dc4530a90267,39.68,Bronze,1.1.7,Mental Health Minimum Data Set,Not Rated,67.46,74.6
76.19,ALLIANCE > NHS DIGITAL,75.31,f61f116d-f732-450e-9d34-c6ae00e3fd1e,25.58,ad376d74-4f12-4fb4-8d34-a9e7d0b45b3b,28.57,Silver,1.1.7,COVID-19 SARI-Watch (formerly CHESS),Bronze,77.78,84.13
19.05,,33.95,0cac3870-dd13-44fc-97c2-4bdb67550b39,51.16,ad5dd22c-f6e1-4338-9d4e-80e4b9ec8f26,50.79,Not Rated,1.1.7,2019 UK Parkinson's Audit - Elderly care and neurology,Not Rated,41.27,33.33
88.1,HUB > GUT REACTION,83.58,02ddc5c9-03d4-40e4-9934-e60817ec8f3e,20.93,ad638da8-366b-481f-995e-fc326301eb16,23.81,Silver,1.1.7,IBD NIHR BioResource: Contact detail,Silver,84.12,92.06
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,0d4f0103-82d8-43f4-8058-4aec80ea562f,16.28,adbee090-9634-455e-9be1-62843158fb08,15.87,Bronze,1.1.7,Cardiff School of Dentistry Tooth Bank,Silver,72.22,60.32
92.86,HUB > DISCOVER NOW,87.13,788857b5-6a5b-4ec2-825e-d965e291cf45,18.6,adce90ad-d576-4c98-9de9-dca19f7f4d41,22.22,Gold,1.1.7,North West London Admitted Patient Care Data (NWL APC),Gold,87.31,96.83
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,cee932f8-151c-4834-ac6d-61d842f9d170,16.28,ae2022bc-2083-4e57-b825-1fb610d910ee,15.87,Bronze,1.1.7,Biobank for patients with retinal degenerations & dystrophies,Silver,72.22,60.32
19.05,,32.78,c8f2ee14-2831-445d-a207-2f7f932f4735,53.49,ae68c3c8-7930-40bd-86e8-7ca1aa6ce57d,55.56,Not Rated,1.1.7,COVID antigen testing - Pillar 2,Not Rated,38.88,33.33
95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,69bdac5f-bb70-4ca5-a5ce-51a6106ad00b,20.93,ae788191-69e5-4a03-b11b-bd25574b0e4f,30.16,Silver,1.1.7,Cystic Fibrosis Patient NTM culture,Gold,84.92,100.0
19.05,ALLIANCE > BARTS HEALTH,39.76,cae0a9a5-1bf2-49c3-b8d1-c315d3239074,39.53,ae9e8a9f-533f-4823-8e00-84e39ad2c266,38.1,Not Rated,1.1.7,Community Services Dataset,Not Rated,38.88,15.87
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,095d805c-4b62-4726-b968-bb2f1c463701,16.28,af2b3e6d-718e-464a-8c0d-5882fa1d869f,15.87,Bronze,1.1.7,Manchester Cancer Research Centre (MCRC) Biobank,Silver,73.81,63.49
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,097540aa-a0ed-492e-853b-9ebcfd061dea,16.28,af2ecff2-398c-437f-8c45-adef2406ce43,15.87,Bronze,1.1.7,Cardiff University Biobank,Silver,73.81,63.49
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,df9b7bb1-1b26-4e67-b885-df2dcb8e3450,16.28,af4af5cc-a9eb-4e0e-b50a-3cab4ac2daf9,15.87,Bronze,1.1.7,NIHR Exeter Clinical Research Facility,Silver,72.22,60.32
19.05,,33.95,d415a5c5-8432-4a81-937f-12135ade6de7,51.16,af6db86a-b901-442e-adf5-f29f6c1dc16e,50.79,Not Rated,1.1.7,Welsh Ambulance Services NHS Trust (WAST) - Legacy,Not Rated,41.27,33.33
19.05,,32.78,a290592c-a6f5-4874-b283-1d33e923c487,53.49,afc74c32-efdf-4aab-a0bb-fe5586f4af78,55.56,Not Rated,1.1.7,National Audit of Care at the End of Life - organisational level audit,Not Rated,38.88,33.33
4.76,,29.12,5df03d24-ad95-4d64-96df-0684a4f26e58,46.51,b009b68f-730a-4d72-9a3c-c917b1ff715d,46.03,Not Rated,1.1.7,Childhood Pneumonia Governance in Bangladesh,Not Rated,29.36,4.76
19.05,,33.95,3abc20ce-3dc6-4715-9de0-56aa97a6f5ec,51.16,b0319b9b-14ba-4e23-86ff-89363d4d69a7,50.79,Not Rated,1.1.7,COVID antigen testing - Pillar 1,Not Rated,41.27,33.33
19.05,,31.62,57fa56f2-78d1-49af-ab8d-e8146d711868,55.81,b04e89c3-3c56-4ad9-b929-d3937874df52,60.32,Not Rated,1.1.7,Emergency Care Dataset (ECDS),Not Rated,36.5,33.33
19.05,,32.78,d8c67899-2d81-48c2-8482-31cd33973a36,53.49,b05cb16b-80dc-4e16-8d86-8ee741a5e051,55.56,Not Rated,1.1.7,National Audit of Care at the End of Life - case note review,Not Rated,38.88,33.33
19.05,,31.62,6f8182d2-2993-400d-829d-b52cdb324bf3,55.81,b07485ca-2d45-483d-9336-32cca4504712,60.32,Not Rated,1.1.7,SICSAG Episodes (Scottish Intensive Care Audit Group),Not Rated,36.5,33.33
19.05,,33.95,e171a080-a4cd-4e64-9c2b-e72beb7cac78,51.16,b132812c-7a5c-4d2d-aca2-fdcdb890283a,50.79,Not Rated,1.1.7,HIV-POGO,Not Rated,41.27,33.33
19.05,,32.78,0c67a669-7a19-4cb8-b7b0-42a19f84d56d,53.49,b24500e6-4078-43ee-989c-1d425b9d3906,55.56,Not Rated,1.1.7,CPRD Aurum CHESS,Not Rated,38.88,33.33
4.76,,29.12,e63613a9-92e9-4147-8a76-40e4a87ec131,46.51,b2f48da1-d3c6-4126-a74b-e87c2f629ef8,46.03,Not Rated,1.1.7,Lothian Birth Cohort 1936 (LBC1936),Not Rated,29.36,4.76
95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,bea354e8-c552-41ef-80c2-a76ca5767e4b,20.93,b2fb79c5-26db-484b-8e93-1c56d7654f57,30.16,Silver,1.1.7,Cystic Fibrosis Patient Transplants,Gold,84.92,100.0
19.05,,32.78,0c43c0b6-de3a-478b-8190-4da37fbe5ff5,53.49,b3004f9b-11a0-482b-9cec-791b28fd492e,55.56,Not Rated,1.1.7,Fife Microbiology: Tests,Not Rated,38.88,33.33
19.05,,32.78,c319c402-7ca7-4e2b-bd17-a1abacf9f84c,53.49,b32322b4-edd9-48ed-9204-de1259f0dfc1,55.56,Not Rated,1.1.7,Covid 19 Accident and Emergency Statistics,Not Rated,38.88,33.33
95.24,NIHR Health Informatics Collaborative Critical Care Theme,80.18,4f546f1e-433c-4884-a090-2a4520c878ac,34.88,b40777a2-468b-4b45-8b7d-2f62f912e950,39.68,Silver,1.1.7,HIC ICU 8.3.2,Silver,80.16,100.0
80.95,ALLIANCE > SAIL,77.69,0628fb77-057d-4838-b80e-18245a8f535d,25.58,b43309eb-7860-49b7-9f11-1a7a0fd5532e,31.75,Silver,1.1.7,UK Cystic Fibrosis Registry (CYFI),Silver,78.57,88.89
95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,0ad31772-0893-4cf7-bab0-683e80302201,20.93,b5033be2-0744-49c5-a398-a4d3ed4e1deb,30.16,Silver,1.1.7,Cystic Fibrosis Patient Chronic Medication,Gold,84.92,100.0
61.9,ALLIANCE > NHS DIGITAL,58.86,ef22c16c-c294-46e1-abf9-5204212e9053,44.19,b53f716d-a5c3-4ad8-a2aa-cae09c12ac18,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Episodes,Not Rated,62.69,74.6
83.33,ALLIANCE > SAIL,78.88,f102ca50-d1e4-44ec-924e-be89446652af,25.58,b589b19b-b43f-4344-affb-5d7ea328c909,25.4,Silver,1.1.7,Radiotherapy Dataset,Silver,82.54,90.48
19.05,,32.78,c8b6c319-239b-4792-9898-644a63d07ab5,53.49,b63aadf4-da85-478e-a171-05714ef9057e,55.56,Not Rated,1.1.7,National Vascular Registry - Lower Limb Angioplasty clinical dataset,Not Rated,38.88,33.33
4.76,,29.12,d62939c4-e4a8-4fca-91ed-54f7f87fb89e,46.51,b670cfe7-d4e2-46e5-b3e9-dccfd05c02d2,46.03,Not Rated,1.1.7,DataLoch Core,Not Rated,29.36,4.76
69.05,HUB > BREATHE,75.22,59521b01-6adb-4dd3-8b40-dbeb51171e4f,18.6,b6a60be1-5d94-41f9-a426-5f9523a98d50,19.05,Bronze,1.1.7,Development of spirometry predictive values for Indian population,Bronze,69.84,58.73
19.05,,33.95,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,51.16,b6f26b11-da8d-402a-91c7-3b7122be274c,50.79,Not Rated,1.1.7,Welsh Demographic Service (WDSD),Not Rated,41.27,33.33
19.05,,33.95,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,51.16,b6fe3b50-aff3-435d-9c57-8b46eaa34671,50.79,Not Rated,1.1.7,Welsh Longitudinal GP Dataset - Welsh Primary Care (WLGP),Not Rated,41.27,33.33
95.24,ALLIANCE > SAIL,90.64,8ee61578-e298-423a-be22-cb0438023e5c,13.95,b70900e9-85e9-4dd2-ae4b-02523be4219d,15.87,Gold,1.1.7,Cafcass England,Gold,92.06,100.0
19.05,,32.78,ceae4fe0-4e98-4e3c-85db-e86539aade81,53.49,b789c975-7042-445c-bfa6-c24e5ca8a983,55.56,Not Rated,1.1.7,UHB 100K Genomics patient clinical data including their acute care contacts,Not Rated,38.88,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,89497432-17e0-49f4-96a4-65ef57d07701,16.28,b7a352ee-6306-4bd8-b9bc-f2a69fe17d70,15.87,Bronze,1.1.7,Public Health England Seroepidemiology Unit,Silver,72.22,60.32
19.05,,32.78,981b8787-45be-4f61-8625-3e3aae6ef10a,53.49,b8a46533-aa49-49d9-a0a2-7326e37f958e,55.56,Not Rated,1.1.7,CPRD Aurum SGSS,Not Rated,38.88,33.33
4.76,,29.12,57526718-0a9a-42ad-8b7a-582d9ef96d13,46.51,b95a3ebd-f1f2-4f5f-a598-1eaa60dd1790,46.03,Not Rated,1.1.7,COVID-19 Detection from Chest X-Rays using Deep Learning,Not Rated,29.36,4.76
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,47f979bc-da9d-4e9e-9f2b-15e09366db04,18.6,b9642fb3-3bee-491b-8d83-22f9de0fd77f,17.46,Bronze,1.1.7,ESPAC-TPlus,Bronze,71.43,60.32
19.05,,32.78,6a6c4568-59e9-4760-89d6-07558a24944c,53.49,b97ff350-f84d-4739-a4d6-f3a607063799,55.56,Not Rated,1.1.7,2019 UK Parkinson's Audit - Patient Reported Experience Measure (PREM),Not Rated,38.88,33.33
19.05,,33.95,0d556d7e-be27-4979-a09e-d419b2e838f3,51.16,b988b8bc-fbc5-40a7-8123-76ea5286b8c7,50.79,Not Rated,1.1.7,Hospitalised patients with diabetic emergencies & acute diabetic health concerns,Not Rated,41.27,33.33
28.57,ALLIANCE > HQIP,48.0,6c78af2c-3898-435e-b1f4-e6a44682dc71,32.56,b9b4ee9a-3ffa-483d-8e46-16f862c83740,33.33,Not Rated,1.1.7,Paediatric Intensive Care Audit Network - customised data collection,Not Rated,45.24,23.81
4.76,,29.12,cf190350-74c6-45f2-8ede-69ace62eb88d,46.51,b9ffcd6b-cabd-4875-ac5c-5cb878f7290f,46.03,Not Rated,1.1.7,Pneumonia case management practices in selected communities in Pakistan,Not Rated,29.36,4.76
64.29,ALLIANCE > NHS DIGITAL,60.05,3adeb2f4-a924-49cb-9537-84a9a4242a62,44.19,ba071b0b-5ef4-457b-b194-3a69c2c71a06,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v4 (Non-Sensitive) Events,Not Rated,64.28,77.78
19.05,,32.78,b06415af-9151-4ccc-83a1-ab859943fb2b,53.49,ba0bf718-05ab-4a6c-9419-1d04991d9ee9,55.56,Not Rated,1.1.7,National Joint Registry - Primary Elbow Replacement dataset,Not Rated,38.88,33.33
19.05,,32.78,8002b4d7-ff3b-4402-b805-a6a0022836fd,53.49,ba30a8b6-bfc7-4105-b094-11f187c7b293,55.56,Not Rated,1.1.7,Emergency Department (Symphony),Not Rated,38.88,33.33
19.05,,31.62,90131a34-3cc8-4a74-b72f-d9600cfa2808,55.81,ba936454-e65e-491d-a16d-79115a4da09a,60.32,Not Rated,1.1.7,BathTAP Updating Cohort 1,Not Rated,36.5,33.33
19.05,,33.95,594cfe55-96e3-45ff-874c-2c0006eeb881,51.16,bb04212f-0626-4cbe-8863-a2cc1df40683,50.79,Not Rated,1.1.7,COVID-19 Symptom Tracker Dataset (CVST),Not Rated,41.27,33.33
19.05,,33.95,bd85a09c-fe4a-41b8-81d2-77feadcd1a0a,51.16,bb3152a1-aaef-4c0e-b0da-0fa94503b9da,50.79,Not Rated,1.1.7,Patient postcode linked deprivation measures for CPRD Aurum,Not Rated,41.27,33.33
19.05,,32.78,877a7275-b99d-4ed4-9691-de577e0ab49e,53.49,bb61567b-431f-4e30-b906-654490ea14c7,55.56,Not Rated,1.1.7,IBD NIHR BioResource: Case report form,Not Rated,38.88,33.33
19.05,,32.78,e3b36044-e1fb-418b-946a-b83626bf2e3f,53.49,bb833f51-bc38-4489-b693-6658ea772393,55.56,Not Rated,1.1.7,CDE Clinical Events,Not Rated,38.88,33.33
19.05,,32.78,4ac15572-fe9a-46d3-860d-a46b616181f7,53.49,bbd0a590-f4ee-4133-abe0-696cb247b3e0,55.56,Not Rated,1.1.7,Labour Force Survey (Longitudinal),Not Rated,38.88,33.33
4.76,,29.12,0ceaaedc-4904-4820-8b74-d6a8e679fb11,46.51,bbed7a4e-0c38-48b8-b4f8-b617ec307f59,46.03,Not Rated,1.1.7,1958 National Child Development Study (NCDS),Not Rated,29.36,4.76
28.57,ALLIANCE > HQIP,46.84,ac7016ce-f7a9-4c71-bebb-6af6efa27844,34.88,bc236fba-2935-4406-aaa9-0006cbbf693d,34.92,Not Rated,1.1.7,National Cardiac Audit Programme - National Audit of Percutaneous Coronary Interventions (PCI),Not Rated,44.45,23.81
19.05,,33.95,ae2192ce-7d75-4cec-8ebd-e07c2eacb7c3,51.16,bd18eb49-9789-4ed3-a6c1-7b4f851ec2e7,50.79,Not Rated,1.1.7,"Urinary tract infections acute presentations: microbiology, treatment, outcome",Not Rated,41.27,33.33
83.33,ALLIANCE > SAIL,80.03,17056e83-ee5a-4fe7-86e1-f09563256be1,23.26,bd87cdf4-ec39-41f6-bb07-c19f10372840,26.98,Silver,1.1.7,Education Daily Attendance Dataset,Silver,81.75,90.48
64.29,ALLIANCE > NHS DIGITAL,60.05,3d348613-2d66-4814-a294-7e0c365f43f8,44.19,bdc17b2c-8b0f-4959-ab9b-e2de32d8a5f9,49.21,Not Rated,1.1.7,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Events,Not Rated,64.28,77.78
19.05,,32.78,0bf54842-c1db-4bdb-9f55-c5be490bf758,53.49,bdc4999c-71f6-4e94-aabc-e232ff423f10,55.56,Not Rated,1.1.7,Referral to Treatment Times (RTTD),Not Rated,38.88,33.33
59.52,ALLIANCE > OXFORD UNIVERSITY HOSPITALS,65.81,9de2f365-4c5d-4252-acee-6270b113aa93,27.91,be1368c6-c97f-4ce0-8322-f97ccb28b9c3,31.75,Bronze,1.1.7,Oxford Healthcare Workers,Not Rated,68.25,68.25
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,22aa219f-f3c8-4a25-822e-aa2504f6f29a,18.6,be77a483-2eff-4c05-8091-035fe79b3c8a,19.05,Bronze,1.1.7,Barts CTU,Bronze,70.64,60.32
19.05,,31.62,a05aef07-c3fa-4331-905a-6b6f58eac3d5,55.81,be8ec01c-20ea-4863-ba7c-6d103df85a42,60.32,Not Rated,1.1.7,2011 Census - COVID19 Research Database Subset,Not Rated,36.5,33.33
19.05,,33.95,9f689ef4-26c6-4f85-80ff-5116974f315a,51.16,bf36d50c-111e-462a-be66-9ef586df1afb,50.79,Not Rated,1.1.7,Practice postcode linked deprivation measures for CPRD Aurum,Not Rated,41.27,33.33
16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,38.57,2c6adf80-f30b-46c9-b9d4-fe3e68622469,39.53,bf83ada4-b72e-4789-b177-12a53aa763ea,38.1,Not Rated,1.1.7,TheatreEvents,Not Rated,38.09,14.29
19.05,,31.62,cc7aa34f-81df-42f8-ad69-80e136c48bf1,55.81,bfbd3c63-8902-4242-97d5-ca935591e8cb,60.32,Not Rated,1.1.7,EU Farm Structure Survey Wales (EUFS),Not Rated,36.5,33.33
19.05,,32.78,55a744c4-a2d4-4ea0-b0eb-1af6e1465383,53.49,c01fbdae-33e3-4839-b842-3b61a722a925,55.56,Not Rated,1.1.7,"Ventilatory strategies, medications and outcomes for patients with COVID",Not Rated,38.88,33.33
71.43,ALLIANCE > TISSUE DIRECTORY,76.42,b3ec5c18-e339-4bd8-8a59-5a3445a81f16,18.6,c03468f4-ba51-4d9f-a785-f041adb84724,17.46,Bronze,1.1.7,Daisy Tumour Bank,Silver,73.02,63.49
19.05,,32.78,3ddfccc3-ba32-4653-a999-966b8d6c412f,53.49,c13ee365-cc04-4512-b371-7908fb717525,55.56,Not Rated,1.1.7,Hospital Episode Statistics Accident and Emergency,Not Rated,38.88,33.33
95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,88.32,19bc55c2-13d7-4488-a52c-35287483ea4e,18.6,c1682cb7-8f43-49fa-b66a-0a4a205885d3,25.4,Gold,1.1.7,Cystic Fibrosis Patient Demographics,Gold,87.3,100.0
19.05,,33.95,56a66de8-3470-4a36-ac71-4d5471e72654,51.16,c22e5f4e-02e2-4b54-b895-5e31b75a1f44,50.79,Not Rated,1.1.7,National Radiotherapy Dataset (RTDS) for CPRD GOLD,Not Rated,41.27,33.33
19.05,,32.78,98372a87-f3e6-475d-be12-46c0f9587413,53.49,c230a8d8-bf78-4713-8f2f-312162e92e55,55.56,Not Rated,1.1.7,COVID-19 Vaccination Status,Not Rated,38.88,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,ba0edcaf-854d-4907-851a-280b56128b3b,18.6,c2c77d1a-d4d8-40cd-95f3-31912d4bd561,17.46,Bronze,1.1.7,NICAM: Nilotinib treatment for c-KIT mutated advanced AMM,Bronze,71.43,60.32
95.24,ALLIANCE > SAIL,89.48,7465c65e-c321-42e9-a2f4-6bc664caf1fc,16.28,c2ddca9f-f144-437b-ac7a-0a628a50ba1a,20.63,Gold,1.1.7,Outpatient Referral,Gold,89.69,100.0
80.95,ALLIANCE > NHS DIGITAL,77.69,9a434a5c-563b-4da1-9133-9994960ade54,25.58,c2e112a0-a198-46b0-9a0c-ec91edfb6839,26.98,Silver,1.1.7,National Diabetes Audit,Silver,80.16,87.3
19.05,,30.45,ce60d677-6263-4d41-9d45-d3c7ebb3ee36,58.14,c303bdc0-fa5d-4c22-84ca-83577446062d,65.08,Not Rated,1.1.7,Covid Lateral Flow Test (CVLF),Not Rated,34.12,33.33
4.76,,29.12,cd8f4e44-0228-4abd-9286-0509afe9427e,46.51,c34e6ba2-f857-43e9-9cf5-372a44347833,46.03,Not Rated,1.1.7,University College London - Edinburgh-Bristol (UCLEB) multi-omics consortium,Not Rated,29.36,4.76
71.43,ALLIANCE > TISSUE DIRECTORY,76.42,85113a93-89ed-40e3-a479-33b461b91858,18.6,c3b4f4f2-953e-4470-bedd-9d09fd30a508,17.46,Bronze,1.1.7,TRICON8,Silver,73.02,63.49
78.57,ALLIANCE > PUBLIC HEALTH SCOTLAND,75.33,a05aef07-c3fa-4331-905a-6b6f58eac3d5,27.91,c4426ec2-fbf0-45b2-9f68-0477527257a0,33.33,Silver,1.1.7,2011 Census variables (and variable breakdowns),Bronze,76.98,87.3
19.05,,32.78,97896866-ab5e-408a-ac5a-072802db9faf,53.49,c474492c-1c9d-4e94-bc85-270aab69a74d,55.56,Not Rated,1.1.7,Diagnostic and Therapy Services Waiting Times (DATW),Not Rated,38.88,33.33
19.05,,32.78,c7b1e328-f2d7-4d11-b38f-ce9930b95ca0,53.49,c47f463f-6e7e-4abb-b9bc-010ae68156b7,55.56,Not Rated,1.1.7,National Waiting List Open Pathways,Not Rated,38.88,33.33
57.14,ALLIANCE > UNIVERSITY OF NOTTINGHAM,63.45,596077a9-298b-44cc-aa7a-81f04cf5dcb3,30.23,c66f943f-4307-4486-817c-49f6d8b9fd6b,36.51,Not Rated,1.1.7,PANTHER study,Not Rated,65.08,66.67
19.05,,33.95,5844bde6-628d-4e76-bb56-3534e2728eb6,51.16,c6859b1b-4d5b-46bd-8532-089cff743be7,50.79,Not Rated,1.1.7,Child Health Systems Programme - 4-5 year review,Not Rated,41.27,33.33
54.76,HUB > BREATHE,64.59,bc5d6d69-ec03-42fe-a63b-638c25c5258c,25.58,c6e2fffb-4817-462e-ba7e-ff546728f3d1,25.4,Not Rated,1.1.7,Exogenous sex steroid hormones and asthma in females of reproductive age,Not Rated,61.11,47.62
64.29,ALLIANCE > NHS DIGITAL,60.05,334afc50-a05a-43b9-aa1e-a012a22733e0,44.19,c713773c-e961-400e-b44a-947002deb073,49.21,Not Rated,1.1.7,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Episodes,Not Rated,64.28,77.78
76.19,ALLIANCE > TISSUE DIRECTORY,77.63,b3b790a7-a455-4efb-9c68-60e7131cb836,20.93,c78122ae-8be1-40d7-8567-b83059941c16,19.05,Bronze,1.1.7,SCOT translational sample collection,Silver,73.81,66.67
19.05,,33.95,865c99c4-bbe9-45de-83b9-290fb54d5470,51.16,c8654ef8-585c-4ac4-ac0e-33a875d407a1,50.79,Not Rated,1.1.7,UHB Linked Diabetic Eye Disease in Acute Diabetic Hospital Admissions,Not Rated,41.27,33.33
19.05,,33.95,1d5b9205-dae4-4b0e-a3d3-04707875edf8,51.16,c8edcbd8-40e6-4c34-b138-307a94c19cc0,50.79,Not Rated,1.1.7,Admissions and Discharges,Not Rated,41.27,33.33
19.05,,32.78,c43501ec-08b4-4d33-a7dd-d19fca821925,53.49,c8f36174-aaa7-4388-bea9-48fffb2c441c,55.56,Not Rated,1.1.7,HES Accident and Emergency data for CPRD Aurum,Not Rated,38.88,33.33
19.05,,32.78,fa257aa8-51fc-4eb7-a448-e473fa54686d,53.49,c9322345-9fe2-404e-8dcb-0b4d8856459b,55.56,Not Rated,1.1.7,Emergency Department Dataset Daily (EDDD),Not Rated,38.88,33.33
19.05,,32.78,15cf4241-abad-4dcc-95b0-8cd7c02be999,53.49,c93ff611-458c-4fc8-bb94-5274988f7f7f,55.56,Not Rated,1.1.7,Annual District Death Extract (ADDE),Not Rated,38.88,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,f86400cb-7cab-4e34-aab6-57138b6a96c2,16.28,c960ffab-a94c-45e3-96a0-598719acfbf5,15.87,Bronze,1.1.7,National Diet and Nutrition Survey (NDNS),Silver,72.22,60.32
64.29,ALLIANCE > NHS DIGITAL,60.05,01c88a30-b14d-401e-82bb-165cbde81942,44.19,c97b8058-a6a4-4c8d-92e1-6e9f4cddd301,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Records,Not Rated,64.28,77.78
19.05,,33.95,f5f6d882-163d-4ef1-a53e-000fba409480,51.16,c9809e56-5b29-4ab4-a5f3-f72a2d6419fc,50.79,Not Rated,1.1.7,COVID-19 Test Results (PATD),Not Rated,41.27,33.33
19.05,,33.95,1d574c14-1af0-490d-9c4e-be88cfd0e345,51.16,c9c2f711-00a0-4b5a-abf8-2d1353d7cd67,50.79,Not Rated,1.1.7,CPRD Aurum,Not Rated,41.27,33.33
73.81,ALLIANCE > NHS DIGITAL,72.95,2004c512-f7c9-4995-b820-55f36aa3fad2,27.91,ca05a688-c305-4ebd-967f-facb010c29bf,26.98,Silver,1.1.7,Secondary Uses Services Payment By Results,Bronze,76.98,80.95
95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,88.32,11360490-8da3-4a25-bb87-4fcc249b9af5,18.6,ca2c6ec0-00ce-42fc-a077-88911259576c,25.4,Gold,1.1.7,Cystic Fibrosis Patient Annual Review Encounters,Gold,87.3,100.0
19.05,,32.78,c294bb01-062b-494e-942b-1efe8cbac3dc,53.49,ca8c912d-82c4-481e-b17a-b567e3bf3c72,55.56,Not Rated,1.1.7,NHS Tayside and Fife Haematology (Lab Data Restructured),Not Rated,38.88,33.33
95.24,ALLIANCE > CYSTIC FIBROSIS TRUST,87.16,f72e80fc-dcd3-4457-ae91-dd14449002dd,20.93,caa644b6-a50d-455b-bee1-96232443e2b9,30.16,Silver,1.1.7,Cystic Fibrosis Patient Liver Enzyme,Gold,84.92,100.0
4.76,,29.12,97ac8a7d-30b9-4fa6-84db-b4f9430fc1d6,46.51,caab69a0-b560-4320-ac61-557f81f37ae3,46.03,Not Rated,1.1.7,The Million Women Study,Not Rated,29.36,4.76
19.05,,33.95,be7efa4f-e500-4a54-8157-6c4442a7e8a8,51.16,cace4854-a8de-4487-9c43-fe580b341d26,50.79,Not Rated,1.1.7,Northern Ireland Regional Maternity system (NIMATS),Not Rated,41.27,33.33
19.05,,33.95,b54d9224-a03f-4d53-8de8-c253b65a8172,51.16,cb0b4506-8c28-4cad-abf0-1abaf59c6a2c,50.79,Not Rated,1.1.7,ECHO,Not Rated,41.27,33.33
71.43,ALLIANCE > TISSUE DIRECTORY,76.42,e0b951ba-0f7d-4743-9374-b965042accdd,18.6,cb7370a6-a1b0-4473-a32f-ec85ec0155a5,19.05,Bronze,1.1.7,UKCTOCS Longitudinal Women's Cohort (UKLWC),Silver,72.22,63.49
19.05,,33.95,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,51.16,cbab40e4-9e61-4466-b706-db47771d2512,50.79,Not Rated,1.1.7,Congenital Anomaly Register and Information Service (CARIS),Not Rated,41.27,33.33
19.05,,32.78,d94a604c-5733-4f07-93bb-e77b6ea2313f,53.49,cbb0568c-510e-49de-af43-edb9345535a8,55.56,Not Rated,1.1.7,Falls & Fragility Fracture Audit  Fracture Liaison Service  clinical dataset,Not Rated,38.88,33.33
19.05,,31.62,69a356d6-599e-4d02-8241-066ce3c297bd,55.81,cc1a15ea-1bca-42c5-9915-8e6bfd733d6e,60.32,Not Rated,1.1.7,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - Scotland,Not Rated,36.5,33.33
64.29,ALLIANCE > NHS DIGITAL,60.05,c00d5ad2-d5d2-4318-8849-4c2fe52aabd0,44.19,cc383a3f-1c47-4b7d-99cf-be8ee0afe401,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v4.1 (Sensitive) Records,Not Rated,64.28,77.78
73.81,ALLIANCE > TISSUE DIRECTORY,76.44,18bc81e3-7d99-4152-bd7a-3c90ee7e489d,20.93,cde234d0-748b-4df6-a59d-3268cc7e8c1d,19.05,Bronze,1.1.7,RIO,Silver,72.22,63.49
92.86,ALLIANCE > SAIL,88.29,bff94600-a254-4111-82f7-6167084d81ca,16.28,ce192e2e-4f31-4bb0-9c1f-5c4173c03011,20.63,Gold,1.1.7,Postponed Admitted Procedures,Gold,88.89,98.41
19.05,ALLIANCE > BARTS HEALTH,39.76,173d07ab-5930-4d19-b3de-dcca193e62fd,39.53,ce1bcddb-a6af-4511-84c6-2a252d3eb202,38.1,Not Rated,1.1.7,Maternity Services Dataset,Not Rated,38.88,15.87
19.05,,33.95,29a714e1-5289-4362-be24-2848c954344e,51.16,ce251255-cef6-4963-9ca5-ec798ab157d2,50.79,Not Rated,1.1.7,CAFCASS Wales (CAFW),Not Rated,41.27,33.33
92.86,HUB > DISCOVER NOW,85.97,65dad445-ed81-4005-9f5a-4f8a7164043e,20.93,ce896b89-5f4a-407c-bb10-7eec51089458,26.98,Silver,1.1.7,North West London Community Data (NWL COM),Silver,84.92,96.83
95.24,ALLIANCE > SAIL,90.64,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,13.95,cea328df-abe5-48fb-8bcb-c0a5b6377446,15.87,Gold,1.1.7,Welsh Demographic Service (WDS),Gold,92.06,100.0
71.43,HUB > BREATHE,77.58,490747bf-b268-41f3-8f35-f6bc4a4bdbfa,16.28,cf64602c-7703-4f29-bd90-e0d511e2b24e,17.46,Bronze,1.1.7,4 LMIC Asian Country ChrOnic: estimating respiratory disease burden in adults,Silver,71.43,60.32
92.86,ALLIANCE > SAIL,88.29,0bf54842-c1db-4bdb-9f55-c5be490bf758,16.28,cfdb9fbd-9f67-435c-b257-6b51430451bb,20.63,Gold,1.1.7,Referral to Treatment Times,Gold,88.89,98.41
19.05,,31.62,0b630200-1e7c-4b19-ad53-bcc8863f7ade,55.81,cfea1343-daea-43cf-b73c-c4eebecee182,60.32,Not Rated,1.1.7,Labour Force Survey (Household),Not Rated,36.5,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,cd833805-f0a8-4ddb-a50d-b12695c92120,16.28,d006821e-a507-4699-b560-b5d023e09d4b,15.87,Bronze,1.1.7,Cancer Group CTR Cardiff trials,Silver,72.22,60.32
19.05,,33.95,f9cf4be7-fbc9-4601-8beb-5d3c3596bf04,51.16,d07f2709-ccc7-410b-9b73-a45918e21fed,50.79,Not Rated,1.1.7,Child Health Systems Programme - 6-8week review,Not Rated,41.27,33.33
19.05,,32.78,f857055b-c29e-4c7f-99ce-65f4ed59648e,53.49,d094b10a-b1b4-4805-9424-33547e9c46ba,55.56,Not Rated,1.1.7,National Vascular Registry Audit - Carotid Endarterectomy Clinical Dataset,Not Rated,38.88,33.33
28.57,ALLIANCE > HQIP,46.84,a464c126-8591-4af6-a10f-99c020f59527,34.88,d15b6d4a-a5de-4df4-8f29-4a8926af8024,34.92,Not Rated,1.1.7,National Audit of Psychosis - Early Intervention Psychosis Audit patient experience survey,Not Rated,44.45,23.81
92.86,ALLIANCE > SAIL,88.29,50ef6443-ed4b-40f9-97fb-1cfd53be6579,16.28,d27f265d-8931-4f76-83a2-cb47189a53f0,17.46,Gold,1.1.7,Welsh Dispensing Dataset,Gold,90.47,98.41
19.05,,32.78,877a7275-b99d-4ed4-9691-de577e0ab49e,53.49,d2981964-3ff7-47e2-91e1-ac5812227a80,55.56,Not Rated,1.1.7,NIHR IBD BioResource: Case report form,Not Rated,38.88,33.33
33.33,ALLIANCE > NHS DIGITAL,41.09,55614ed3-2484-4408-a4e9-e5fffed9e8e4,51.16,d2af6a29-291b-4444-a17c-40f4208f1e1b,53.97,Not Rated,1.1.7,Patient Reported Outcome Measures,Not Rated,46.03,46.03
95.24,ALLIANCE > SAIL,88.32,204fa806-071d-4410-9c2c-143017d32d24,18.6,d2da2750-7482-4ce9-ae5c-2ab393408a67,25.4,Gold,1.1.7,Education - Wales,Gold,87.3,100.0
19.05,,32.78,da91f0eb-1761-485b-8b7f-9121b6a1d004,53.49,d3010e1b-09ea-49e5-a5fb-3cf5a030fda6,55.56,Not Rated,1.1.7,Cancer Network Information System - CNIS / CANISC,Not Rated,38.88,33.33
19.05,,32.78,87966461-0162-4649-84e3-76adc5cd0274,53.49,d3e74665-3555-4955-823f-37295862e4b6,55.56,Not Rated,1.1.7,HES Critical Care data for QResearch,Not Rated,38.88,33.33
16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,6590f79d-cfea-4695-9fe0-dc5f85e6d273,37.21,d3fd4dac-2d15-401c-8185-905ee108d9ce,36.51,Not Rated,1.1.7,JANUS,Not Rated,38.89,14.29
19.05,,32.78,12a77014-4a77-4eb1-8b26-f49689352d1b,53.49,d42aa93a-ecc3-480b-a55b-d089dbc11413,55.56,Not Rated,1.1.7,Annual District Birth Extract (ADBE),Not Rated,38.88,33.33
19.05,,33.95,49b67625-4c9a-4101-a982-e733e7db20ca,51.16,d4683e8d-9c3f-4e5e-874c-80333a1ef719,50.79,Not Rated,1.1.7,National Neonatal Audit Programme - clinical audit,Not Rated,41.27,33.33
19.05,,32.78,e50d2b20-ef95-43fe-bbf0-83224d88e480,53.49,d524cd6b-14be-44a5-868c-f3e187d4e5d8,55.56,Not Rated,1.1.7,Follow-COVID,Not Rated,38.88,33.33
16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,5d7465f6-ced8-434b-9907-d357ad125024,37.21,d57a096a-4fa3-4529-b508-0b9df0f1893c,36.51,Not Rated,1.1.7,OUH Patient Master Index,Not Rated,38.89,14.29
47.62,OTHER > The University of Cambridge,62.18,c1fa9b47-a954-4587-a0c2-bae0f3ec2b9b,23.26,d58d02f1-47c2-44fc-b16e-4f6cbbb46e62,22.22,Not Rated,1.1.7,INTERVAL,Not Rated,60.32,42.86
4.76,,29.12,198bd2cc-ca40-4dff-992c-a9480703fc37,46.51,d5af13e0-cbcc-47f9-8d85-21867f198051,46.03,Not Rated,1.1.7,Use of digital auscultation to improve diagnosis of paediatric pneumonia,Not Rated,29.36,4.76
52.38,OTHER > UNIVERSITY OF CAMBRIDGE,61.08,9e89af6b-bfa8-43dc-a2d4-5540c899a670,30.23,d614f4fc-fae9-4775-86d9-4d4710017cf4,34.92,Not Rated,1.1.7,TRACK-COVID,Not Rated,63.49,61.9
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,a1d16f3f-c7e7-41c5-a071-07889bf49ab1,18.6,d6296f3e-ccd9-46a5-acc9-50eb5aa41c56,17.46,Bronze,1.1.7,UNIRAD UK Sample collection,Bronze,71.43,60.32
19.05,,32.78,3afbb83d-d47b-43b3-a202-0d3081e5d294,53.49,d6d1588d-b65c-479d-8f15-7fddf5ed4cc0,55.56,Not Rated,1.1.7,NACAP Pulmonary rehabilitation - clinical audit,Not Rated,38.88,33.33
19.05,,31.62,5345e2b8-13f3-41ce-9f56-87aaa9f3f55e,55.81,d7b7faa1-e8c5-4c0b-8dc0-a9af1ec659da,60.32,Not Rated,1.1.7,UK BioLAM,Not Rated,36.5,33.33
19.05,,32.78,4bcf64a6-f404-4ef4-ae6e-172512ab5f43,53.49,d7eeb562-2433-47c9-8b3f-72d55c24bb45,55.56,Not Rated,1.1.7,HES Admitted Patient Care data for CPRD GOLD,Not Rated,38.88,33.33
4.76,,29.12,a3d85fd2-9df3-4f6e-9035-0830a3488ddb,46.51,d7f1b4ab-ae3c-4318-afc9-1b561d46d442,46.03,Not Rated,1.1.7,Research on use of an online learning platform on under-five pneumonia,Not Rated,29.36,4.76
19.05,,31.62,9cff3fc9-25d6-49fe-8218-dbbc3b3bc1ab,55.81,d864c698-b98c-4a1e-9c6a-7b941d61a35c,60.32,Not Rated,1.1.7,BathTAP Headache Cohort 1,Not Rated,36.5,33.33
19.05,,32.78,1abc859e-4ac6-431a-b550-af1afb36df1b,53.49,d89732fc-1bc3-4bd6-a634-9e9d03f3fea4,55.56,Not Rated,1.1.7,HIV PiNS,Not Rated,38.88,33.33
19.05,,32.78,1fe02b65-7b77-43bf-93c8-4f0743fee672,53.49,d8fddd9b-56f2-44a5-9bf9-9efd8d727a8a,55.56,Not Rated,1.1.7,COG-UK Viral Genome Sequences,Not Rated,38.88,33.33
4.76,,29.12,f4f0ef1a-46cf-4734-8516-3adb0b62ae6d,46.51,d95be3ed-f767-4ea5-9e4d-295446f68eb5,46.03,Not Rated,1.1.7,Generation Scotland: Scottish Family Health Study,Not Rated,29.36,4.76
19.05,,32.78,3c661240-e4d2-456c-a809-133c23f9c469,53.49,d977abd8-a966-4b4c-99f0-7a4c368f9934,55.56,Not Rated,1.1.7,National Vascular Regsitry - Oragnisational Audit dataset,Not Rated,38.88,33.33
19.05,,31.62,f866b225-10b8-4df4-9c32-072411f816d8,55.81,d9fc7ff7-6de4-4757-a2e3-d49f222ea1dd,60.32,Not Rated,1.1.7,CDE Documentation,Not Rated,36.5,33.33
19.05,,33.95,572b3ccd-4213-4a41-9255-3096952a2954,51.16,da139725-1b1e-4ccd-83ab-2951d2fedca5,50.79,Not Rated,1.1.7,Deeply phenotyped clinical data for hospitalised Atrial Fibrillation patients,Not Rated,41.27,33.33
4.76,,29.12,2c31cb1c-2b3d-40c5-b8d4-bf0b81f089b4,46.51,da191840-9037-4e1f-8e6c-ec66eb80b798,46.03,Not Rated,1.1.7,Child Health Systems Programme - School,Not Rated,29.36,4.76
95.24,ALLIANCE > SAIL,90.64,cfdafacb-48f0-4ad8-9f20-193a5eec2da4,13.95,da5098df-414f-48e0-aaa7-7e2277f80eb7,15.87,Gold,1.1.7,Looked After Children Wales,Gold,92.06,100.0
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,a218d0b4-0273-4a04-ba17-c01dae6dcf33,16.28,da9cdc4c-2790-47f4-b4b5-76e87ce450ae,15.87,Bronze,1.1.7,King's Health Partners Cancer Biobank,Silver,72.22,60.32
64.29,ALLIANCE > NHS DIGITAL,60.05,a1154967-a80e-41da-a9ae-6183584ecf6b,44.19,db113fcd-69a0-4357-9c6d-250085deb3f5,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v4.1 (Sensitive) Events,Not Rated,64.28,77.78
19.05,,32.78,03e77b9d-57b8-44d5-8d64-9b1325958b22,53.49,db53c086-db48-4f7e-9264-ed44a9154753,55.56,Not Rated,1.1.7,National Vascular Registry Audit  - Lower Limb Amputation clinical dataset,Not Rated,38.88,33.33
80.95,HUB > BREATHE,85.83,9f98a674-12f6-42f4-b1a5-322b3b75eef1,9.3,db89a123-0402-4962-8a8f-78557ba4d84f,11.11,Silver,1.1.7,UK Lung Volume Reduction Surgery,Silver,80.16,71.43
21.43,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,42.11,acfbef89-344c-49a5-8079-7344f4316e0f,37.21,dba474a3-90c4-423d-beb0-5ef79c490d24,36.51,Not Rated,1.1.7,"NHS Tayside, A&E Drugs given during an A&E visit",Not Rated,40.48,17.46
4.76,,29.12,51d41006-727e-43d4-bdb6-f8b427c295c6,46.51,dbcf49c1-f23c-4bb8-8c4f-6fc4e996ff97,46.03,Not Rated,1.1.7,The Consequence of Respiratory Syncytial Virus (RSV) Infection in Young Infants,Not Rated,29.36,4.76
19.05,,33.95,d331159b-b286-4ab9-8b36-db39123ec229,51.16,dc5507d0-807e-4981-906b-731690a5e085,50.79,Not Rated,1.1.7,Outpatient Dataset (OPDW),Not Rated,41.27,33.33
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,762976cc-83d0-4b31-a879-37f87f947406,16.28,dcb4c87b-5884-41c0-b9af-d7d094dd0922,15.87,Bronze,1.1.7,NHS Greater Glasgow & Clyde Bio-Repository,Silver,73.81,63.49
19.05,,33.95,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5,51.16,dcb8a41b-f2ac-4ee1-9520-b7ef7214e9d6,50.79,Not Rated,1.1.7,NIHR BioResource: Health and Lifestyle Questionnaire,Not Rated,41.27,33.33
19.05,,32.78,6d044471-62d2-4190-b315-503f77d33ef2,53.49,dcd6f957-1fcc-481a-bbd2-89abfe933449,55.56,Not Rated,1.1.7,Prescribing,Not Rated,38.88,33.33
4.76,,29.12,a71d0b2a-620c-4c04-b7bb-45843461db9f,46.51,dd6e4344-9cee-41f3-8062-6bb9cdfda012,46.03,Not Rated,1.1.7,Decode-ME,Not Rated,29.36,4.76
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,b03835b7-7408-49a0-a9aa-ea405f9855c9,16.28,ddbc149a-db56-41de-bd2c-3624149f6e7e,15.87,Bronze,1.1.7,MesobanK,Silver,72.22,60.32
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,039b55f7-d416-49ab-9bdb-4ff7dbc733df,16.28,ddd49721-ff49-4f68-b3f5-e95a417fb0ac,15.87,Bronze,1.1.7,NIMRAD-TRANS,Silver,72.22,60.32
4.76,,29.12,43636f80-27fd-43d0-8556-d0a2de0cd819,46.51,ddf35f0d-ca89-4f74-bbdd-65d1a84b38ca,46.03,Not Rated,1.1.7,VIKING GENES,Not Rated,29.36,4.76
73.81,HUB > BREATHE,79.93,722be723-04bd-48b4-923b-e7d393f0c22b,13.95,de4b46f5-1591-442d-a896-6e0d91657c01,14.29,Bronze,1.1.7,Children's Health in London and Luton (CHILL),Silver,75.4,65.08
19.05,,32.78,2a3dba77-34ff-4781-b273-1b3d54d11f32,53.49,de8d0b95-b968-45f2-8cd4-2c87d72ff729,55.56,Not Rated,1.1.7,UK Renal Registry - COVID-19 dataset,Not Rated,38.88,33.33
95.24,HUB > DATA-CAN,85.99,3f71bef5-c5a2-400c-a482-2ad30b29a240,23.26,df23aabd-3e5f-4fc2-aad6-af990cff6f19,26.98,Gold,1.1.7,Children’s Kidney Cancers - Great Ormond Street Hospital,Silver,86.51,100.0
90.48,HUB > GUT REACTION,83.61,3c749cfc-4008-4916-b64f-969d6a754c0f,23.26,df3cc57d-08ae-4e81-ae79-283d71cf8d95,28.57,Silver,1.1.7,IBD NIHR BioResource: SNP chip data,Silver,83.34,95.24
19.05,,32.78,e4d8edb3-6e8e-435d-9732-60c83027d8f9,53.49,df55c56f-b081-45f4-b265-ed1b2c6d94cd,55.56,Not Rated,1.1.7,Welsh Health Survey Dataset (WHSD),Not Rated,38.88,33.33
61.9,ALLIANCE > HQIP,68.16,e355c9b9-44f0-4ba3-a872-645aa88f4f2b,25.58,dfba178f-ce67-4c2d-8693-b23110aeecae,23.81,Bronze,1.1.7,National Paediatric Diabetes Audit - core clinical dataset (care processes and outcomes),Bronze,66.66,57.14
19.05,,32.78,5429fc2a-3d72-414d-9393-4079c4c6c0fa,53.49,dfc16033-7620-4002-aa3b-e5bbc400bbfd,55.56,Not Rated,1.1.7,MATCH,Not Rated,38.88,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,019fad36-65ea-4d47-8d6d-a47240eeb801,16.28,dfc3205c-3079-4e95-93e2-8a3a3beeea5a,15.87,Bronze,1.1.7,Generation Scotland,Silver,72.22,60.32
19.05,,32.78,d2c486bb-b95b-4093-bb58-b196cfc08c7b,53.49,dfd65358-d5a4-40f1-873a-c8c304799cbf,55.56,Not Rated,1.1.7,NIHR BioResource: Demographic,Not Rated,38.88,33.33
28.57,ALLIANCE > HQIP,46.84,3efd9b30-1f84-48c0-a3e0-402ecb5c7724,34.88,dfedefac-c389-4d07-a8a3-eb2e4ff34587,34.92,Not Rated,1.1.7,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (organisational),Not Rated,44.45,23.81
4.76,,29.12,607b17d6-74de-466a-a377-238444707abb,46.51,e00284e3-439b-4a6d-9781-679c539404f8,46.03,Not Rated,1.1.7,COVID Tests,Not Rated,29.36,4.76
19.05,,32.78,971e2827-3aa4-4af3-bdce-3c8419897654,53.49,e05de62a-91be-46b8-8c1d-c9ed89d8c740,55.56,Not Rated,1.1.7,Laboratory turnaround times processing electronic blood test orders in the NHS,Not Rated,38.88,33.33
19.05,,32.78,14ed4ab3-470b-45c8-b48f-27fd382a912e,53.49,e096053e-b028-4487-a6d0-6958cbb5f388,55.56,Not Rated,1.1.7,UK Renal Registry - Your Health Survey dataset,Not Rated,38.88,33.33
4.76,,29.12,d602ca39-b287-4047-81c1-d635d3ceed5a,46.51,e09e1735-a54a-49cd-81f1-484040d76a5a,46.03,Not Rated,1.1.7,Beta-blocker Stratification using MRI to assess portal pressure (B-SMaRT),Not Rated,29.36,4.76
78.57,HUB > BREATHE,84.63,fb6d98c5-e41d-4804-bb28-839556e0f657,9.3,e172870f-37c4-4103-afae-8a60cae43ccb,11.11,Silver,1.1.7,SpiroMeta Consortium Dataset,Silver,79.37,69.84
19.05,,33.95,f5c9ba01-a9cb-4a85-9850-d9466b2ff4fb,51.16,e17b9566-76e9-47b4-9cf9-26704e232992,50.79,Not Rated,1.1.7,Patient postcode linked deprivation measures for CPRD GOLD,Not Rated,41.27,33.33
19.05,,32.78,fd876055-ab0f-4562-9e8a-35efa3928b02,53.49,e17fbbfa-72e8-4642-8ec5-0fa25dd56a51,55.56,Not Rated,1.1.7,Cancer registry data for QResearch,Not Rated,38.88,33.33
78.57,HUB > PIONEER,76.5,dd4629c0-14b6-4cba-8dcf-31ec5fea68bb,25.58,e22f93fb-bc08-44eb-b292-dc2baf0ad343,25.4,Silver,1.1.7,Coagulopathies & arterial/venous thrombosis in COVID patients: an OMOP dataset,Silver,80.16,85.71
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,f94168a1-cab8-4211-90e0-38a241609697,18.6,e3373d01-48c6-49bc-8c9b-827831e525b3,17.46,Bronze,1.1.7,"Leeds Dental Institute/School of Dentistry Leeds, Skeletal Tissues Bank",Bronze,71.43,60.32
19.05,,33.95,3bc43876-507b-4dff-bd2b-7df147322e15,51.16,e37a86dc-8544-46aa-8f91-923ced92e263,50.79,Not Rated,1.1.7,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes(Aurum),Not Rated,41.27,33.33
19.05,,33.95,76167567-9221-4024-bccf-dfdfb9e4bb07,51.16,e38ceae6-1ef7-4a26-90c9-9b0c920b3df7,50.79,Not Rated,1.1.7,The impact of multimorbidity on care pathways during COPD hospitalisations,Not Rated,41.27,33.33
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,c8cd0645-b728-4c62-84b8-036c1d8763be,16.28,e443bc67-bc8a-430b-88a9-d3380cd2ae38,15.87,Bronze,1.1.7,eLIXIR - Early Life Data Cross-Linkage in Research,Silver,73.81,63.49
4.76,,29.12,a406d06b-350e-4392-ab4e-b1012e422a34,46.51,e4a1be81-8f3c-4731-ae8a-7cbd594c78f5,46.03,Not Rated,1.1.7,IBD Registry,Not Rated,29.36,4.76
19.05,,33.95,aae02f9e-1bad-415d-9730-c46a07a990aa,51.16,e4a745d6-f44c-481a-b337-aae4cfe72594,50.79,Not Rated,1.1.7,Care Home Dataset (CARE),Not Rated,41.27,33.33
19.05,,30.45,8f486c3d-9504-4a0e-8e24-ab96f057fc9e,58.14,e5a0c70c-7429-487d-8dc7-04cf073191cc,65.08,Not Rated,1.1.7,NHS Scotland General Practice (GP) Contact Data - Subset,Not Rated,34.12,33.33
28.57,ALLIANCE > HQIP,46.84,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6,34.88,e6433c92-8439-4e2e-a3e7-016e7812dcfb,34.92,Not Rated,1.1.7,National Asthma and COPD Audit Programme (NACAP): COPD secondary care clinical dataset,Not Rated,44.45,23.81
4.76,,29.12,25b93812-191f-49bb-bbd0-782fb85b2bd2,46.51,e70f4e13-440b-4dec-a13c-c17d9d9da553,46.03,Not Rated,1.1.7,National Emergency Laparotomy Audit - Patient Audit Dataset,Not Rated,29.36,4.76
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,8437b207-c925-4dd1-9478-5af329cd736e,16.28,e7979d81-708d-4657-857c-4ca95d05cda2,15.87,Bronze,1.1.7,IDRIS Trial,Silver,73.81,63.49
61.9,ALLIANCE > GREAT ORMOND STREET HOSPITAL,68.16,435bfcda-f378-44f6-9387-042d959eb945,25.58,e79c5f26-deb0-4531-834d-58912c9fe663,30.16,Bronze,1.1.7,COVID-19 Staff Testing of Antibody Responses Study (Co-STARS),Bronze,69.84,69.84
19.05,,31.62,2d79feab-3046-4735-a4ec-a4c11c9c1aa8,55.81,e7b615a0-2867-47ff-bb40-0d459b41226c,60.32,Not Rated,1.1.7,BathTAP Headache Cohort 2,Not Rated,36.5,33.33
19.05,,32.78,584cbecc-43ef-4015-adf7-ff70178d7abe,53.49,e8932b23-ed21-40f4-8fb1-00ef186e6ee1,55.56,Not Rated,1.1.7,Air Pollution Exposure Estimates,Not Rated,38.88,33.33
61.9,HUB > BREATHE,70.48,e8afaf39-86fa-4085-a075-6118cc25fae0,20.93,e8c3b66d-f06b-4e3f-944d-f65235133f00,20.63,Bronze,1.1.7,Strategy introducing Pulmonary Rehabilitation for COPD management in rural India,Bronze,66.67,53.97
19.05,,33.95,9c6e891f-6449-48d2-a1c3-8dd236e34bbd,51.16,e956a7a4-896b-47dc-8d98-f48385d110f7,50.79,Not Rated,1.1.7,Brecon Dataset (BREC),Not Rated,41.27,33.33
19.05,,32.78,a1bef3a6-9700-43a5-8f3e-dad44ce1fe10,53.49,e97f2bd0-48c1-4cd8-9d18-780f21a52b45,55.56,Not Rated,1.1.7,HES Diagnostic Imaging Dataset for CPRD GOLD,Not Rated,38.88,33.33
19.05,,32.78,18bfe765-5733-41f3-8114-0a1ec2524b5b,53.49,e9820518-54e3-46d1-a63f-c5da867dcd82,55.56,Not Rated,1.1.7,IBD NIHR BioResource: Health and Lifestyle Questionnaire,Not Rated,38.88,33.33
19.05,,32.78,4b33fc6d-3cac-4404-adac-d693328456fa,53.49,e9902b10-84ca-495f-a4d9-a9948d0d64ca,55.56,Not Rated,1.1.7,National Asthma and COPD Audit Programme - Pulmonary rehab organisational audit,Not Rated,38.88,33.33
19.05,,33.95,1861b3dd-4969-490e-9faf-c57809f56bc1,51.16,e9cdc12c-6938-4c18-b45c-e0a77df6de56,50.79,Not Rated,1.1.7,Hospitalised Community Acquired Pneumonia before & during the COVID-19 pandemic,Not Rated,41.27,33.33
95.24,ALLIANCE > SAIL,89.48,fb3fac03-a428-4b3f-8058-5622e1fd57d8,16.28,ea9fa5fb-928d-4736-8fbf-e3b58a49c6d6,20.63,Gold,1.1.7,Children Receiving Care and Support Census,Gold,89.69,100.0
16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,a80b2567-4755-46f1-bd2a-f3817ce4f10c,37.21,eaca9ed1-30b6-4157-8894-8e53efc84849,36.51,Not Rated,1.1.7,Sunquest,Not Rated,38.89,14.29
19.05,,32.78,21dc2345-3983-4a46-960c-f17974bc7b71,53.49,eacd1a6e-6060-4843-ac9b-ff01e1dfe9c3,55.56,Not Rated,1.1.7,HES Outpatient data for CPRD GOLD,Not Rated,38.88,33.33
19.05,,32.78,81c53293-ef64-4507-8fcf-2a254dc19936,53.49,eaec06fa-a27e-46d1-9be9-6e1f9a16fb5d,55.56,Not Rated,1.1.7,Scottish Birth Record (SBR),Not Rated,38.88,33.33
4.76,,29.12,f12cb023-1402-49d1-aa27-e0fe4ed19fd7,46.51,eb030592-7f5d-4969-abde-c4a962251406,46.03,Not Rated,1.1.7,English Longitudinal Study of Ageing (ELSA),Not Rated,29.36,4.76
4.76,,29.12,1d6b02f1-47b8-42ad-919d-f738b545cff7,46.51,eb376dc5-1abb-4d06-a39a-e479078bcf9d,46.03,Not Rated,1.1.7,ICT-based intervention for adult asthma with limited health literacy,Not Rated,29.36,4.76
19.05,,32.78,bfb90d2b-746d-44a6-a896-4979d73d9276,53.49,eb62e466-f199-43ea-b07a-3aa468be5076,55.56,Not Rated,1.1.7,Quality of Life of Colorectal Cancer Survivors:Patient Reported Outcomes (Aurum),Not Rated,38.88,33.33
95.24,ALLIANCE > SAIL,89.48,15cf4241-abad-4dcc-95b0-8cd7c02be999,16.28,eba50bb1-e971-4062-8ece-81be39ceca5b,20.63,Gold,1.1.7,Annual District Death Extract,Gold,89.69,100.0
19.05,,32.78,464d8653-4e69-406b-93fd-d68c29d5dfdc,53.49,ebc7383b-000d-4d7b-a8db-7f7ce6b1a183,55.56,Not Rated,1.1.7,Health & Attainment of Pupils in a Primary Education Network (HAPN),Not Rated,38.88,33.33
19.05,,32.78,5616e0a6-22f1-43a5-a2bd-dcecfa2f3b70,53.49,ec121652-b3ab-4f90-8b93-ab5f6b1bc64c,55.56,Not Rated,1.1.7,Community Services Data Set,Not Rated,38.88,33.33
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,10d0def8-dc03-473f-b60b-4c0dc3642a25,16.28,ece82228-9af1-4699-a763-b4608908b645,15.87,Bronze,1.1.7,NHS Grampian Biorepository,Silver,73.81,63.49
4.76,,29.12,8ca5cc9c-bb4e-4fa4-b430-165720cd9634,46.51,ed8683b0-1745-47fe-b644-710e6b8dca33,46.03,Not Rated,1.1.7,The Fenland Study,Not Rated,29.36,4.76
28.57,ALLIANCE > HQIP,46.84,025c9e8a-938b-4886-9e03-fcad90fe7157,34.88,ee099373-8a72-4ec7-818f-3cbb9c8a793d,34.92,Not Rated,1.1.7,Falls and Fragility Fracture Audit Programme National Hip Database Facilities Survey 2019,Not Rated,44.45,23.81
69.05,ALLIANCE > TISSUE DIRECTORY,75.22,33b1a989-5f61-412e-bdae-b551c92d1ed6,18.6,ee4a73ef-fb4e-4926-9fcc-db6b44b1447e,19.05,Bronze,1.1.7,The PEACE Study,Bronze,70.64,60.32
19.05,,32.78,80564a6b-1458-41de-a131-772eb93c0509,53.49,eec9fec3-2257-4dd2-a3a9-8c164322fbaa,55.56,Not Rated,1.1.7,Hospital Episode Statistics Critical Care,Not Rated,38.88,33.33
19.05,,32.78,bcfd3b49-f7f0-489e-bc1b-bcce0bd261f2,53.49,eee15509-f23a-441e-b5be-ee76bd2ba649,55.56,Not Rated,1.1.7,Scottish Covid-19 Vaccination Data,Not Rated,38.88,33.33
4.76,,29.12,932cecdf-65fb-4e3d-9454-7a2d0585e970,46.51,ef478925-7612-4cd6-a10e-5e64ee8a0f4d,46.03,Not Rated,1.1.7,Understanding Society,Not Rated,29.36,4.76
19.05,,32.78,8a438697-7cdd-4716-8824-8685fa8eb314,53.49,ef4c90fc-03b6-4b21-a45f-bcd7cabb0857,55.56,Not Rated,1.1.7,SGSS data for QResearch,Not Rated,38.88,33.33
19.05,ALLIANCE > BARTS HEALTH,39.76,0f07f939-1265-4e8b-aaa6-d897d254c2f3,39.53,ef727724-6c38-483b-b28d-8e94b5a9d7ac,38.1,Not Rated,1.1.7,Freetext Dataset,Not Rated,38.88,15.87
19.05,,32.78,b734a1b5-37d3-4859-85d4-bf011df2a951,53.49,efc0be66-e680-4166-ba58-d507f4c02d88,55.56,Not Rated,1.1.7,Mother-Baby Link for CPRD GOLD,Not Rated,38.88,33.33
19.05,,31.62,e253257c-48c2-491b-b3b9-205161a16a7e,55.81,f0109da2-6452-45a9-928e-5376dcb78609,60.32,Not Rated,1.1.7,Coronavirus and the Social Impacts on Great Britain,Not Rated,36.5,33.33
19.05,,33.95,731dc868-3e79-4722-9b79-6bb8dec9435b,51.16,f08bfb75-f2b8-4afb-9c3d-59cdd2b6b3ce,50.79,Not Rated,1.1.7,GP Out of Hours,Not Rated,41.27,33.33
83.33,ALLIANCE > SAIL,78.88,e4d8edb3-6e8e-435d-9732-60c83027d8f9,25.58,f0fc13b4-f801-4647-82f3-07ed07f26ea0,28.57,Silver,1.1.7,Welsh Health Survey Dataset,Silver,80.96,90.48
19.05,,32.78,71d37610-ac55-432d-82a3-bdb04407acd8,53.49,f13d5f5a-08b3-49be-8d5e-48772a612cb0,55.56,Not Rated,1.1.7,Welsh Results Reports Service (WRRS),Not Rated,38.88,33.33
19.05,,32.78,bc6a661a-4447-40ad-bc92-3007e89688c9,53.49,f14341fe-2f15-48a7-bcd6-3c4d298375d1,55.56,Not Rated,1.1.7,Assessing acuity scores – NEWS2 in acute illnesses with component markers,Not Rated,38.88,33.33
19.05,,33.95,e77af7a3-32fa-4a08-8455-4fb489e5b64a,51.16,f16f0b1b-650d-486b-bc89-946b1623103e,50.79,Not Rated,1.1.7,Child Health Systems Programme - 13-15 Month Review,Not Rated,41.27,33.33
19.05,,31.62,65b04cbe-1b5c-44d7-b640-ce63fb106401,55.81,f19b7888-344d-47af-878a-82a270a30d22,60.32,Not Rated,1.1.7,NIMS - National immunisation data for QResearch,Not Rated,36.5,33.33
80.95,HUB > DISCOVER NOW,77.69,0d5a40e6-52c0-43c4-bd9f-f2a803cc8ff6,25.58,f2268d4e-0149-4913-9832-0399960eecd4,31.75,Silver,1.1.7,North West London Acute Patient level Data (NWL Acute PLD),Silver,77.78,87.3
19.05,ALLIANCE > BARTS HEALTH,39.76,51b41359-1558-48df-9950-88f75ca6ac4c,39.53,f2b4211b-1af7-46ff-82a3-35b29d1d478e,38.1,Not Rated,1.1.7,"Problems, Diagnosis and Procedures",Not Rated,38.88,15.87
19.05,,32.78,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c,53.49,f2c2ea2f-f5e8-4297-8510-c2d430ff0946,55.56,Not Rated,1.1.7,Emergency Department Dataset (EDDS),Not Rated,38.88,33.33
19.05,,33.95,7af96f17-5ab6-4275-b8ef-61a3e053d342,51.16,f3957e36-25eb-4e0a-a69a-a1c0ce85cb4f,50.79,Not Rated,1.1.7,Identification of Medical Admissions suitable for Same Day Emergency Care (SDEC),Not Rated,41.27,33.33
19.05,,33.95,5713fd1a-4358-4485-bed5-83fb25ec2fce,51.16,f3f24eff-a21b-45e4-92a2-71c162426f53,50.79,Not Rated,1.1.7,Capture-24: Activity tracker dataset for human activity recognition,Not Rated,41.27,33.33
19.05,,32.78,9fc11eb5-3e64-491d-9b50-43a84bd76fee,53.49,f55f5b6d-bc40-4fd9-924c-79a2fed5c270,55.56,Not Rated,1.1.7,HES Emergency Care (Accident & Emergency) data for QResearch,Not Rated,38.88,33.33
19.05,,32.78,0d9db5af-972a-4597-ae5b-f9c2fdeddeff,53.49,f563f791-c2e4-426b-97be-a91ea82c4e40,55.56,Not Rated,1.1.7,ONS Death Registration data for QResearch,Not Rated,38.88,33.33
19.05,,32.78,4385ed4c-1c42-4ba5-b57f-9ab18e5ffbe1,53.49,f58a3c47-44aa-4815-aeab-e19a4a330926,55.56,Not Rated,1.1.7,UHB Linked Diabetic Eye Disease and Cardiac Outcomes,Not Rated,38.88,33.33
19.05,,32.78,2c737d63-69f4-4a02-8df9-54c1e65e845f,53.49,f635894a-61b8-40ad-bfa2-4c31ef23ad34,55.56,Not Rated,1.1.7,Epilepsy 12 - National organisational audit and Trust profile,Not Rated,38.88,33.33
4.76,,29.12,3558f8a1-6d52-4b59-b513-51c068095bc2,46.51,f636abcd-91b1-4408-b44b-5f6274bc98d6,46.03,Not Rated,1.1.7,National Cardiac Audit Programme - Myocardial Ischaemia National Audit (MINAP),Not Rated,29.36,4.76
95.24,ALLIANCE > SAIL,89.48,291c0dd4-0988-42d2-8e0b-878a892add57,16.28,f6aa8836-b437-40b6-bd1e-ae20010048dd,20.63,Gold,1.1.7,Substance Misuse Dataset,Gold,89.69,100.0
92.86,HUB > DISCOVER NOW,85.97,602d8093-6a1e-42cf-a89c-8bf0d47ecc8c,20.93,f6e25ba4-4f7a-436e-a5f9-f0257d45a612,23.81,Gold,1.1.7,North West London Integrated Care Record (NWL ICR),Silver,86.51,96.83
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,07d1b768-78f6-41e8-995a-66afd2549b34,16.28,f71e0f89-edf6-4070-9045-6024b00f79ca,15.87,Bronze,1.1.7,PHOTO Translational bladder cancer biorepository,Silver,73.81,63.49
19.05,,31.62,fcf5a844-f48d-428e-aa06-abe64e66185e,55.81,f76d0428-f93c-41ba-9ebb-08e4211bf17a,60.32,Not Rated,1.1.7,Suspected Cancer Pathway Monthly (SCPM),Not Rated,36.5,33.33
76.19,ALLIANCE > NHS DIGITAL,75.31,f201b68f-d995-4a70-a9ee-aa3510232777,25.58,f80940e8-0ee1-46be-876b-46fb4bbbc4d2,25.4,Silver,1.1.7,Medicines dispensed in Primary Care (NHSBSA data),Bronze,78.57,82.54
19.05,,32.78,2b6409db-a669-4bef-9fd5-39c2b6f8d5e9,53.49,f82b398a-7e53-4851-ab7b-07508f810ebc,55.56,Not Rated,1.1.7,Hospital Episode Statistics Admitted Patient Care,Not Rated,38.88,33.33
76.19,HUB > PIONEER,75.31,1a66dbc1-4f06-455c-85fc-68b372575cad,25.58,f8a268c1-831c-4c80-b62c-e254a572b9a0,25.4,Silver,1.1.7,Ventilation strategies for patients on intensive care,Bronze,79.36,84.13
19.05,,32.78,fe1684ef-69ee-4490-9ab8-b26e990c9060,53.49,f98965a8-1ff3-4981-8462-fbc8005775b6,55.56,Not Rated,1.1.7,Growing up in Bradford (BiB),Not Rated,38.88,33.33
19.05,,33.95,c7f7541b-5030-40b9-962a-4aba44af7e1a,51.16,f98d83ec-ad27-46d7-9786-7a0f2749aa11,50.79,Not Rated,1.1.7,2019 UK Parkinson's Audit - Speech and language therapy,Not Rated,41.27,33.33
19.05,,33.95,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef,51.16,f98f9578-a4a3-4d93-b32e-f30ff75888b7,50.79,Not Rated,1.1.7,Bowel Screening Wales (SBSW),Not Rated,41.27,33.33
40.48,ALLIANCE > IMPERIAL COLLEGE LONDON,58.61,70656016-c1c9-4bc2-93d1-c66341fcdf36,23.26,f9959c00-c063-4fbf-933d-755e3b6ecedc,22.22,Not Rated,1.1.7,Real-time Assessment of Community Transmission (REACT) Study 2: COVID antibody,Not Rated,57.14,36.51
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,20639743-9a28-43dd-a8af-7571ece2a7f8,16.28,f99d82da-13eb-42db-ad0d-348be2173535,15.87,Bronze,1.1.7,Tommy's National Reproductive Health Biobank,Silver,73.81,63.49
71.43,ALLIANCE > TISSUE DIRECTORY,76.42,df94730b-374b-4d91-8116-1c10a7c77c4e,18.6,f9c40294-92d8-45cd-b11a-70eb0fc09004,17.46,Bronze,1.1.7,PHOENIX DDR-Anti-PD-L1 Trial,Silver,73.02,63.49
19.05,,32.78,d357be1e-27fe-4b2f-9174-3a2a03ecc12b,53.49,fa07a8df-4584-4dc1-87f9-f03ff8d31861,55.56,Not Rated,1.1.7,National Vascular Registry Audit - Lower Limb Bypass clinical dataset,Not Rated,38.88,33.33
30.95,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,48.04,f397acff-a7af-4062-8e8b-c85889cc41df,34.88,fa179e24-2068-4c34-b73c-230003010e9f,34.92,Not Rated,1.1.7,Genvasc Primary Care Data,Not Rated,45.24,25.4
19.05,,33.95,ad36dc03-1856-44de-99b0-1af6f312d86b,51.16,fa45c071-1852-4c02-bddc-fda4517bffa8,50.79,Not Rated,1.1.7,Scottish Cancer Registry (SMR06),Not Rated,41.27,33.33
95.24,ALLIANCE > SAIL,90.64,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b,13.95,fb4a069b-fd74-47b2-bbb1-9cde6b590d66,15.87,Gold,1.1.7,Breast Test Wales,Gold,92.06,100.0
80.95,HUB > BREATHE,85.83,b850e56c-5c5b-413e-b829-743772053978,9.3,fb50af29-4aa6-4071-9300-bd2d57c850b0,11.11,Silver,1.1.7,Idiopathic Pulmonary Fibrosis (IPF) Genome-wide Association Study,Silver,80.16,71.43
19.05,,32.78,39055449-c074-4b58-adb2-b1c0d2441c4d,53.49,fb65ff7c-fc02-402e-ab55-59765d7b0d43,55.56,Not Rated,1.1.7,NHS Tayside and Fife Immunology,Not Rated,38.88,33.33
4.76,,29.12,48adf432-9b66-4d03-a25e-008fbbb24f56,46.51,fba3b66d-8d3a-473f-bb3d-537a6ab1fa7a,46.03,Not Rated,1.1.7,Asymptomatic COVID-19 in Education (ACE) Cohort,Not Rated,29.36,4.76
28.57,ALLIANCE > HQIP,46.84,33b36393-3760-40d8-bb98-61806fea5398,34.88,fbb5d74c-802a-4888-9452-3e0faf257f82,34.92,Not Rated,1.1.7,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (clinical),Not Rated,44.45,23.81
28.57,ALLIANCE > HQIP,48.0,f857055b-c29e-4c7f-99ce-65f4ed59648e,32.56,fc08ad6a-3e94-44db-a122-945c4c875616,33.33,Not Rated,1.1.7,National Vascular Registry Audit Carotid Endarterectomy Clinical Dataset,Not Rated,45.24,23.81
19.05,,32.78,014e7973-b43e-4a4a-91b4-de3f353b71b9,53.49,fc4b3dea-b56b-4beb-87f0-921fb9d8836a,55.56,Not Rated,1.1.7,Systemic Anti-Cancer Treatment (SACT) data for CPRD GOLD,Not Rated,38.88,33.33
92.86,HUB > DISCOVER NOW,87.13,75638d2c-556a-46b6-afcc-7ab425b34679,18.6,fc704af0-368b-4dd0-866f-753b6d1dccf8,25.4,Silver,1.1.7,North West London High Cost Drugs Data (NWL HCD),Gold,85.72,96.83
16.67,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.73,c4538af4-505f-45df-aeae-788ddfd7cb54,37.21,fc7b44f0-eb69-4257-8c07-7516c1210c46,36.51,Not Rated,1.1.7,CellPath,Not Rated,38.89,14.29
4.76,,29.12,c8a28f0b-a5f8-4dbb-8d71-5b89c7cb3111,46.51,fc7ea07b-d60f-4be9-a840-89b17d4c2414,46.03,Not Rated,1.1.7,National Bowel Cancer Audit - clinical dataset,Not Rated,29.36,4.76
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,47b544f4-301c-43e0-b347-fc623ea1a8b3,16.28,fd2317ea-c729-433b-b578-309118118b78,15.87,Bronze,1.1.7,Infectious Diseases BioBank at King's College London,Silver,72.22,60.32
80.95,ALLIANCE > NHS DIGITAL,76.52,11d3cf0f-ae5d-42f4-a756-b98c3eff46bc,27.91,fd296ed6-6e12-49ab-9e5f-f40428a47b02,28.57,Silver,1.1.7,MSDS (Maternity Services Data Set),Silver,79.37,87.3
45.24,HUB > BREATHE,59.83,0911f991-6c0f-4412-b805-1ee0ded93a12,25.58,fdb053d7-375a-4422-aa16-c899661d72b1,26.98,Not Rated,1.1.7,"Projections of global, regional and national prevalence of asthma from 2018-2040",Not Rated,54.77,36.51
19.05,,32.78,7325c42d-6974-4f1b-acd6-5a3c9d22f4a1,53.49,fdb46c60-780a-47fa-bc7e-e367c2f64900,55.56,Not Rated,1.1.7,CPRD GOLD SGSS,Not Rated,38.88,33.33
19.05,,32.78,6664317b-39b9-4133-b6c7-ec4bddf78c76,53.49,fe168c6f-7533-413e-94fd-066fd845d7c0,55.56,Not Rated,1.1.7,National Joint Registry - Revision Knee Replacement dataset,Not Rated,38.88,33.33
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,9d56ae46-5955-4f03-a93c-a4a6d9f641ab,16.28,fe3f2246-aec4-4be4-8f51-3e5bde80931d,15.87,Bronze,1.1.7,Bristol Biobank,Silver,72.22,60.32
19.05,,33.95,ed131fee-0635-4613-a453-a383d5dd7cec,51.16,fe8852b2-9d0b-4145-8f5c-531378731d39,50.79,Not Rated,1.1.7,Healthcare Workers Risk Assessment (HWRA),Not Rated,41.27,33.33
19.05,,33.95,6009f720-3cd5-449d-b36b-e2ccf3fbc73a,51.16,feb9a877-2e22-4a5b-a260-5c5186224028,50.79,Not Rated,1.1.7,Emergency hospital admissions in patients from care home settings,Not Rated,41.27,33.33
28.57,ALLIANCE > HQIP,46.84,e06b951b-e9d8-4a2c-a51f-1d819f669205,34.88,fed22efe-8a84-4b1e-a642-2412a1420ce8,34.92,Not Rated,1.1.7,Falls and Fragility Fracture Audit Programme National Hip Database clinical dataset,Not Rated,44.45,23.81
69.05,ALLIANCE > TISSUE DIRECTORY,76.38,b5217dcb-582f-4914-ae45-9eb3899add30,16.28,fede80e2-aea9-4229-8024-39b09110be7b,15.87,Bronze,1.1.7,REQUITE,Silver,72.22,60.32
19.05,,31.62,69a356d6-599e-4d02-8241-066ce3c297bd,55.81,fee7f039-99d6-4eab-951d-b35e0ae71a75,60.32,Not Rated,1.1.7,UK SARS-CoV-2 viral sequencing data (COG-UK data)-Lineage/Variant Data-Scotland,Not Rated,36.5,33.33
19.05,,33.95,a1c4dda9-d34b-443f-aaaf-231f2e0c31fa,51.16,ff0750c4-2765-4bf6-a294-33215f1ced77,50.79,Not Rated,1.1.7,The impact of COVID on hospitalised patients with COPD and hospital services,Not Rated,41.27,33.33
4.76,,29.12,6265a41f-9444-457b-b401-1d0978f5c58a,46.51,ff0ee5d5-aeb4-4dc0-bddf-79336e0ab004,46.03,Not Rated,1.1.7,Enhancing access to pulmonary rehabilitation through implementation research,Not Rated,29.36,4.76
19.05,,33.95,59fb436a-f8c3-4d4a-bc76-d4a02904b078,51.16,ff10d5c4-42a2-4a06-b6af-a2f7393c62e0,50.79,Not Rated,1.1.7,Mortality (Death registration),Not Rated,41.27,33.33
64.29,ALLIANCE > NHS DIGITAL,60.05,b9f24f81-bcf2-4e47-8909-0d5414e2d7a4,44.19,ff2c6982-00f3-4483-9fc2-19b3a7211d8d,49.21,Not Rated,1.1.7,Mental Health Minimum Dataset v4 (Non-Sensitive) Records,Not Rated,64.28,77.78
4.76,,29.12,cd3555b0-514a-4693-8f68-c8267a8e9939,46.51,ff727b8e-4805-424a-ba34-acc9b90225fe,46.03,Not Rated,1.1.7,Oxford Carpal Tunnel Syndrome (CTS) Cohort,Not Rated,29.36,4.76
71.43,ALLIANCE > TISSUE DIRECTORY,77.58,edafebac-9479-4d2c-b44e-349091d5b35b,16.28,ff8231e5-3ede-4844-a21b-b1d05120e07e,15.87,Bronze,1.1.7,IMPORT HIGH trial blood samples,Silver,73.81,63.49
